0000077476-26-000007 | 10-K | XBRL Viewer

Print Document

Share-Based Compensation Share-Based Compensation (Schedule of Weighted-Average Black-Scholes Fair Value Assumptions) (Details)	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Expected life	7 years	7 years	7 years
Risk-free interest rate	4.10%	4.20%	4.20%
Expected volatility	16.00%	16.00%	16.00%
Expected dividend yield	3.50%	2.90%	2.70%

Intangible Assets - Impairment of Intangible Assets (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Indefinite-lived Intangible Assets [Line Items]
Goodwill, Impairment Loss	$ 0	$ 0
Impairment charges related to brands - Pre-tax			$ 600
Impairment charges related to brands - After-tax			$ 500
Impairment charges related to brands - Per-share amount			$ 0.35
Impairment charges related to goodwill - Pre-tax			$ 300
Impairment charges related to goodwill - After tax			$ 300
Impairment charges related to goodwill - Per share amount			$ 0.22
Impairment of intangible assets
Indefinite-lived Intangible Assets [Line Items]
Asset Impairment Charges, after-tax	$ 1,500
Impairment Effect on Earnings Per Share, after Tax	$ 1.11
Asset Impairment Charges	$ 1,900

Acquisitions & Divestitures - poppi (Details) - poppi acquisition - USD ($) $ in Millions	May 19, 2025	Dec. 27, 2025
Acquisitions & Divestitures [Line Items]
Business Combination, Contingency Recognized at Acquisition Date, Liability Assumed, Fair Value	$ 180
Business Combination, Consideration Transferred	$ 1,950
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Indefinite-Lived		$ 2,000

Income Taxes (Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Income Tax Contingency [Line Items]
Income before income taxes in Foreign	$ 9,438	$ 9,356	$ 7,297
Income before income taxes	10,244	11,946	11,417
Income before income taxes in U.S	806	2,590	4,120
Income Tax Expense (Benefit), Continuing Operations [Abstract]
Current: U.S. Federal	299	1,033	1,133
Current: Foreign	1,583	1,406	1,201
Current: State	42	255	309
Provision for income taxes, Current total	1,924	2,694	2,643
Deferred: U.S. Federal	116	(306)	(109)
Deferred: Foreign	(116)	(10)	(212)
Deferred: State	25	(58)	(60)
Provision for income taxes, Deferred total	25	(374)	(381)
Provision for income taxes	1,949	2,320	2,262
Deferred tax liabilities
Debt guarantee of wholly-owned subsidiary	578	578
Property, plant and equipment	2,047	1,868
Deferred tax liability, recapture of NOL	488	488
Deferred Tax Liabilities, Deferred Expense	238	112
Deferred Tax - Lease liability	819	772
Other	486	301
Gross deferred tax liabilities	4,656	4,119
Deferred tax assets
Net carryforwards	6,849	6,737
Deferred Tax Assets, Goodwill and Intangible Assets	1,996	1,599
Share-based compensation	141	148
Retiree medical benefits	96	104
Other employee-related benefits	372	415
Deductible state tax and interest benefits	181	202
Deferred Tax - Right of Use Asset	819	773
Deferred Tax Asset - capitalized research and development	134	256
Other	927	948
Gross deferred tax assets	11,515	11,182
Valuation allowances	(6,120)	(6,185)	(6,478)
Deferred Tax Assets, Net of Valuation Allowance, Total	5,395	4,997
Deferred Tax Assets, Net	(739)	(878)
Valuation Allowance [Abstract]
Balance, beginning of year	6,185	6,478	5,013
(Benefit)/provision	(284)	(198)	1,419
Other additions/(deductions)	219	(95)	46
Balance, end of year	6,120	6,185	6,478
Additions for tax positions from prior years	124	108
Reductions for tax positions from prior years	(76)	(46)
Settlement payments	(114)	(24)
Statutes of limitations expiration	(18)	(31)
Translation and other	23	(26)
Balance, end of year	2,376	2,284	$ 2,093
Balance, beginning of year	2,284	2,093
Additions for tax positions related to the current year	$ 153	$ 210

Supplemental Financial Information (Schedule of Supplemental Balance Sheet Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Accounts and notes receivable
Trade receivables	$ 9,265	$ 8,487
Other receivables	2,471	2,202
Total receivables	11,736	10,689
Analysis of valuation allowances
Allowance, beginning of year	356	175	$ 150
Net amounts charged to expense	61	228	55
Deductions	(55)	(36)	(26)
Other	(132)	(11)	(4)
Allowance, end of year	230	356	175
Net receivables	11,506	10,333
Inventories (c)
Raw materials	2,581	2,440
Work-in-process	143	104
Finished goods	3,121	2,762
Inventories	5,845	5,306
Property, plant and equipment, net [Abstract]
Property, plant and equipment, gross	60,909	56,005
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	31,004	27,997
Property, Plant and Equipment, net	29,905	28,008
Depreciation	3,213	2,945	2,714
Other assets
Other Assets	8,984	6,951
Noncurrent notes and accounts receivable	136	111
Deferred marketplace spending	205	100
Prepaid Expense and Other Assets, Noncurrent	1,449	1,190
Operating Lease, Right-of-Use Asset	3,745	3,383
Other Assets, Miscellaneous	923	821
Accounts payable and other current liabilities
Accounts payable	11,704	10,997
Accrued marketplace spending	3,512	3,458
Accrued compensation and benefits	2,230	2,256
Dividends payable	1,967	1,885
Operating Lease, Liability, Current	719	642
Other current liabilities	5,771	5,216
Accounts payable and other current liabilities	25,903	24,454
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	60,909	56,005
Supplier Finance Program, Obligation, Current	1,681	1,478	$ 1,655
Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)	82	(93)
Supplier Finance Program, Obligation, Settlement	6,547	6,636
Supplier Finance Program, Obligation, Addition	6,668	6,552
Land [Member]
Property, plant and equipment, net [Abstract]
Property, plant and equipment, gross	1,110	1,136
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	1,110	1,136
Buildings And Improvements
Property, plant and equipment, net [Abstract]
Property, plant and equipment, gross	13,875	11,938
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 13,875	11,938
Buildings And Improvements \| Maximum
Property, Plant and Equipment [Line Items]
Average Useful Life (Years)	44 years
Buildings And Improvements \| Minimum
Property, Plant and Equipment [Line Items]
Average Useful Life (Years)	15 years
Construction In Progress
Property, plant and equipment, net [Abstract]
Property, plant and equipment, gross	$ 4,811	5,941
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	4,811	5,941
Machinery And Equipment, Including Fleet And Software
Property, plant and equipment, net [Abstract]
Property, plant and equipment, gross	41,113	36,990
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 41,113	$ 36,990
Machinery And Equipment, Including Fleet And Software \| Maximum
Property, Plant and Equipment [Line Items]
Average Useful Life (Years)	15 years
Machinery And Equipment, Including Fleet And Software \| Minimum
Property, Plant and Equipment [Line Items]
Average Useful Life (Years)	5 years

Restructuring and Impairment Charges (Tables)

12 Months Ended

Dec. 27, 2025

2019 Productivity Plan [Member]

Total Restructuring Cost and Reserve [Line Items]

Restructuring and Related Costs [Table Text Block]

The total plan pre-tax charges are expected to be incurred by segment approximately as follows:


	PFNA		PBNA		IB Franchise		EMEA		LatAm Foods		Asia Pacific Foods		Corporate
Expected pre-tax charges	20	%	25	%	2	%	25	%	10	%	3	%	15	%

A summary of our 2019 Productivity Plan charges is as follows:


	2025		2024		2023
Cost of sales	$	236	$	133	$	13
Selling, general and administrative expenses	728		551		433
Impairment of intangible assets	—		14		—
Other pension and retiree medical benefits expense/(income) (a)	19		29		(1)
Total restructuring and impairment charges	$	983	$	727	$	445
After-tax amount	$	792	$	563	$	349
Impact on net income attributable to PepsiCo per common share	$	(0.58)	$	(0.41)	$	(0.25)


	2025		2024		2023		Plan to Date through 12/27/2025
PFNA	$	344	$	161	$	42	$	776
PBNA	281		238		41		786
IB Franchise	14		24		11		65
EMEA	195		116		227		956
LatAm Foods	52		49		29		299
Asia Pacific Foods	12		9		8		99
Corporate	66		101		88		484
	964		698		446		3,465
Other pension and retiree medical benefits expense/(income) (a)	19		29		(1)		145
Total	$	983	$	727	$	445	$	3,610

(a)Income amount represents adjustments for changes in estimates of previously recorded amounts.


	Plan to Date through 12/27/2025
Severance and other employee costs	$	1,789
Asset impairments	546
Other costs	1,275
Total	$	3,610

A summary of our 2019 Productivity Plan is as follows:


	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total


Liability as of December 31, 2022	$	188	$	—	$	8	$	196
2023 restructuring charges	243		2		200		445
Cash payments (a)	(242)		—		(192)		(434)
Non-cash charges and translation	(1)		(2)		(7)		(10)
Liability as of December 30, 2023	188		—		9		197
2024 restructuring charges	384		114		229		727
Cash payments (a)	(204)		—		(232)		(436)
Non-cash charges and translation	(30)		(114)		20		(124)
Liability as of December 28, 2024	338		—		26		364
2025 restructuring charges	355		240		388		983
Cash payments (a)	(384)		—		(412)		(796)
Non-cash charges and translation	(1)		(240)		16		(225)
Liability as of December 27, 2025	$	308	$	—	$	18	$	326

(a)Excludes cash expenditures of $12 million in 2025, $7 million in 2024 and $1 million in 2023, reported in the cash flow statement in pension and retiree medical plan contributions.

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Net Income Attributable to PepsiCo per Common Share (Basic and Diluted Net Income Attributable to PepsiCo per Common Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Earnings Per Share [Abstract]
Net income available for PepsiCo common shareholders - Value	$ 8,240	$ 9,578	$ 9,074
Net income available for PepsiCo common stockholders - Shares	1,369	1,373	1,376
Basic net income attributable to PepsiCo per common share	$ 6.02	$ 6.97	$ 6.59
Stock options and RSUs - Shares	4	5	7
Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units	$ 0	$ 0	$ 0
Diluted shares - Value	$ 8,240	$ 9,578	$ 9,074
Diluted shares - Shares	1,373	1,378	1,383
Diluted net income attributable to PepsiCo per common share	$ 6.00	$ 6.95	$ 6.56
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	8	4	3

Intangible Assets (Schedule of Goodwill) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Indefinite-lived Intangible Assets [Line Items]
Goodwill	$ 18,916	$ 17,534	$ 17,728
Goodwill, Acquired During Period	804	162
PepsiCo Foods North America [Member]
Indefinite-lived Intangible Assets [Line Items]
Goodwill	1,422	791	642
Goodwill, Acquired During Period	625	159
PepsiCo Beverages North America [Member]
Indefinite-lived Intangible Assets [Line Items]
Goodwill	12,125	11,925	11,961
Goodwill, Acquired During Period	179	0
International Beverage Franchise [Member]
Indefinite-lived Intangible Assets [Line Items]
Goodwill	1,921	1,918	1,986
Goodwill, Acquired During Period	0	0
Asia Pacific Foods (Segment) [Member]
Indefinite-lived Intangible Assets [Line Items]
Goodwill	375	352	364
Goodwill, Acquired During Period	0	3
Europe, Middle East & Africa (Segment) [Member]
Indefinite-lived Intangible Assets [Line Items]
Goodwill	2,688	2,194	2,382
Goodwill, Acquired During Period	0	0
Latin America Foods (Segment) [Member]
Indefinite-lived Intangible Assets [Line Items]
Goodwill	385	354	$ 393
Goodwill, Acquired During Period	0	0
Goodwill [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	578	(356)
Goodwill [Member] \| PepsiCo Foods North America [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	6	(10)
Goodwill [Member] \| PepsiCo Beverages North America [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	21	(36)
Goodwill [Member] \| International Beverage Franchise [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	3	(68)
Goodwill [Member] \| Asia Pacific Foods (Segment) [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	23	(15)
Goodwill [Member] \| Europe, Middle East & Africa (Segment) [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	494	(188)
Goodwill [Member] \| Latin America Foods (Segment) [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments	$ 31	$ (39)

Intangible Assets

12 Months Ended

Dec. 27, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets Disclosure [Text Block]

Intangible Assets

A summary of our amortizable intangible assets is as follows:


		2025						2024						2023
	Average Useful Life (Years)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Acquired franchise rights	56 – 60	$	835	$	(244)	$	591	$	821	$	(223)	$	598
Customer relationships (a)	15 – 24	773		(347)		426		565		(279)		286
Brands	20 – 40	1,084		(1,021)		63		1,051		(977)		74
Other identifiable intangibles	10 – 24	433		(294)		139		420		(276)		144
Total		$	3,125	$	(1,906)	$	1,219	$	2,857	$	(1,755)	$	1,102
Amortization expense						$	83					$	74	$	75

(a)Increase is primarily related to acquisitions of poppi and Siete. See Note 13 for further information on acquisitions.

Amortization is recognized on a straight-line basis over an intangible asset’s estimated useful life. Amortization of intangible assets for each of the next five years, based on existing intangible assets as of December 27, 2025 and using average 2025 foreign exchange rates, is expected to be as follows:


	2026		2027		2028		2029		2030
Five-year projected amortization	$	78	$	74	$	73	$	72	$	63

Depreciable and amortizable assets are evaluated for impairment upon a significant change in the operating or macroeconomic environment. In these circumstances, if an evaluation of the undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on discounted future cash flows. Useful lives are periodically evaluated to determine whether events or circumstances have occurred which indicate the need for revision.

Indefinite-Lived Intangible Assets

In 2025, business performance in conjunction with lower expectations of future business performance compared to projections, as well as the transaction discussed below, indicated a deterioration of the significant inputs used to determine the fair value of our indefinite-lived intangible assets in certain markets and required us to perform quantitative assessments on certain assets. The fair value of our indefinite-lived intangible assets was estimated using discounted cash flows under the income approach, which we consider to be a Level 3 (significant unobservable inputs) measurement. We determined that the carrying value exceeded the fair value, which reflected our most current estimates of future sales and their contributions to operating profit and expected future cash flows (including perpetuity growth assumptions), as well as an increase in the weighted-average cost of capital. As a result of the quantitative assessments, we recorded pre-tax impairment charges of $1.9 billion ($1.5 billion after-tax or $1.11 per share) in impairment of intangible assets primarily comprised of the Rockstar brand in our PBNA, EMEA, and IB Franchise segments.

On August 28, 2025, we consummated a transaction with Celsius, pursuant to which we acquired convertible preferred shares and transferred cash and certain non-cash assets, primarily the Rockstar brand of $0.5 billion in the United States and Canada (Celsius Transaction). For further information on the convertible preferred shares, see Note 9. On the same date, we entered into an agreement with Celsius to be the exclusive distributor for the Alani Nu brand in certain channels in the United States and Canada that commenced in the fourth quarter of 2025.

As discussed in Note 2, we perform our annual impairment assessment on indefinite-lived intangible assets during our third quarter. The annual impairment assessment on indefinite-lived intangible assets performed in the third quarter of 2025, based on best available market information and our internal forecasts and operating plans at the time, did not result in any further material impairment charges.

As of December 27, 2025, the estimated fair value of the SodaStream reporting unit narrowly exceeded its carrying value. Given the low coverage, there could be further impairment to the carrying value of the SodaStream reporting unit goodwill if future sales and operating profit results are not in line with the forecasted future cash flows of the business and/or if macroeconomic conditions worsen and drive an increase in the weighted-average cost of capital used to estimate its fair value. We continue to monitor the performance of the SodaStream reporting unit, as well as all of our indefinite-lived intangible assets.

We did not recognize any impairment charges for goodwill in the years ended December 27, 2025 and December 28, 2024.

In 2023, macroeconomic conditions, including higher interest rates, inflationary costs, and the ongoing conflict in the Middle East, and recent business performance indicated a deterioration of the significant inputs used to determine the fair value of our indefinite-lived intangible assets in various markets,

primarily assumptions underlying the weighted-average cost of capital and the impact of economic uncertainty on current and future financial performance, and required us to perform a quantitative assessment on certain assets. The fair value of our indefinite-lived intangible assets was estimated using discounted cash flows under the income approach, which we consider to be a Level 3 measurement. We determined that the carrying value exceeded the fair value for certain of our intangible assets, which reflects the increase in the weighted-average cost of capital as well as our most current estimates of future sales and their contributions to operating profit and expected future cash flows (including perpetuity growth assumptions). As a result of the quantitative assessment, we recorded pre-tax impairment charges of $0.6 billion ($0.5 billion after-tax or $0.35 per share) for brands and $0.3 billion ($0.3 billion after-tax or $0.22 per share) for goodwill, both in impairment of intangible assets, primarily related to the SodaStream brand and reporting unit in our IB Franchise segment, in the year ended December 30, 2023. See Note 1 for further information.

For further information on our policies for indefinite-lived intangible assets, see Note 2.

The components of indefinite-lived intangible assets are as follows:


	2025		2024
Goodwill	$	18,916	$	17,534
Other indefinite-lived intangible assets
Reacquired franchise rights	7,542		7,437
Acquired franchise rights (a)	2,099		1,858
Brands (b)	4,206		4,404
Total indefinite-lived intangible assets	$	32,763	$	31,233

(a)Increase is primarily related to acquired distribution rights for the Alani Nu brand.

(b)Decrease is primarily related to impairments of the Rockstar and Be & Cheery brands as well as the sale of the Rockstar brand in connection with the transaction described above, partially offset by acquisitions of poppi and Siete. See Note 13 for further information on acquisitions.

The change in the book value of goodwill is as follows:


	PFNA		PBNA		IB Franchise		EMEA(a)		LatAm Foods		Asia Pacific Foods		Total
Balance as of December 30, 2023	$	642	$	11,961	$	1,986	$	2,382	$	393	$	364	$	17,728
Acquisitions (b)	159		—		—		—		—		3		162

Translation and other	(10)		(36)		(68)		(188)		(39)		(15)		(356)
Balance as of December 28, 2024	791		11,925		1,918		2,194		354		352		17,534
Acquisitions (b)	625		179		—		—		—		—		804
Translation and other	6		21		3		494		31		23		578
Balance as of December 27, 2025	$	1,422	$	12,125	$	1,921	$	2,688	$	385	$	375	$	18,916

(a)Translation and other in 2024 primarily reflects the depreciation of the Russian ruble and euro. Translation and other in 2025 primarily reflects appreciation of the Russian ruble, euro and South African rand.

(b)Primarily related to the acquisitions of Sabra in 2024 and Siete in 2025 in our PFNA segment and poppi in our PBNA segment. See Note 13 for further information on acquisitions.

Income Taxes (Tables)

12 Months Ended

Dec. 27, 2025

Income Tax Contingency [Line Items]

Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]

The components of income before income taxes are as follows:


	2025		2024		2023
United States	$	806	$	2,590	$	4,120
Foreign	9,438		9,356		7,297
	$	10,244	$	11,946	$	11,417

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

The provision for income taxes consisted of the following:


	2025		2024		2023
Current:
U.S. Federal	$	299	$	1,033	$	1,133
Foreign	1,583		1,406		1,201
State	42		255		309
	1,924		2,694		2,643
Deferred:
U.S. Federal	116		(306)		(109)
Foreign	(116)		(10)		(212)
State	25		(58)		(60)
	25		(374)		(381)
	$	1,949	$	2,320	$	2,262

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

A reconciliation of the U.S. Federal statutory tax rate to our 2025 annual tax rate is as follows:


	Amount		Tax Rate
U.S. Federal statutory tax	$	2,151	21.0	%
State income tax, net of U.S. Federal tax benefit (a)	25		0.2
Changes in valuation allowances	12		0.1
Foreign tax effects
Ireland
Statutory income tax rate differential	(119)		(1.2)
Other	24		0.2
Singapore
Tax incentive	(113)		(1.1)
Other	(26)		(0.3)
Switzerland
Changes in valuation allowances	(149)		(1.5)
Other	32		0.3
Bermuda
Statutory income tax rate differential	(310)		(3.0)
Other foreign jurisdictions	21		0.2

Effect of cross-border tax laws (b)
Transfer pricing adjustments	128		1.3
Global intangible low-tax income (GILTI)	115		1.1
Other	(110)		(1.0)
Tax credits	(29)		(0.3)
Changes in unrecognized tax benefits	181		1.8
Nondeductible and nontaxable items, net	(31)		(0.3)
Other	147		1.5
Reported tax	$	1,949	19.0	%

(a)State taxes in California, Illinois, New Jersey, Texas, Minnesota, Oregon, Wisconsin, Louisiana, Michigan, and Arizona make up the majority (greater than 50%) of the tax effect in this category.

(b)Includes the impact of any tax credits.

A reconciliation of the U.S. Federal statutory tax rate to our 2024 and 2023 annual tax rate is as follows:


	2024		2023
U.S. Federal statutory tax rate	21.0	%	21.0	%
State income tax, net of U.S. Federal tax benefit	1.3		1.8
Lower taxes on foreign results	(2.5)		(2.5)


Juice Transaction	—		(0.1)

Other, net	(0.4)		(0.4)
Annual tax rate	19.4	%	19.8	%

A summary of income taxes paid in 2025 is as follows:


	Amount
U.S. Federal	$	1,107
U.S. State and Local (a)	243






Foreign
Ireland	424
Mexico	313
Russia	237

Other	759
	1,733
Total	$	3,083

(a)No single state or local jurisdiction accounts for more than 5% of the total income taxes paid.

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

Deferred tax liabilities and assets are comprised of the following:


	2025		2024
Deferred tax liabilities
Property, plant and equipment	$	2,047	$	1,868
Right-of-use assets	819		772
Debt guarantee of wholly-owned subsidiary	578		578
Recapture of net operating losses	488		488
Pension liabilities	238		112

Other	486		301
Gross deferred tax liabilities	4,656		4,119

Deferred tax assets
Net carryforwards	6,849		6,737
Intangible assets other than nondeductible goodwill	1,996		1,599
Lease liabilities	819		773
Share-based compensation	141		148
Retiree medical benefits	96		104
Other employee-related benefits	372		415

Deductible state tax and interest benefits	181		202
Capitalized research and development	134		256
Other	927		948
Gross deferred tax assets	11,515		11,182
Valuation allowances	(6,120)		(6,185)
Deferred tax assets, net	5,395		4,997
Net deferred tax (assets)/liabilities	$	(739)	$	(878)

A summary of our valuation allowance activity is as follows:


	2025		2024		2023
Balance, beginning of year	$	6,185	$	6,478	$	5,013
(Benefit)/provision	(284)		(198)		1,419
Other additions/(deductions)	219		(95)		46
Balance, end of year	$	6,120	$	6,185	$	6,478

Summary of Income Tax Contingencies [Table Text Block]

Our major taxing jurisdictions and the related open tax audits are as follows:


Jurisdiction	Years Open to Audit	Years Currently Under Audit
United States	2014-2024	2014-2019
Mexico	2014-2024	2014-2020
Canada (Domestic)	2021-2024	2021
Canada (International)	2012-2024	2012-2021
Russia	2022-2024	None

Reserves Rollforward

A reconciliation of unrecognized tax benefits is as follows:


	2025		2024
Balance, beginning of year	$	2,284	$	2,093
Additions for tax positions related to the current year	153		210
Additions for tax positions from prior years	124		108
Reductions for tax positions from prior years	(76)		(46)
Settlement payments	(114)		(24)
Statutes of limitations expiration	(18)		(31)
Translation and other	23		(26)
Balance, end of year	$	2,376	$	2,284

Acquisitions & Divestiture - Summary of Acquisition and Divestiture-Related Charges (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Acquisitions & Divestitures [Line Items]
Acquisition and divestiture-related charges	$ 453	$ 22	$ 41
Acquisition and divestiture-related charges, after-tax	$ 347	$ 18	$ 23
Acquisition and divestiture-related charges, PerShare	$ (0.25)	$ (0.01)	$ (0.02)
PepsiCo Foods North America [Member] \| Operating Segments [Member]
Acquisitions & Divestitures [Line Items]
Acquisition and divestiture-related charges	$ 28	$ 9	$ 0
PepsiCo Beverages North America [Member] \| Operating Segments [Member]
Acquisitions & Divestitures [Line Items]
Acquisition and divestiture-related charges	422	8	16
Europe, Middle East & Africa (Segment) [Member] \| Operating Segments [Member]
Acquisitions & Divestitures [Line Items]
Acquisition and divestiture-related charges	0	0	(2)
Asia Pacific Foods (Segment) [Member] \| Operating Segments [Member]
Acquisitions & Divestitures [Line Items]
Acquisition and divestiture-related charges	3	5	2
Corporate Segment [Member] \| Operating Segments [Member]
Acquisitions & Divestitures [Line Items]
Acquisition and divestiture-related charges	0	0	25
Cost of sales
Acquisitions & Divestitures [Line Items]
Acquisition and divestiture-related charges	57	0	0
Selling, general and administrative expenses
Acquisitions & Divestitures [Line Items]
Acquisition and divestiture-related charges	346	22	41
Impairment of intangible assets
Acquisitions & Divestitures [Line Items]
Acquisition and divestiture-related charges	50	0	0
Operating (Income) Loss
Acquisitions & Divestitures [Line Items]
Acquisition and divestiture-related charges	$ 453	$ 22	$ 41

Intangible Assets (Future Amortization) (Details) $ in Millions	12 Months Ended
	Dec. 27, 2025 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2024	$ 78
2025	74
2026	73
2027	72
2028	$ 63
Finite-Lived Intangible Assets, Expected Amortization	5 years

Share-Based Compensation Share-Based Compensation (Tables)

12 Months Ended

Dec. 27, 2025

Share-Based Payment Arrangement [Abstract]

Share-based Payment Arrangement, Cost by Plan [Table Text Block]

The following table summarizes our total share-based compensation expense, which is primarily recorded in selling, general and administrative expenses, and excess tax benefits recognized:


	2025		2024		2023
Share-based compensation expense - equity awards	$	288	$	362	$	380
Share-based compensation expense - liability awards	13		7		19
Restructuring charges	(8)		(5)		(1)
Total	$	293	$	364	$	398
Income tax benefits recognized in earnings related to share-based compensation	$	53	$	68	$	73
Excess tax benefits related to share-based compensation	$	3	$	33	$	36

Schedule Of Weighted-Average Black-Scholes Fair Value Assumptions

Our weighted-average Black-Scholes fair value assumptions are as follows:


	2025		2024		2023
Expected life	7 years		7 years		7 years
Risk-free interest rate	4.1	%	4.2	%	4.2	%
Expected volatility	16	%	16	%	16	%
Expected dividend yield	3.5	%	2.9	%	2.7	%

Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of our stock option activity for the year ended December 27, 2025 is as follows:


	Options(a)	Weighted-Average Exercise Price Per Unit		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value(a)
Outstanding at December 28, 2024	11,055	$	143.88
Granted	1,804	$	150.28
Exercised	(896)	$	108.72
Forfeited/expired	(642)	$	163.52
Outstanding at December 27, 2025	11,321	$	146.60	6.0	$	100,992
Exercisable at December 27, 2025	6,279	$	134.10	4.2	$	98,385
Expected to vest as of December 27, 2025	4,793	$	162.45	8.2	$	2,468

(a)In thousands.

Our RSU and PSU Activity

A summary of our RSU and PSU activity for the year ended December 27, 2025 is as follows:


	RSUs/PSUs(a)	Weighted-Average Grant-Date Fair Value Per Unit		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value(a)
Outstanding at December 28, 2024	5,366	$	166.09
Granted	2,199	$	153.22
Converted	(1,849)	$	163.78
Forfeited	(607)	$	163.47
Outstanding at December 27, 2025 (b)	5,109	$	161.72	1.3	$	734,635
Expected to vest as of December 27, 2025 (c)	4,411	$	162.11	1.2	$	634,185

(a)In thousands. Outstanding awards are disclosed at target.

(b)The outstanding PSUs for which the vesting period has not ended as of December 27, 2025, at the threshold, target and maximum award levels were zero, 0.7 million and 1.4 million, respectively.

(c)Represents the number of outstanding awards expected to vest, including estimated performance adjustments on all outstanding PSUs as of December 27, 2025.

Schedule of Liability Award Vested and Expected to Vest [Table Text Block]

A summary of our long-term cash activity for the year ended December 27, 2025 is as follows:


	Long-Term Cash Award(a)		Balance Sheet Date Fair Value(b)		Contractual Life Remaining (years)
Outstanding at December 28, 2024	$	53,970
Granted	21,636
Vested	(11,274)
Forfeited	(7,297)
Outstanding at December 27, 2025 (c)	$	57,035	$	36,064	1.2
Expected to vest as of December 27, 2025	$	54,169	$	33,597	1.2

(a)In thousands, disclosed at target.

(b)In thousands, based on the most recent valuation as of December 27, 2025.

(c)The outstanding awards for which the vesting period has not ended as of December 27, 2025, at the threshold, target and maximum award levels based on the achievement of its market conditions were zero, $57 million and $114 million, respectively.

Other Share-Based Compensation Data

The following is a summary of other share-based compensation data:


	2025		2024		2023
Stock Options
Total number of options granted (a)	1,804		2,034		2,162
Weighted-average grant-date fair value per unit of options granted	$	21.13	$	27.29	$	29.81
Total intrinsic value of options exercised (a)	$	35,558	$	99,388	$	100,209
Total grant-date fair value of options vested (a)	$	32,506	$	14,759	$	11,830
RSUs/PSUs
Total number of RSUs/PSUs granted (a)	2,199		2,348		2,151
Weighted-average grant-date fair value per unit of RSUs/PSUs granted	$	153.22	$	164.25	$	171.11
Total intrinsic value of RSUs/PSUs converted (a)	$	299,958	$	372,612	$	396,123
Total grant-date fair value of RSUs/PSUs vested (a)	$	300,591	$	280,673	$	286,605

(a)In thousands.

Supply Chain Financing

12 Months Ended

Dec. 27, 2025

Text Block [Abstract]

Supplier Finance Program

Supply Chain Financing Arrangements

As part of our evolving market practices, we work with our suppliers to optimize our terms and conditions, which include the extension of payment terms. Our current payment terms with a majority of our suppliers generally range from 60 to 90 days, which we deem to be commercially reasonable. We will continue to monitor economic conditions and market practice working with our suppliers to adjust as necessary. We also maintain voluntary supply chain finance agreements with several participating global financial institutions. Under these agreements, our suppliers, at their sole discretion, may elect to sell their accounts receivable with PepsiCo to these participating global financial institutions. Supplier participation in these financing arrangements is voluntary. Our suppliers negotiate their financing agreements directly with the respective global financial institutions and we are not a party to these agreements. These financing arrangements allow participating suppliers to leverage PepsiCo’s creditworthiness in establishing credit spreads and associated costs, which generally provides our suppliers with more favorable terms than they would be able to secure on their own. Neither PepsiCo nor any of its subsidiaries provide any guarantees to any third party in connection with these financing arrangements. We have no economic interest in our suppliers’ decision to participate in these agreements. Our obligations to our suppliers, including amounts due and scheduled payment terms, are not impacted. All outstanding amounts related to suppliers participating in such financing arrangements are recorded within accounts payable and other current liabilities in our consolidated balance sheet.

A summary of our outstanding obligations confirmed as valid under the supplier finance program is as follows:


	2025		2024
Confirmed obligations outstanding at beginning of year	$	1,478	$	1,655
Invoices confirmed	6,668		6,552
Confirmed invoices paid	(6,547)		(6,636)
Translation and other	82		(93)
Confirmed obligations outstanding at end of year	$	1,681	$	1,478

Basis of Presentation and Our Segments (Segment Reporting Information by Net Revenue and PP&E) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Segment Reporting Information [Line Items]
Net Revenue	$ 93,925	$ 91,854	$ 91,471
Property, Plant and Equipment, net	29,905	28,008
UNITED STATES
Segment Reporting Information [Line Items]
Net Revenue	52,228	51,668	52,165
Property, Plant and Equipment, net	16,671	16,550
MEXICO
Segment Reporting Information [Line Items]
Net Revenue	$ 6,947	$ 7,123	7,011
Property Plant And Equipment Net Percent of Total	9.00%	8.00%
RUSSIAN FEDERATION
Segment Reporting Information [Line Items]
Net Revenue	$ 4,768	$ 3,880	3,566
CANADA
Segment Reporting Information [Line Items]
Net Revenue	3,729	3,764	3,722
UNITED KINGDOM
Segment Reporting Information [Line Items]
Net Revenue	2,142	2,063	1,946
CHINA
Segment Reporting Information [Line Items]
Net Revenue	2,621	2,709	2,703
SOUTH AFRICA
Segment Reporting Information [Line Items]
Net Revenue	1,767	1,859	1,707
All Other Countries [Member]
Segment Reporting Information [Line Items]
Net Revenue	17,941	$ 17,023	16,872
Property Plant And Equipment Net Percent of Total		5.00%
BRAZIL
Segment Reporting Information [Line Items]
Net Revenue	1,782	$ 1,765	$ 1,779
International [Member]
Segment Reporting Information [Line Items]
Property, Plant and Equipment, net	$ 13,234	$ 11,458

Insider Trading Arrangements	4 Months Ended
Insider Trading Arrangements	Dec. 27, 2025
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Acquisitions & Divestitures - Sabra (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
	Dec. 03, 2024	Dec. 28, 2024
Sabra acquisition
Acquisitions & Divestitures [Line Items]
Equity Method Investment, Ownership Percentage	50.00%
Sabra acquisition
Acquisitions & Divestitures [Line Items]
Business Combination, Consideration Transferred	$ 241
Gain (Loss) on Investments		$ 122
Gain (Loss) on Investments, after tax		$ 92
Gain (Loss) on Investments, per share impact		$ 0.07
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Indefinite-Lived		$ 300
Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment		$ 100
Business Combination, Voting Equity Interest Acquired, Percentage	50.00%

Share-Based Compensation Share-Based Compensation (Narrative) (Details) shares in Millions, $ in Millions	12 Months Ended
	Dec. 27, 2025 USD ($) option / rSU shares	Dec. 28, 2024 USD ($)	Dec. 30, 2023 USD ($)
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Common stock, capital shares reserved for future issuance \| shares	89
Share-based Payment Arrangement, Expense	$ 288	$ 362	$ 380
Allocated Share-Based Compensation Liability Awards	13	7	19
Share-based Payment Arrangement, Expensed and Capitalized, Amount, Total	293	364	398
Income tax benefits recognized in earnings related to share-based compensation	53	68	73
Share-Based Payment Arrangement, Exercise of Option, Tax Benefit	3	33	36
Unrecognized compensation cost related to nonvested share-based compensation grants	$ 329
Acquisition-related awards remaining vesting period	3 years
Percent of liability awards granted to senior officers	34.00%
Share-based Compensation
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Restructuring Charges	$ (8)	$ (5)	$ (1)
Restricted Stock Units (RSUs)
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Award equivalence, ratio of stock options to RSUs \| option / rSU	4
Stock Options
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Stock option exercisable life	10 years
Award equivalence, ratio of stock options to RSUs \| option / rSU	1
PEP Equity Performance Unit [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Percent of equity awards granted to Senior Officers as performance-based RSUs	66.00%

Share-Based Compensation

12 Months Ended

Dec. 27, 2025

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Stock-Based Compensation

Share-Based Compensation

Our share-based compensation program is designed to attract and retain employees while also aligning employees’ interests with the interests of our shareholders. PepsiCo has granted stock options, RSUs,

PSUs and long-term cash awards to employees under the shareholder-approved PepsiCo, Inc. Long-Term Incentive Plan (LTIP). Executives who are awarded long-term incentives based on their performance may generally elect to receive their grant in the form of stock options or RSUs, or a combination thereof. Executives who elect stock options receive four stock options for every one RSU that would have otherwise been granted. Certain executive officers and other senior executives do not have a choice and are granted 66% PSUs and 34% long-term cash, each of which are subject to pre-established performance targets.

The Company may use authorized and unissued shares to meet share requirements resulting from the exercise of stock options and the vesting of RSUs and PSUs.

As of December 27, 2025, 89 million shares were available for future share-based compensation grants under the LTIP.

The following table summarizes our total share-based compensation expense, which is primarily recorded in selling, general and administrative expenses, and excess tax benefits recognized:


	2025		2024		2023
Share-based compensation expense - equity awards	$	288	$	362	$	380
Share-based compensation expense - liability awards	13		7		19
Restructuring charges	(8)		(5)		(1)
Total	$	293	$	364	$	398
Income tax benefits recognized in earnings related to share-based compensation	$	53	$	68	$	73
Excess tax benefits related to share-based compensation	$	3	$	33	$	36

As of December 27, 2025, there was $329 million of total unrecognized compensation cost related to nonvested share-based compensation grants. This unrecognized compensation cost is expected to be recognized over a weighted-average period of two years.

Method of Accounting and Our Assumptions

The fair value of share-based award grants is amortized to expense over the vesting period, primarily three years. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. In addition, we use historical data to estimate forfeiture rates and record share-based compensation expense only for those awards that are expected to vest.

We do not backdate, reprice or grant share-based compensation awards retroactively. Repricing of awards would require shareholder approval under the LTIP.

Stock Options

A stock option permits the holder to purchase shares of PepsiCo common stock at a specified price. We account for our employee stock options under the fair value method of accounting using a Black-Scholes valuation model to measure stock option expense at the date of grant. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of grant and generally have a 10-year term.

Our weighted-average Black-Scholes fair value assumptions are as follows:


	2025		2024		2023
Expected life	7 years		7 years		7 years
Risk-free interest rate	4.1	%	4.2	%	4.2	%
Expected volatility	16	%	16	%	16	%
Expected dividend yield	3.5	%	2.9	%	2.7	%

The expected life is the period over which our employee groups are expected to hold their options. It is based on our historical experience with similar grants. The risk-free interest rate is based on the expected U.S. Treasury rate over the expected life. Volatility reflects movements in our stock price over the most recent historical period equivalent to the expected life. Dividend yield is estimated over the expected life based on our stated dividend policy and forecasts of net income, share repurchases and stock price.

A summary of our stock option activity for the year ended December 27, 2025 is as follows:


	Options(a)	Weighted-Average Exercise Price Per Unit		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value(a)
Outstanding at December 28, 2024	11,055	$	143.88
Granted	1,804	$	150.28
Exercised	(896)	$	108.72
Forfeited/expired	(642)	$	163.52
Outstanding at December 27, 2025	11,321	$	146.60	6.0	$	100,992
Exercisable at December 27, 2025	6,279	$	134.10	4.2	$	98,385
Expected to vest as of December 27, 2025	4,793	$	162.45	8.2	$	2,468

(a)In thousands.

Restricted Stock Units and Performance Stock Units

Each RSU represents our obligation to deliver to the holder one share of PepsiCo common stock when the award vests at the end of the service period. PSUs are awards pursuant to which a number of shares are delivered to the holder upon vesting at the end of the service period based on PepsiCo’s performance against specified financial performance metrics. The number of shares may be increased to the maximum or reduced to the minimum threshold based on the results of these performance metrics in accordance with the terms established at the time of the award. During the vesting period, RSUs and PSUs accrue dividend equivalents that pay out in cash (without interest) if and when the applicable RSU or PSU vests and becomes payable.

The fair value of RSUs and PSUs is measured at the market price of the Company’s stock on the date of grant.

A summary of our RSU and PSU activity for the year ended December 27, 2025 is as follows:


	RSUs/PSUs(a)	Weighted-Average Grant-Date Fair Value Per Unit		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value(a)
Outstanding at December 28, 2024	5,366	$	166.09
Granted	2,199	$	153.22
Converted	(1,849)	$	163.78
Forfeited	(607)	$	163.47
Outstanding at December 27, 2025 (b)	5,109	$	161.72	1.3	$	734,635
Expected to vest as of December 27, 2025 (c)	4,411	$	162.11	1.2	$	634,185

(a)In thousands. Outstanding awards are disclosed at target.

(b)The outstanding PSUs for which the vesting period has not ended as of December 27, 2025, at the threshold, target and maximum award levels were zero, 0.7 million and 1.4 million, respectively.

(c)Represents the number of outstanding awards expected to vest, including estimated performance adjustments on all outstanding PSUs as of December 27, 2025.

Long-Term Cash

Certain executive officers and other senior executives were granted long-term cash awards for which final payout is based on PepsiCo’s total shareholder return relative to a specific set of peer companies and achievement of a specified performance target over a three-year performance period.

Long-term cash awards that qualify as liability awards under share-based compensation guidance are valued through the end of the performance period on a mark-to-market basis using the Monte Carlo simulation model.

A summary of our long-term cash activity for the year ended December 27, 2025 is as follows:


	Long-Term Cash Award(a)		Balance Sheet Date Fair Value(b)		Contractual Life Remaining (years)
Outstanding at December 28, 2024	$	53,970
Granted	21,636
Vested	(11,274)
Forfeited	(7,297)
Outstanding at December 27, 2025 (c)	$	57,035	$	36,064	1.2
Expected to vest as of December 27, 2025	$	54,169	$	33,597	1.2

(a)In thousands, disclosed at target.

(b)In thousands, based on the most recent valuation as of December 27, 2025.

Other Share-Based Compensation Data

The following is a summary of other share-based compensation data:


	2025		2024		2023
Stock Options
Total number of options granted (a)	1,804		2,034		2,162
Weighted-average grant-date fair value per unit of options granted	$	21.13	$	27.29	$	29.81
Total intrinsic value of options exercised (a)	$	35,558	$	99,388	$	100,209
Total grant-date fair value of options vested (a)	$	32,506	$	14,759	$	11,830
RSUs/PSUs
Total number of RSUs/PSUs granted (a)	2,199		2,348		2,151
Weighted-average grant-date fair value per unit of RSUs/PSUs granted	$	153.22	$	164.25	$	171.11
Total intrinsic value of RSUs/PSUs converted (a)	$	299,958	$	372,612	$	396,123
Total grant-date fair value of RSUs/PSUs vested (a)	$	300,591	$	280,673	$	286,605

(a)In thousands.

As of December 27, 2025 and December 28, 2024, there were approximately 341,000 and 311,000 outstanding awards, respectively, consisting primarily of phantom stock units that were granted under the PepsiCo Director Deferral Program and will be settled in shares of PepsiCo common stock pursuant to the LTIP at the end of the applicable deferral period, not included in the tables above.

Our Significant Accounting Policies (Concentration of Credit Risk) (Details)	12 Months Ended
	Dec. 27, 2025
Customer Concentration Risk \| Wal-Mart \| Revenue, Net
Concentration Risk [Line Items]
Concentration risk, percentage	14.00%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 18
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-18

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 20
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 954
-SubTopic 310
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478785/954-310-50-2

+ Details

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References + Details

Pension, Retiree Medical and Savings Plans (Estimated Future Benefit Payments) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2026	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023	Jan. 22, 2026
Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Employer contributions/funding		$ 354	$ 236
Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Discretionary		261	161	$ 267
Non-discretionary		160	134	97
Defined Benefit Plan, Expected Future Benefit Payment, Year One		1,259
Defined Benefit Plan, Expected Future Benefit Payment, Year Two		963
Defined Benefit Plan, Expected Future Benefit Payment, Year Three		951
Defined Benefit Plan, Expected Future Benefit Payment, Year Four		977
Defined Benefit Plan, Expected Future Benefit Payment, Year Five		999
Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years		5,242
Employer contributions/funding		421	295	364
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Discretionary		0	0	0
Non-discretionary		51	53	46
Defined Benefit Plan, Expected Future Benefit Payment, Year One		76
Defined Benefit Plan, Expected Future Benefit Payment, Year Two		74
Defined Benefit Plan, Expected Future Benefit Payment, Year Three		72
Defined Benefit Plan, Expected Future Benefit Payment, Year Four		70
Defined Benefit Plan, Expected Future Benefit Payment, Year Five		68
Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years		305
Employer contributions/funding		51	53	46
us-gaap_DomesticPlanMember-Discretionary contributions
Defined Benefit Plan Disclosure [Line Items]
Discretionary		250	$ 150	$ 250
Years 2029 Through 2033
Defined Benefit Plan Disclosure [Line Items]
Subsidies expected to be received under the 2003 Medicare Act		2
Maximum \| Years 2024 Through 2028
Defined Benefit Plan Disclosure [Line Items]
Subsidies expected to be received under the 2003 Medicare Act		$ 1
Forecast [Member] \| Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Non-discretionary	$ 80
Forecast [Member] \| Retiree Medical Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Non-discretionary	$ 55
Forecast [Member] \| Domestic plan -Plan I
Defined Benefit Plan, Expected Future Employer Contributions [Abstract]
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year					$ 200
Forecast [Member] \| International plan
Defined Benefit Plan, Expected Future Employer Contributions [Abstract]
Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year					$ 52

Intangible Assets (Policies)	12 Months Ended
Intangible Assets (Policies)	Dec. 27, 2025
Goodwill and Intangible Assets Disclosure [Abstract]
Property, Plant and Equipment, Impairment	Depreciable and amortizable assets are evaluated for impairment upon a significant change in the operating or macroeconomic environment. In these circumstances, if an evaluation of the undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on discounted future cash flows. Useful lives are periodically evaluated to determine whether events or circumstances have occurred which indicate the need for revision.
Goodwill and Intangible Assets, Policy [Policy Text Block]	Goodwill and Other Intangible Assets Indefinite-lived intangible assets and goodwill are not amortized and, as a result, are assessed for impairment at least annually, using either a qualitative or quantitative approach. We perform this annual assessment during our third quarter, or more frequently if circumstances indicate that the carrying value may not be recoverable. Where we use the qualitative assessment, first we determine if, based on qualitative factors, it is more likely than not that an impairment exists. Factors considered include macroeconomic conditions (including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment), industry and competitive conditions, legal and regulatory environment, historical financial performance and significant changes in the brand or reporting unit. If the qualitative assessment indicates that it is more likely than not that an impairment exists, then a quantitative assessment is performed. In the quantitative assessment for indefinite-lived intangible assets and goodwill, an assessment is performed to determine the fair value of the indefinite-lived intangible asset and the reporting unit, respectively. Estimated fair value is determined using discounted cash flows and requires an analysis of several estimates including future cash flows or income consistent with management’s strategic business plans, annual sales growth rates, perpetuity growth assumptions and the selection of assumptions underlying a discount rate (weighted-average cost of capital) based on market data available at the time. Significant management judgment is necessary to estimate the impact of competitive operating, macroeconomic and other factors (including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment) to estimate future levels of sales, operating profit or cash flows. All assumptions used in our impairment evaluations for indefinite-lived intangible assets and goodwill, such as forecasted growth rates (including perpetuity growth assumptions) and weighted-average cost of capital, are based on the best available market information and are consistent with our internal forecasts and operating plans. A deterioration in these assumptions could adversely impact our results. Amortizable intangible assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. If an evaluation of the undiscounted future cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on its discounted future cash flows. See Note 4 for further information.

Financial Instruments (Tables)

12 Months Ended

Dec. 27, 2025

Derivative Instruments and Hedges, Assets [Abstract]

Schedule of Notional Amounts of Outstanding

The notional amounts of our financial instruments used to hedge the above risks as of December 27, 2025 and December 28, 2024 are as follows:


	Notional Amounts(a)
	2025		2024
Commodity contracts	$	1.5	$	1.4
Interest rate swap contracts	$	2.0	$	2.0
Foreign exchange contracts (b)	$	3.1	$	3.1
Cross-currency contracts	$	1.7	$	1.2
Non-derivative debt instruments (b)	$	4.4	$	2.9

(a)In billions.

(b)Subsequent to December 27, 2025, we designated $1.6 billion of foreign exchange contracts maturing in February 2026 and $4.5 billion of existing euro denominated debt as net investment hedges to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.

Fair Values Of Financial Assets And Liabilities

The fair values of our financial assets and liabilities as of December 27, 2025 and December 28, 2024 are categorized as follows:


		2025				2024
	Fair Value Hierarchy Levels(a)	Assets(a)		Liabilities(a)		Assets(a)		Liabilities(a)
Available-for-sale debt securities (b)	3	$	2,127	$	—	$	1,041	$	—
Index funds (c)	1	341		—		336		—
Deferred compensation (d)	2	—		495		—		503
Contingent consideration (e)	3	—		278		—		—


Derivatives designated as fair value hedging instruments:
Interest rate swap contracts (f)	2	19		3		—		46


Derivatives designated as cash flow hedging instruments:
Foreign exchange contracts (g)	2	6		28		55		3
Cross-currency contracts (g)	2	—		102		—		165

Commodity contracts (h)	2	116		5		27		6
		122		135		82		174
Derivatives designated as net investment hedging instruments:
Foreign exchange contracts (g)	2	—		1		—		—
Cross-currency contracts (g)	2	—		34		1		4
		—		35		1		4

Derivatives not designated as hedging instruments:
Foreign exchange contracts (g)	2	6		32		28		12

Commodity contracts (h)	2	4		9		3		10
		10		41		31		22
Total derivatives at fair value (i)		151		214		114		246
Total		$	2,619	$	987	$	1,491	$	749

(a)Fair value hierarchy levels are defined in Note 7. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities.

(b)Classified as other assets. The fair value of our investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80% probability that a certain market-based condition will be met and an average estimated discount rate of 8.5% and 7.3% as of December 27, 2025 and December 28, 2024, respectively. The fair value of the other investment is estimated using a lattice model primarily based on the underlying stock price, volatility and certain significant unobservable inputs, such as a discount rate of 8.3% based on an estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement.

(c)Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.

(d)Based on the fair value of investments corresponding to employees’ investment elections.

(e)In connection with our acquisition of poppi, we recorded a liability at fair value for the contingent consideration payable upon achievement of certain performance milestones by the third quarter of 2027, with a maximum payment of $300 million. If these performance milestones are not met, no payment will be made. The fair value of the liability is estimated using discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as forecasts of net revenue and margin. An increase in the net revenue and margin forecasts would result in a higher fair value measurement, while a decrease in the net revenue and margin forecasts would result in a lower fair value measurement. As of December 27, 2025, the fair value of the contingent consideration was $278 million, comprised of the acquisition date fair value of $180 million and a fair value increase of $98 million recorded in selling, general and administrative expenses.

(f)Based on Secured Overnight Financing Rate forward rates. As of December 27, 2025, the carrying amount of hedged fixed-rate debt was $2.0 billion, which was classified on the balance sheet within long-term debt obligations.

(g)Based on recently reported market transactions of spot and/or forward rates.

(h)Primarily based on recently reported market transactions of swap arrangements.

(i)Derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on our balance sheet as of December 27, 2025 and December 28, 2024 were not material. Collateral received or posted against our asset or liability positions was not material. Exchange-traded commodity futures are cash-settled on a daily basis and, therefore, not included in the table.

Effective Portion Of Pre-Tax (Gains)/Losses On Derivative Instruments

Losses/(gains) on our fair value hedges recognized in the income statement are as follows:



	2025		2024
Interest rate swap contracts (a)	$	(62)	$	46

(a)Interest rate derivative losses/(gains) are included in net interest expense and other. These losses/(gains) are substantially offset by decreases/increases in the value of the underlying debt, which are also included in net interest expense and other.

Losses/(gains) on our cash flow hedges are categorized as follows:



	Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss			Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(a)
		2025		2024		2025		2024
Foreign exchange contracts		$	95	$	(101)	$	12	$	(6)
Cross-currency contracts		(63)		46		(67)		48
Commodity contracts		(218)		57		(77)		123

Total		$	(186)	$	2	$	(132)	$	165

(a)Foreign exchange derivative losses/(gains) are included in net revenue and cost of sales. Cross-currency interest rate swap derivative losses/(gains) are included in selling, general and administrative expenses. Commodity derivative losses/(gains) are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. See Note 11 for further information.

Losses/(gains) on our net investment hedges are categorized as follows:


	Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss			Losses/(Gains) Recognized in Income Statement(a)
		2025		2024		2025		2024
Non-derivative debt instruments		$	337	$	(133)	$	—	$	—
Cross-currency contracts		33		3		(13)		(5)
Foreign exchange contracts		(13)		—		—		—
Total		$	357	$	(130)	$	(13)	$	(5)

(a)Amount excluded from the assessment of effectiveness recognized in earnings associated with cross-currency interest rate swaps and

forward contracts.

Derivatives Not Designated as Hedging Instruments

Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows:




	2025						2024
	Cost of sales		Selling, general and administrative expenses		Total		Cost of sales		Selling, general and administrative expenses		Total
Foreign exchange contracts	$	1	$	66	$	67	$	1	$	2	$	3
Commodity contracts	16		6		22		2		8		10
Total	$	17	$	72	$	89	$	3	$	10	$	13

Debt Securities, Available-for-Sale

The activity related to our Level 3 investments in certain available-for-sale debt securities is as follows:


	2025		2024
Celsius:
Balance, beginning of year	$	785	$	1,156
Acquired	590		—
Net unrealized gain/(loss)	507		(350)
Cash dividends received	(30)		(21)
Balance, end of year	1,852		785
Other:
Balance, beginning of year	256		—
Transfer from Level 2 (a)	—		184
Net unrealized gain	19		72
Balance, end of year	275		256
Total Level 3 available-for-sale balance, end of year	$	2,127	$	1,041

(a)Unobservable inputs to the fair value became more significant.

- Definition

Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-9

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aa)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (aaa)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-2

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 320
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481800/320-10-50-3

+ Details

Debt Obligations and Commitments (Tables)

12 Months Ended

Dec. 27, 2025

Debt Disclosure [Abstract]

Schedule of Long and Short-Term Debt Contractural Commitments

The following table summarizes our debt obligations:


	2025(a)		2024(a)
Short-term debt obligations (b)
Current maturities of long-term debt	$	4,030	$	4,004
Commercial paper (3.8% and 4.5%)	2,641		2,818
Other borrowings	190		260
	$	6,861	$	7,082
Long-term debt obligations (b)



Notes due 2025 (3.2%)	$	—	$	3,999
Notes due 2026 (3.6% and 3.7%)	4,003		3,941
Notes due 2027 (3.2% and 3.1%)	3,933		3,370
Notes due 2028 (2.4% and 2.1%)	4,203		3,240
Notes due 2029 (4.3% and 4.6%)	4,043		3,239
Notes due 2030 (3.2% and 2.6%)	4,171		2,472
Notes due 2031-2060 (3.4% and 3.2%)	25,956		20,928
Other, due 2025-2042	42		39
	46,351		41,228
Less: current maturities of long-term debt obligations	4,030		4,004
Total	$	42,321	$	37,224

(a)Amounts are shown net of unamortized net discounts of $224 million and $267 million for 2025 and 2024, respectively.

(b)The interest rates presented reflect weighted-average effective interest rates at year-end. Certain of our fixed rate indebtedness have been swapped to floating rates through the use of interest rate derivative instruments. See Note 9 for further information regarding our interest rate swap contracts.

Schedule of Debt Issuances

In 2025, we issued the following senior notes:


Interest Rate		Maturity Date	Principal Amount(a)
4.400	%	February 2027	$	500
4.450	%	February 2028	$	750
4.600	%	February 2030	$	1,000
5.000	%	February 2035	$	1,250
4.100	%	January 2029	$	750
4.300	%	July 2030	$	650
4.650	%	July 2032	$	850
5.000	%	July 2035	$	1,250
3.450	%	July 2037	€	500	(b)
4.050	%	July 2055	€	500	(b)

(a)Excludes debt issuance costs, discounts and premiums.

(b)These notes, issued in euros, were designated as net investment hedges to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.

Consolidated Statement of Equity - USD ($)
shares in Thousands, $ in Millions

Total

Common Stock, par value 1-2/3 cents per share

Capital In Excess Of Par Value

Retained Earnings

Accumulated Other Comprehensive Loss

Total Common Shareholders' Equity

Noncontrolling Interests

Treasury Stock, Common

Stock Repurchased During Period, Value

$ (1,000)

Balance, beginning of year, repurchased common stock at Dec. 31, 2022

(490,000)

Balance, end of year, repurchased common stock at Dec. 30, 2023

(493,000)

Balance, outstanding, beginning of year (in shares) at Dec. 31, 2022

1,377,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock Repurchased During Period, Shares

(3,000)

(6,000)

Balance, outstanding, end of year (in shares) at Dec. 30, 2023

1,374,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Share-based compensation expense

$ 379

Stock option exercises, RSUs and PSUs converted

(107)

$ 223

Share-based Payment Arrangement, Decrease for Tax Withholding Obligation

(140)

Other

(5)

Share repurchases

$ 0

Stock option exercises (in shares)

3,000

Other (in shares)

Other, net

$ (3)

$ 1

Dividends, Common Stock, Cash

^[1]

$ (6,839)

Balance, beginning of year at Dec. 31, 2022

4,134

67,800

$ (15,302)

124

(39,506)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net Income (Loss) Attributable to Noncontrolling Interest

$ 81

Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

(68)

Other comprehensive income/(loss) attributable to PepsiCo

(232)

Balance, end of year at Dec. 30, 2023

18,637

$ 23

4,261

70,035

(15,534)

$ 18,503

134

(40,282)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

$ 9,074

9,074

Common Stock, Dividends, Per Share, Declared

$ 4.9450

Stock Repurchased During Period, Value

$ (1,000)

Balance, end of year, repurchased common stock at Dec. 28, 2024

(495,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock Repurchased During Period, Shares

(2,000)

(6,000)

Balance, outstanding, end of year (in shares) at Dec. 28, 2024

1,372,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Share-based compensation expense

357

Stock option exercises, RSUs and PSUs converted

(90)

$ 256

Share-based Payment Arrangement, Decrease for Tax Withholding Obligation

(135)

Other

(8)

Share repurchases

$ 0

Stock option exercises (in shares)

4,000

Other (in shares)

Other, net

(3)

$ 5

Dividends, Common Stock, Cash

^[1]

(7,347)

Net Income (Loss) Attributable to Noncontrolling Interest

$ 48

Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

(49)

Other comprehensive income/(loss) attributable to PepsiCo

(2,078)

Balance, end of year at Dec. 28, 2024

18,171

$ 23

4,385

72,266

(17,612)

18,041

130

(41,021)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

$ 9,578

9,578

Common Stock, Dividends, Per Share, Declared

$ 5.3300

Stock Repurchased During Period, Value

$ (1,000)

Balance, end of year, repurchased common stock at Dec. 27, 2025

(500,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock Repurchased During Period, Shares

(5,000)

(7,000)

Balance, outstanding, end of year (in shares) at Dec. 27, 2025

1,367,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Share-based compensation expense

280

Stock option exercises, RSUs and PSUs converted

(92)

$ 189

Share-based Payment Arrangement, Decrease for Tax Withholding Obligation

(113)

Other

(9)

Share repurchases

$ 0

Stock option exercises (in shares)

896

2,000

Other (in shares)

Other, net

$ 0

Dividends, Common Stock, Cash

^[1]

(7,718)

Net Income (Loss) Attributable to Noncontrolling Interest

$ 55

Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

(44)

Other comprehensive income/(loss) attributable to PepsiCo

2,588

Balance, end of year at Dec. 27, 2025

20,547

$ 23

$ 4,451

72,788

$ (15,024)

$ 20,406

$ 141

$ (41,832)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

$ 8,240

Common Stock, Dividends, Per Share, Declared

$ 5.6225

[1]	(a) Cash dividends declared per common share were $5.6225, $5.3300 and $4.9450 for 2025, 2024 and 2023, respectively.

Basis of Presentation and Our Segments (Schedule of Quarterly Reporting) (Details)	3 Months Ended			4 Months Ended
	Sep. 06, 2025	Jun. 14, 2025	Mar. 22, 2025	Dec. 27, 2025
U.S. and Canada
Segment Reporting Information [Line Items]
Quarterly reporting calendar, period	84 days	84 days	84 days	112 days
International Divisions
Segment Reporting Information [Line Items]
Quarterly Financial Information, Reporting Calendar, Period	June, July and August	March, April and May	January and February	September, October, November and December

Restructuring and Impairment Charges (Expected Pre-Tax Charges for 2019 Productivity Plan) (Details) - 2019 Productivity Plan [Member] $ in Millions	Dec. 27, 2025 USD ($)
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost	$ 6,150
Restructuring and Related Cost, Expected Cash Expenditures	$ 5,100
Severance and Other Employee Costs
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	50.00%
Asset Impairments
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	15.00%
Other Costs
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	35.00%
Corporate
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	15.00%
PepsiCo Foods North America [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	20.00%
International Beverage Franchise [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	2.00%
PepsiCo Beverages North America [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	25.00%
Latin America Foods (Segment) [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	10.00%
Europe, Middle East & Africa (Segment) [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	25.00%
Asia Pacific Foods (Segment) [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs	3.00%

Pension, Retiree Medical and Savings Plans (Weighted-Average Assumptions to Determine Projected Benefit Liability and Benefit Expense for Pension and Retiree Medical Plans) (Details)	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Discount rate	5.50%	5.70%	5.10%
Service Cost Discount Rate	5.80%	5.10%	5.40%
Interest cost discount rate	5.40%	5.10%	5.40%
Expected return on plan assets	7.50%	7.40%	7.40%
Rate of salary increases	3.10%	3.90%	3.90%
Rate of salary increases	3.90%	3.90%	3.20%
International
Defined Benefit Plan Disclosure [Line Items]
Discount rate	5.80%	5.50%	5.10%
Service Cost Discount Rate	7.80%	6.90%	7.00%
Interest cost discount rate	5.30%	5.00%	5.40%
Expected return on plan assets	5.80%	5.80%	5.70%
Rate of salary increases	4.50%	4.00%	4.30%
Rate of salary increases	4.00%	4.30%	4.20%
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Discount rate	5.20%	5.50%	5.10%
Service Cost Discount Rate	5.60%	5.10%	5.40%
Interest cost discount rate	5.20%	5.00%	5.30%
Expected return on plan assets	7.10%	7.10%	7.10%

Share-Based Compensation Share-Based Compensation (Restricted Stock Units Activity) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Beginning Balance	5,366
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance	5,109	5,366
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance	4,411
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted	2,199
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations	(607)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 153.22	$ 164.25	$ 171.11
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(1,849)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	$ 163.78
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$ 163.47
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	1 year 3 months 18 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Aggregate Intrinsic Value	$ 734,635
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value	$ 162.11
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Weighted Average Remaining Contractual Term	1 year 2 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Aggregate Intrinsic Value	$ 634,185
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 161.72	$ 166.09
Performance Shares [Member] \| Target Award Level
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares	700
Performance Shares [Member] \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares	0
Performance Shares [Member] \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares	1,400

Debt Obligations and Commitments (Schedule of Long and Short-Term Debt Contractual Commitments) - Euro (Details) € in Millions	Dec. 27, 2025 EUR (€)
Three Point Four Five Percent Notes Due July 2037 \| Notes Due 2037
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	3.45%
Debt Instrument, Face Amount	€ 500
Four Point Zero Five Percent Notes Due July 2055 \| Notes Due 2055
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	4.05%
Debt Instrument, Face Amount	€ 500

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482900/835-30-50-1

+ Details

Document and Entity Information - USD ($) $ in Billions	12 Months Ended
Document and Entity Information - USD ($) $ in Billions	Dec. 27, 2025	Jan. 23, 2026	Jun. 13, 2025
Document and Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 27, 2025
Document Transition Report	false
Entity File Number	1-1183
Entity Registrant Name	PepsiCo, Inc.
Entity Incorporation, State or Country Code	NC
Entity Tax Identification Number	13-1584302
Entity Address, Address Line One	700 Anderson Hill Road
Entity Address, City or Town	Purchase
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10577
City Area Code	(914)
Local Phone Number	253-2000
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 179.0
Entity Common Stock, Shares Outstanding		1,366,649,053
Documents Incorporated by Reference [Text Block]	Portions of the Proxy Statement relating to PepsiCo, Inc.’s 2026 Annual Meeting of Shareholders are incorporated by reference into Part III of this Form 10-K.
Amendment Flag	false
Entity Central Index Key	0000077476
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-27
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Common Stock, par value 1-2/3 cents per share
Document and Entity Information [Line Items]
Title of 12(b) Security	Common Stock, par value 1-2/3 cents per share
Trading Symbol	PEP
Security Exchange Name	NASDAQ
2.625% Senior Notes Due 2026
Document and Entity Information [Line Items]
Title of 12(b) Security	2.625% Senior Notes Due 2026
Trading Symbol	PEP26
Security Exchange Name	NASDAQ
0.750% Senior Notes Due 2027
Document and Entity Information [Line Items]
Title of 12(b) Security	0.750% Senior Notes Due 2027
Trading Symbol	PEP27
Security Exchange Name	NASDAQ
0.875% Senior Notes Due 2028
Document and Entity Information [Line Items]
Title of 12(b) Security	0.875% Senior Notes Due 2028
Trading Symbol	PEP28
Security Exchange Name	NASDAQ
0.500% Senior Notes Due 2028
Document and Entity Information [Line Items]
Title of 12(b) Security	0.500% Senior Notes Due 2028
Trading Symbol	PEP28A
Security Exchange Name	NASDAQ
3.200% Senior Notes Due 2029
Document and Entity Information [Line Items]
Title of 12(b) Security	3.200% Senior Notes Due 2029
Trading Symbol	PEP29
Security Exchange Name	NASDAQ
1.125% Senior Notes Due 2031
Document and Entity Information [Line Items]
Title of 12(b) Security	1.125% Senior Notes Due 2031
Trading Symbol	PEP31
Security Exchange Name	NASDAQ
0.400% Senior Notes Due 2032
Document and Entity Information [Line Items]
Title of 12(b) Security	0.400% Senior Notes Due 2032
Trading Symbol	PEP32
Security Exchange Name	NASDAQ
0.750% Senior Notes Due 2033
Document and Entity Information [Line Items]
Title of 12(b) Security	0.750% Senior Notes Due 2033
Trading Symbol	PEP33
Security Exchange Name	NASDAQ
3.550% Senior Notes Due 2034
Document and Entity Information [Line Items]
Title of 12(b) Security	3.550% Senior Notes Due 2034
Trading Symbol	PEP34
Security Exchange Name	NASDAQ
3.450% Senior Notes Due 2037
Document and Entity Information [Line Items]
Title of 12(b) Security	3.450% Senior Notes Due 2037
Trading Symbol	PEP37
Security Exchange Name	NASDAQ
0.875% Senior Notes Due 2039
Document and Entity Information [Line Items]
Title of 12(b) Security	0.875% Senior Notes Due 2039
Trading Symbol	PEP39
Security Exchange Name	NASDAQ
1.050% Senior Notes Due 2050
Document and Entity Information [Line Items]
Title of 12(b) Security	1.050% Senior Notes Due 2050
Trading Symbol	PEP50
Security Exchange Name	NASDAQ
4.050% Senior Notes Due 2055
Document and Entity Information [Line Items]
Title of 12(b) Security	4.050% Senior Notes Due 2055
Trading Symbol	PEP55
Security Exchange Name	NASDAQ

Net Income Attributable to PepsiCo per Common Share

12 Months Ended

Dec. 27, 2025

Earnings Per Share [Abstract]

Net Income Attributable To PepsiCo Per Common Share

Net Income Attributable to PepsiCo per Common Share

The computations of basic and diluted net income attributable to PepsiCo per common share are as follows:


	2025			2024			2023
	Income		Shares(a)	Income		Shares(a)	Income		Shares(a)
Basic net income attributable to PepsiCo per common share	$	6.02		$	6.97		$	6.59
Net income available for PepsiCo common shareholders	$	8,240	1,369	$	9,578	1,373	$	9,074	1,376
Dilutive securities:
Stock options, RSUs, PSUs and other (b)	—		4	—		5	—		7

Diluted	$	8,240	1,373	$	9,578	1,378	$	9,074	1,383
Diluted net income attributable to PepsiCo per common share	$	6.00		$	6.95		$	6.56

(a)Weighted-average common shares outstanding (in millions).

(b)The dilutive effect of these securities is calculated using the treasury stock method.

The weighted-average amount of antidilutive securities excluded from the calculation of diluted earnings per common share was 8 million, 4 million and 3 million for the years ended December 27, 2025, December 28, 2024 and December 30, 2023, respectively.

Financial Instruments - Losses (Gains) On Derivative Instruments - Cash-flow Hedges (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Derivatives, Fair Value [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, before Reclassification and Tax	$ (186)	$ 6	$ 188
Foreign Exchange Forward Contracts \| Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, before Reclassification and Tax	95	(101)
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement - Foreign Currency Cash Flow Hedge (Gain) Loss Reclassified to Earnings, Net	12	(6)
Commodity Contracts \| Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, before Reclassification and Tax	(218)	57
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement - Commodity contracts	(77)	123
Cross Currency Interest Rate Contract [Member] \| Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, before Reclassification and Tax	(63)	46
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement - Cross-currency contracts	(67)	48
Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Loss (Gain) on Cash Flow Hedge Recognized in Net Income, Net, Pretax	(132)	165
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, before Reclassification and Tax	$ (186)	$ 2

Share-Based Compensation Share-Based Compensation (Other Stock-Based Compensation Data) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,804	2,034	2,162
Weighted-average grant-date fair value per unit of options granted	$ 21.13	$ 27.29	$ 29.81
Total intrinsic value of options exercised (a)	$ 35,558	$ 99,388	$ 100,209
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	32,506	14,759	$ 11,830
LiabilityAwards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
LiabilityAwardsNonvestedNumber	57,035	$ 53,970
LiabilityAwardsNonvestedBalanceSheetFairValue	$ 36,064
LiabilityAwardsNonvestedRemainingContractualTerm	1 year 2 months 12 days
LiabilityAwardsGranted	$ 21,636
Liability Awards Vested	(11,274)
LiabilityAwardsForfeituresExpirations	(7,297)
LiabilityAwardsExpectedtoVest,Outstanding,Number	54,169
LiabilityAwardsExpectedtoVest,BalanceSheetFairValue	$ 33,597
LiabilityAwardsExpectedtoVest,RemainingContractualTerm	1 year 2 months 12 days
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding	$ 57,000
Performance Shares [Member] \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding	0
Performance Shares [Member] \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding	$ 114,000
Restricted Stock Units (RSUs)
Equity Instruments Other Than Options
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	2,199	2,348	2,151
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 153.22	$ 164.25	$ 171.11
Total intrinsic value of converted units	$ 299,958	$ 372,612	$ 396,123
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	$ 300,591	$ 280,673	$ 286,605

Share-Based Compensation Share-Based Compensation (Policies)	12 Months Ended
	Dec. 27, 2025
Share-Based Payment Arrangement [Abstract]
Share-based Payment Arrangement	The fair value of share-based award grants is amortized to expense over the vesting period, primarily three years. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. In addition, we use historical data to estimate forfeiture rates and record share-based compensation expense only for those awards that are expected to vest. We do not backdate, reprice or grant share-based compensation awards retroactively. Repricing of awards would require shareholder approval under the LTIP.

- Definition

Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.

+ References

+ Details

Income Taxes (Narrative) (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2025 USD ($) $ / shares	Dec. 28, 2024 USD ($) $ / shares	Dec. 30, 2023 USD ($)
Income Tax Contingency [Line Items]
Deferred Tax Assets, Goodwill and Intangible Assets	$ 1,996	$ 1,599
Reserves For Income Taxes	(2,400)
Interest accrued	450	469
Interest accrued recognized	(2)	103
Operating loss carryforwards	35,500
Income tax undistributed international earnings	12,000
Transition tax liability	965
Transition tax, payments made	772	579	$ 309
Tax benefit related to impairment of certain investments for local statutory reporting	$ 54	$ 68
Tax benefit related to impairment of certain investments for local statutory reporting - per share amount \| $ / shares	$ 0.04	$ 0.05
Global Minimum Tax	0.15
Expire in 2026
Income Tax Contingency [Line Items]
Operating loss carryforwards	$ 800
Expire Between 2027 and 2044
Income Tax Contingency [Line Items]
Operating loss carryforwards	29,900
Carried Forward Indefinitely
Income Tax Contingency [Line Items]
Operating loss carryforwards	$ 4,800

Pension, Retiree Medical and Savings Plans Retiree Medical Cost Trend Rates (Details)	12 Months Ended
	Dec. 26, 2026	Dec. 27, 2025
Defined Benefit Plans and Other Postretirement Benefit Plans Table [Line Items]
Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year		5.00%
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate		4.00%
Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate		2046
Forecast [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table [Line Items]
Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year	8.00%
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate	4.00%
Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate	2046

Consolidated Statement of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Operating Activities
Net income	$ 8,295	$ 9,626	$ 9,155
Depreciation and amortization	3,451	3,160	2,948
Impairment and other charges	1,946	714	1,230
Product recall-related impact	0	187	136
Payments for product recall-related impact	(6)	(148)	0
Operating lease right-of-use asset amortization	727	655	570
Share-based compensation expense	288	362	380
Restructuring Charges	983	727	445
Cash payments for restructuring charges	(796)	(436)	(434)
Pension and retiree medical plan expenses	504	414	150
Pension and retiree medical plan contributions	(472)	(348)	(410)
Deferred income taxes and other tax charges and credits	71	(42)	(271)
Tax payments related to the TCJ Act	(772)	(579)	(309)
Change in assets and liabilities [Abstract]
Accounts and notes receivable	(580)	(138)	(793)
Inventories	(150)	(314)	(261)
Prepaid expenses and other current assets	195	40	(13)
Accounts payable and other current liabilities	(677)	(943)	420
Income taxes payable	(433)	(123)	310
Other, net	(712)	(311)	189
Net Cash Provided by Operating Activities	12,087	12,507	13,442
Investing Activities
Capital spending	(4,415)	(5,318)	(5,518)
Sales of property, plant and equipment	528	342	198
Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets	(3,391)	(256)	(314)
Divestitures, sales of investments in noncontrolled affiliates and other assets	39	166	75
Short-term investments, by original maturity:
More than three months - purchases	(190)	(425)	(555)
More than three months - maturities	605	0	556
More than three months - Sales	0	0	12
Three months or less, net	45	5	3
Other investing, net	(100)	14	48
Net Cash Used for Investing Activities	(6,879)	(5,472)	(5,495)
Financing Activities
Proceeds from issuances of long-term debt	8,189	4,042	5,482
Payments of long-term debt	(4,082)	(3,886)	(3,005)
Short-term borrowings, by original maturity
More than three months - proceeds	6,391	5,786	5,428
More than three months - payments	(7,920)	(5,639)	(3,106)
Three months or less, net	1,170	392	(29)
Cash dividends paid	(7,638)	(7,229)	(6,682)
Share repurchases - common	(1,000)	(1,000)	(1,000)
Proceeds from exercises of stock options	97	166	116
Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted	(113)	(135)	(140)
Other financing	(73)	(53)	(73)
Net Cash Used for Financing Activities	(4,979)	(7,556)	(3,009)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	422	(687)	(277)
Net Increase/(Decrease) in Cash and Cash Equivalents and Restricted Cash	651	(1,208)	4,661
Cash and cash equivalents and restricted cash	9,204	8,553	9,761
Acquisition and divestiture-related charges	453	22	41
Payments for Merger Related Costs	$ (228)	$ (18)	$ (41)

Pension, Retiree Medical and Savings Plans (Selected Information About Plans with Liability for Service to Date and Total Benefit Liability in Excess of Plan Assets) (Details) - USD ($) $ in Millions	Dec. 27, 2025	Dec. 28, 2024
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit, Unfunded plans	$ 632
Domestic Plan
Selected information for plans with accumulated benefit obligation in excess of plan assets
Obligation for service to date	(7,123)	$ (7,315)
Fair value of plan assets	6,480	6,399
Selected information for plans with projected benefit obligation in excess of plan assets
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation	(7,126)	(7,502)
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets	6,480	6,399
Foreign Plan [Member]
Selected information for plans with accumulated benefit obligation in excess of plan assets
Obligation for service to date	(279)	(194)
Fair value of plan assets	177	135
Selected information for plans with projected benefit obligation in excess of plan assets
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation	(435)	(346)
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets	177	165
Retiree Medical Plan
Selected information for plans with projected benefit obligation in excess of plan assets
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation	(623)	(616)
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets	$ 155	$ 163

Income Taxes - Schedule for Principal Reasons for Difference in Effective and Statutory Tax Rates (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Effective Income Tax Rate Reconciliation [Line Items]
Effective Income Tax Rate Reconciliation, Cross-Border, Transfer pricing adjustments, Amount	$ 128
Effective Income Tax Rate Reconciliation, GILTI, Percent	1.10%
Effective Income Tax Rate Reconciliation, GILTI, Amount	$ 115
Effective Income Tax Rate Reconciliation, Cross-Border, Other, Amount	$ (110)
Effective Income Tax Rate Reconciliation, Cross-Border, Other, Percent	(1.00%)
Effective Income Tax Rate Reconciliation, Tax Credit, Percent	(0.30%)
Effective Income Tax Rate Reconciliation, Tax Credit, Amount	$ (29)
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent	1.80%
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount	$ 181
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent	(0.30%)
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount	$ (31)
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent	1.50%	(0.40%)	(0.40%)
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	$ 147
Effective Income Tax Rate Reconciliation, Percent	19.00%	19.40%	19.80%
Provision for income taxes	$ 1,949	$ 2,320	$ 2,262
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	$ 2,151
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%	21.00%	21.00%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent	0.20%	1.30%	1.80%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	$ 25
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent		(2.50%)	(2.50%)
Effective Income Tax Rate Reconciliation, Cross-Border, Transfer pricing adjustments, Percent	1.30%
International Reorganization		0.00%	(0.10%)
IRELAND \| Statutory Income Tax Rate Differential [Domain]
Effective Income Tax Rate Reconciliation [Line Items]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	(1.20%)
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount	$ (119)
IRELAND \| Other Adjustments [Domain]
Effective Income Tax Rate Reconciliation [Line Items]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	0.20%
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount	$ 24
SINGAPORE \| Other Adjustments [Domain]
Effective Income Tax Rate Reconciliation [Line Items]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	(0.30%)
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount	$ (26)
SINGAPORE \| Tax Incentive [Domain]
Effective Income Tax Rate Reconciliation [Line Items]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	(1.10%)
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount	$ (113)
Foreign Tax Jurisdiction, Other
Effective Income Tax Rate Reconciliation [Line Items]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	0.20%
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount	$ 21
BERMUDA \| Statutory Income Tax Rate Differential [Domain]
Effective Income Tax Rate Reconciliation [Line Items]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	(3.00%)
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount	$ (310)
SWITZERLAND
Effective Income Tax Rate Reconciliation [Line Items]
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	(1.50%)
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	$ (149)
SWITZERLAND \| Other Adjustments [Domain]
Effective Income Tax Rate Reconciliation [Line Items]
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent	0.30%
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount	$ 32
Domestic Tax Jurisdiction
Effective Income Tax Rate Reconciliation [Line Items]
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	0.10%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	$ 12

Debt Obligations and Commitments (Narrative) (Details) - USD ($) $ in Millions	Dec. 27, 2025	Dec. 28, 2024
Debt Instrument [Line Items]
Line of Credit Facility, Outstanding Borrowings	$ 0
International Divisions
Debt Instrument [Line Items]
Line of Credit Facility, Amount Outstanding	272	$ 325
Multi Tranche Notes Due 2023-2026 \| Defeasance of Long Term Debt
Debt Instrument [Line Items]
Debt Instrument, Repurchase Amount		102
Debt Instrument, Face Amount		94
Five Year Unsecured Revolving Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity	5,000	5,000
Line of Credit Swing Line Subfacility	750
Line of Credit Facility, Maximum Borrowing Capacity	5,750
364 Day Unsecured Revolving Credit Agreement Member
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity	5,000	$ 5,000
Line of Credit Facility, Maximum Borrowing Capacity	$ 5,750

Pension, Retiree Medical and Savings Plans

12 Months Ended

Dec. 27, 2025

Retirement Benefits, Description [Abstract]

Pension, Retiree Medical and Savings Plans

In 2025 and 2024, we recognized pre-tax settlement charges of $237 million ($183 million after-tax or $0.13 per share) and $213 million ($165 million after-tax or $0.12 per share), respectively, in a U.S. qualified defined benefit pension plan due to lump sum distributions to retired or terminated employees and the purchases of group annuity contracts whereby a third-party insurance company assumed the obligation to pay and administer future benefit payments for certain retirees. The settlement charges were triggered when the aggregate of the cumulative lump sum distributions and the annuity contract premiums exceeded the total annual service and interest cost.

As of December 31, 2025, benefit accruals for salaried participants in the U.S. qualified defined benefit plans were frozen.

Gains and losses resulting from actual experience differing from our assumptions, including the difference between the actual and expected return on plan assets, as well as changes in our assumptions, are determined at each measurement date. These differences are recognized as a component of net gain or loss in accumulated other comprehensive loss within common shareholders’ equity. If this net accumulated gain or loss exceeds 10% of the greater of the market-related value of plan assets or plan obligations, a portion of the net gain or loss is included in other pension and retiree medical benefits (expense)/income for the following year based upon the average remaining service life for participants in PepsiCo Employees Retirement Hourly Plan (Plan H) (approximately 10 years) and retiree medical (approximately 12 years), and the remaining life expectancy for participants in PepsiCo Employees Retirement Plan I (Plan I) (approximately 26 years).

The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost/(credit)) is included in other pension and retiree medical benefits (expense)/income on a straight-line basis over the average remaining service life for participants in Plan H, and the remaining life expectancy for participants in Plan I, except that prior service cost/(credit) for salaried participants subject to the benefit accruals freeze effective December 31, 2025 was amortized on a straight-line basis over the period up to the effective date of the freeze.

Selected financial information for our pension and retiree medical plans is as follows:


	Pension								Retiree Medical
	U.S.				International
	2025		2024		2025		2024		2025		2024
Change in projected benefit obligation
Obligation at beginning of year	$	11,324	$	12,035	$	2,786	$	2,986	$	616	$	677
Service cost	312		347		47		46		31		31
Interest cost	586		585		152		144		30		32
Plan amendments	10		12		1		1		—		—
Participant contributions	—		—		2		2		—		—
Experience loss/(gain)	247		(563)		(74)		(55)		18		(44)
Benefit payments	(640)		(617)		(112)		(108)		(74)		(78)
Settlement/curtailment	(678)		(506)		(109)		(62)		—		—
Special termination benefits	21		31		—		—		—		1
Other, including foreign currency adjustment	—		—		234		(168)		2		(3)
Obligation at end of year	11,182		11,324		2,927		2,786		623		616

Change in fair value of plan assets
Fair value at beginning of year	10,609		11,541		3,397		3,528		163		183
Actual return on plan assets	1,296		(10)		149		142		15		5
Employer contributions/funding	354		236		67		59		51		53
Participant contributions	—		—		2		2		—		—
Benefit payments	(640)		(617)		(112)		(108)		(74)		(78)
Settlement	(670)		(539)		(109)		(62)		—		—
Other, including foreign currency adjustment	—		(2)		258		(164)		—		—
Fair value at end of year	10,949		10,609		3,652		3,397		155		163
Funded status	$	(233)	$	(715)	$	725	$	611	$	(468)	$	(453)





Amounts recognized
Other assets	$	413	$	388	$	983	$	792	$	—	$	—
Other current liabilities	(61)		(85)		(14)		(10)		(55)		(52)
Other liabilities	(585)		(1,018)		(244)		(171)		(413)		(401)
Net amount recognized	$	(233)	$	(715)	$	725	$	611	$	(468)	$	(453)

Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	$	3,035	$	3,618	$	612	$	633	$	(295)	$	(333)
Prior service cost/(credit)	61		54		(3)		(5)		(9)		(14)
Total	$	3,096	$	3,672	$	609	$	628	$	(304)	$	(347)

Changes recognized in net loss/(gain) included in other comprehensive loss
Net (gain)/loss arising in current year	$	(252)	$	320	$	(21)	$	8	$	14	$	(36)
Amortization and settlement recognition	(331)		(298)		(59)		(43)		25		25
Foreign currency translation loss/(gain)	—		—		59		(39)		(1)		1
Total	$	(583)	$	22	$	(21)	$	(74)	$	38	$	(10)

Accumulated benefit obligation at end of year	$	11,093	$	11,069	$	2,740	$	2,638

The net gain arising in the current year is primarily attributable to higher actual asset return as compared to expected return on plan assets, partially offset by losses due to changes in discount rates and demographic experience.

The amount we report in operating profit as pension and retiree medical cost is service cost, which is the value of benefits earned by employees for working during the year.

The amounts we report below operating profit as pension and retiree medical cost consist of the following components:

•Interest cost is the accrued interest on the projected benefit obligation due to the passage of time.

•Expected return on plan assets is the long-term return we expect to earn on plan investments for our funded plans that will be used to settle future benefit obligations.

•Amortization of prior service cost/(credit) represents the recognition in the income statement of benefit changes resulting from plan amendments.

•Amortization of net loss/(gain) represents the recognition in the income statement of changes in the amount of plan assets and the projected benefit obligation based on changes in assumptions and actual experience.

•Settlement/curtailment loss/(gain) represents the result of actions that effectively eliminate all or a portion of related projected benefit obligations. Settlements are triggered when payouts to settle the projected benefit obligation of a plan due to lump sums or other events exceed the total of annual service and interest cost. Settlements are recognized when actions are irrevocable and we are relieved of the primary responsibility and risk for projected benefit obligations. Lump sum payouts are generally higher when interest rates are lower. Curtailments are recognized when events such as plant closures, the sale of a business, or plan changes result in a significant reduction of future service or benefits. Curtailment losses are recognized when an event is probable and estimable, while curtailment gains are recognized when an event has occurred (when the related employees terminate or an amendment is adopted).

•Special termination benefits are the additional benefits offered to employees upon departure due to actions such as restructuring.

The components of total pension and retiree medical benefit costs are as follows:


	Pension												Retiree Medical
	U.S.						International
	2025		2024		2023		2025		2024		2023		2025		2024		2023
Service cost	$	312	$	347	$	327	$	47	$	46	$	43	$	31	$	31	$	29
Other pension and retiree medical benefits expense/(income):
Interest cost	586		585		593		152		144		141		30		32		36
Expected return on plan assets	(805)		(871)		(851)		(202)		(205)		(192)		(11)		(13)		(13)
Amortization of prior service costs/(credits)	3		(24)		(26)		(1)		(2)		(1)		(5)		(5)		(6)
Amortization of net losses/(gains)	84		77		70		27		21		13		(25)		(25)		(27)
Net settlement/curtailment losses (a)	247		254		4		32		22		10		—		—		—
Special termination benefits	21		31		(1)		—		—		—		—		1		—
Total other pension and retiree medical benefits expense/(income)	136		52		(211)		8		(20)		(29)		(11)		(10)		(10)
Total	$	448	$	399	$	116	$	55	$	26	$	14	$	20	$	21	$	19

(a)In 2025 and 2024, U.S. includes settlement charges of $237 million ($183 million after-tax or $0.13 per share) and $213 million ($165 million after-tax or $0.12 per share), respectively, related to the aggregate of lump sum distributions and the purchases of group annuity contracts exceeding the total of annual service and interest cost.

The following table provides the weighted-average assumptions used to determine net periodic benefit cost and projected benefit obligation for our pension and retiree medical plans:


	Pension												Retiree Medical
	U.S.						International
	2025		2024		2023		2025		2024		2023		2025		2024		2023
Net Periodic Benefit Cost
Service cost discount rate	5.8	%	5.1	%	5.4	%	7.8	%	6.9	%	7.0	%	5.6	%	5.1	%	5.4	%
Interest cost discount rate	5.4	%	5.1	%	5.4	%	5.3	%	5.0	%	5.4	%	5.2	%	5.0	%	5.3	%
Expected return on plan assets	7.5	%	7.4	%	7.4	%	5.8	%	5.8	%	5.7	%	7.1	%	7.1	%	7.1	%
Rate of salary increases	3.9	%	3.9	%	3.2	%	4.0	%	4.3	%	4.2	%

Projected Benefit Obligation
Discount rate	5.5	%	5.7	%	5.1	%	5.8	%	5.5	%	5.1	%	5.2	%	5.5	%	5.1	%
Rate of salary increases	3.1	%	3.9	%	3.9	%	4.5	%	4.0	%	4.3	%

The following table provides selected information about plans with accumulated benefit obligation and total projected benefit obligation in excess of plan assets:


	Pension								Retiree Medical
	U.S.				International
	2025		2024		2025		2024		2025		2024
Selected information for plans with accumulated benefit obligation in excess of plan assets
Obligation for service to date	$	(7,123)	$	(7,315)	$	(279)	$	(194)
Fair value of plan assets	$	6,480	$	6,399	$	177	$	135
Selected information for plans with projected benefit obligation in excess of plan assets
Benefit obligation	$	(7,126)	$	(7,502)	$	(435)	$	(346)	$	(623)	$	(616)
Fair value of plan assets	$	6,480	$	6,399	$	177	$	165	$	155	$	163

Of the total projected pension benefit obligation as of December 27, 2025, approximately $632 million relates to plans that we do not fund because the funding of such plans does not receive favorable tax treatment.

Future Benefit Payments

Our estimated future benefit payments are as follows:


	2026		2027		2028		2029		2030		2031 - 2035
Pension	$	1,259	$	963	$	951	$	977	$	999	$	5,242
Retiree medical (a)	$	76	$	74	$	72	$	70	$	68	$	305

(a)Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be less than $1 million for each of the years from 2026 through 2030 and approximately $2 million in total for 2031 through 2035.

These future benefit payments to beneficiaries include payments from both funded and unfunded plans.

Funding

Contributions to our pension and retiree medical plans were as follows:


	Pension						Retiree Medical
	2025		2024		2023		2025		2024		2023
Discretionary (a)	$	261	$	161	$	267	$	—	$	—	$	—
Non-discretionary	160		134		97		51		53		46
Total	$	421	$	295	$	364	$	51	$	53	$	46

(a)Includes $250 million contribution in 2025, $150 million contribution in 2024 and $250 million contribution in 2023 to fund our U.S. qualified defined benefit plans.

We made discretionary contributions of $200 million to a U.S. qualified defined benefit plan and $52 million to our international pension benefit plans in January 2026. In addition, in 2026, we expect to make non-discretionary contributions of approximately $80 million to our U.S. and international pension benefit plans and contributions of approximately $55 million for retiree medical benefits.

We also regularly evaluate opportunities to reduce risk and volatility associated with our pension and retiree medical plans.

Plan Assets

Our pension plan investment strategy includes the use of actively managed accounts and is reviewed periodically in conjunction with plan obligations, an evaluation of market conditions, tolerance for risk and cash requirements for benefit payments. This strategy is also applicable to funds held for the retiree medical plans. Our investment objective includes ensuring that funds are available to meet the plans’ benefit obligations when they become due. Assets contributed to our pension plans are no longer controlled by us, but become the property of our individual pension plans. However, we are indirectly impacted by changes in these plan assets as compared to changes in our projected obligations. Our overall investment policy is to prudently invest plan assets in a well-diversified portfolio of equity and high-quality debt securities and real estate to achieve our long-term return expectations. Our investment policy also permits the use of derivative instruments, such as futures and forward contracts, to reduce interest rate and foreign currency risks. Futures contracts represent commitments to purchase or sell securities at a future date and at a specified price. Forward contracts consist of currency forwards. We also participate in securities lending programs to generate additional income by loaning plan assets to borrowers on a fully collateralized basis, including both cash and non-cash collaterals.

For 2026 and 2025, our expected long-term rate of return on U.S. plan assets is 7.8% and 7.5%, respectively. Our target investment allocations for U.S. plan assets are as follows:


	2026		2025
Fixed income	58	%	56	%
U.S. equity	22	%	22	%
International equity	16	%	18	%
Real estate	4	%	4	%

Actual investment allocations may vary from our target investment allocations due to prevailing market conditions. We regularly review our actual investment allocations and periodically rebalance our investments.

The expected return on plan assets is based on our investment strategy and our expectations for long-term rates of return by asset class, taking into account volatility and correlation among asset classes and our historical experience. We also review current levels of interest rates and inflation to assess the reasonableness of the long-term rates. We evaluate our expected return assumptions annually to ensure

that they are reasonable. To calculate the expected return on plan assets, our market-related value of assets for fixed income is the actual fair value. For all other asset categories, such as equity securities, we use a method that recognizes investment gains or losses (the difference between the expected and actual return based on the market-related value of assets) over a five-year period. This has the effect of reducing year-to-year volatility.

Plan assets measured at fair value as of year-end 2025 and 2024 are categorized consistently by Level 1 (quoted prices in active markets for identical assets), Level 2 (significant other observable inputs) and Level 3 in both years and are as follows:


	Fair Value Hierarchy Level	2025		2024
U.S. plan assets (a)(b)
Equity securities, including preferred stock (c)	1	$	4,248	$	4,270
Government securities (d)	2	1,573		1,538
Corporate bonds (d)	2	3,963		3,903
Mortgage-backed securities (d)	2	134		125
Contracts with insurance companies (e)	3	1		1
Cash and cash equivalents (f) (g)	1, 2	700		732
Sub-total U.S. plan assets		10,619		10,569
Investments measured at net asset value (h)		817		561
Securities lending payables, net of dividends and interest receivable (g)		(332)		(358)
Total U.S. plan assets		$	11,104	$	10,772
International plan assets
Equity securities (c)	1	$	1,215	$	1,172
Government securities (d)	2	987		932
Corporate bonds (d)	2	610		469
Fixed income commingled funds (i)	1	616		557
Contracts with insurance companies (e)	3	—		29
Cash and cash equivalents	1	85		128
Sub-total international plan assets		3,513		3,287
Investments measured at net asset value (h)		122		79
Dividends and interest receivable		17		31
Total international plan assets		$	3,652	$	3,397

(a)Includes $155 million and $163 million in 2025 and 2024, respectively, of retiree medical plan assets that are restricted for purposes of providing health benefits for U.S. retirees and their beneficiaries.

(b)Includes securities loaned to borrowers under the securities lending program with fair value of $649 million and $630 million in 2025 and 2024, respectively.

(c)Invested in U.S. and international common stock and commingled funds, and the preferred stock portfolio was invested in domestic and international corporate preferred stock investments. The common and preferred stock investments are based on quoted prices in active markets. The commingled funds are based on the published price of the fund and include one large-cap fund that represents 12% of total U.S. plan assets for both 2025 and 2024.

(d)These investments are based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets. Corporate bonds of U.S.-based companies represents 31% of total U.S. plan assets for both 2025 and 2024.

(e)Based on the fair value of the contracts as determined by the insurance companies using inputs that are not observable. During 2025, our international plans liquidated Level 3 investments, resulting in no Level 3 assets as of year-end. The changes in U.S. Level 3 amounts were not significant in the years ended December 27, 2025 and December 28, 2024.

(f)Includes Level 1 assets of $446 million and $456 million, and Level 2 assets of $254 million and $276 million for 2025 and 2024, respectively.

(g)Includes $430 million and $447 million of cash collateral for 2025 and 2024, respectively, under the securities lending program offset by corresponding securities lending payable of the same amount. The net impact on the fair value of U.S. plan assets is zero.

(h)Includes investments in private credit funds, limited partnerships and mortgage funds. These funds are based on the net asset value of the investments owned by these funds as determined by independent third parties using inputs that are not observable. The majority of the funds are redeemable quarterly subject to availability of cash and have notice periods ranging from 30 to 90 days.

(i)Based on the published price of the fund.

Retiree Medical Cost Trend Rates

The assumed health care cost trend rates are as follows:


	2026		2025
Average increase assumed	8	%	5	%
Ultimate projected increase	4	%	4	%
Year of ultimate projected increase	2046		2046

Annually, we review external data and our historical experience to estimate assumed health care cost trend rates that impact our retiree medical plan obligation and expense, however the cap on our share of retiree medical costs limits the impact.

Savings Plan

Certain U.S. employees are eligible to participate in a 401(k) savings plan, which is a voluntary defined contribution plan. The plan is designed to help employees accumulate savings for retirement and we make Company matching contributions for certain employees on a portion of employee contributions based on years of service.

Certain U.S. employees, who are either not eligible to participate in a defined benefit pension plan or whose benefit is capped, are also eligible to receive an employer contribution based on either years of service or age and years of service regardless of employee contribution.

In 2025, 2024 and 2023, our total Company contributions were $434 million, $411 million and $356 million, respectively.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (o)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (p)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (q)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 60
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480266/715-60-50-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 70
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480794/715-70-50-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480482/715-20-55-17

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/715/tableOfContent

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

+ Details

Leases, Codification Topic 842 (Policies)	12 Months Ended
Leases, Codification Topic 842 (Policies)	Dec. 27, 2025
Leases [Abstract]
Lessee, Leases	Lessee We determine whether an arrangement is a lease at inception. We have operating leases for plants, warehouses, distribution centers, storage facilities, offices and other facilities, as well as machinery and equipment, including fleet. Our leases generally have remaining lease terms of up to 20 years, some of which include options to extend the lease term for up to five years and some of which include options to terminate the lease within one year. We consider these options in determining the lease term used to establish our right-of-use assets and lease liabilities. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We have lease agreements that contain both lease and non-lease components. For real estate leases, we account for lease components together with non-lease components (e.g., common-area maintenance).
Lessor, Leases	Lessor We have various arrangements for certain foodservice and vending equipment under which we are the lessor. These leases meet the criteria for operating lease classification. Lease income associated with these leases is not material.

Insider Trading Policies and Procedures	12 Months Ended
Insider Trading Policies and Procedures	Dec. 27, 2025
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Financial Instruments - Losses (Gains) on Derivative Instruments - Fair Value Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024
Interest Rate Swap [Member] \| Fair Value Hedging
Derivative Instruments, Loss (Gain) [Line Items]
Fair Value Hedge, (Gain) Loss on Interest Rate Swap Contract	$ (62)	$ 46

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 182
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-182

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(5)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(6)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4CCC
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4CCC
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4CCC
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4CC
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (bb)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E

+ Details

Net Income Attributable to PepsiCo per Common Share (Tables)

12 Months Ended

Dec. 27, 2025

Earnings Per Share [Abstract]

Basic And Diluted Net Income Attributable To PepsiCo Per Common Share

The computations of basic and diluted net income attributable to PepsiCo per common share are as follows:


	2025			2024			2023
	Income		Shares(a)	Income		Shares(a)	Income		Shares(a)
Basic net income attributable to PepsiCo per common share	$	6.02		$	6.97		$	6.59
Net income available for PepsiCo common shareholders	$	8,240	1,369	$	9,578	1,373	$	9,074	1,376
Dilutive securities:
Stock options, RSUs, PSUs and other (b)	—		4	—		5	—		7

Diluted	$	8,240	1,373	$	9,578	1,378	$	9,074	1,383
Diluted net income attributable to PepsiCo per common share	$	6.00		$	6.95		$	6.56

(a)Weighted-average common shares outstanding (in millions).

(b)The dilutive effect of these securities is calculated using the treasury stock method.

Financial Instruments (Narrative) (Details) - USD ($)	12 Months Ended
Financial Instruments (Narrative) (Details) - USD ($)	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Derivatives, Fair Value [Line Items]
Derivative with Credit Risk Related Contingent Features Net Liability Position , Aggregate Fair Value	$ 96,000,000
Collateral Already Posted, Aggregate Fair Value	0
Debt instrument, fair value	46,000,000,000	$ 40,000,000,000
Expected reclassification of net gain/(losses) related to hedge from accumulated OCI into net income within the next 12 months	100,000,000
Cash and cash equivalents and restricted cash	9,204,000,000	8,553,000,000	$ 9,761,000,000	$ 5,100,000,000
Short-term Investments	371,000,000	$ 761,000,000
Credit-Risk-Related Contingent Features Triggered	$ 0
Gain (Loss) on Discontinuation of Cash Flow Hedge Due to Forecasted Transaction Probable of Not Occurring, Net	not material
Variable Rate [Domain]
Derivatives, Fair Value [Line Items]
Total Debt, Percentage Bearing Variable Interest, Percentage Rate	11.00%	13.00%
Commodity Contracts
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date	2 years
Foreign Exchange Contract
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date	2 years
Interest Rate Contracts
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date	6 years
Cross Currency Interest Rate Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date	12 years
Net Investment Hedge Cross Currency Interest Rate Contract
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date	10 years
Net Investment Hedge Foreign Exchange Contract
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date	1 year

Acquisitions & Divestitures (Tables)

12 Months Ended

Dec. 27, 2025

Acquisitions & Divestitures [Abstract]

Business Combination, Separately Recognized Transaction

A summary of charges is as follows:


	2025		2024		2023
Cost of sales	$	57	$	—	$	—
Selling, general and administrative expenses	346		22		41
Impairment of intangible assets	50		—		—
Total	$	453	$	22	$	41
After-tax amount	$	347	$	18	$	23
Impact on net income attributable to PepsiCo per common share	$	(0.25)	$	(0.01)	$	(0.02)


	2025		2024		2023
PFNA	$	28	$	9	$	—
PBNA	422		8		16

EMEA (a)	—		—		(2)

Asia Pacific Foods	3		5		2
Corporate	—		—		25
Total	$	453	$	22	$	41

(a)Income amount represents adjustments for changes in estimates of previously recorded amounts.

Consolidated Statement of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Net income	$ 8,295	$ 9,626	$ 9,155
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	1,723	(1,962)	(307)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax	44	113	(32)
Other comprehensive loss
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	452	5	(358)
Pension and retiree medical:
Other Comprehensive Income, Other, Net of Tax	369	(234)	465
Other Comprehensive Income/(Loss), after-tax amount	2,588	(2,078)	(232)
Comprehensive income	10,883	7,548	8,923
Comprehensive income attributable to noncontrolling interests	55	48	81
Comprehensive Income Attributable to PepsiCo	$ 10,828	$ 7,500	$ 8,842

Audit Information	12 Months Ended
Audit Information	Dec. 27, 2025
Audit Information [Abstract]
Auditor Name	KPMG LLP
Auditor Location	New York, New York
Auditor Firm ID	185

Basis of Presentation and Our Segments (Policies)

12 Months Ended

Dec. 27, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Consolidation, Policy

The accompanying consolidated financial statements have been prepared in accordance with GAAP and include the consolidated accounts of PepsiCo, Inc. and the affiliates that we control. In addition, we include our share of the results of certain other affiliates using the equity method based on our economic ownership interest, our ability to exercise significant influence over the operating or financial decisions of these affiliates or our ability to direct their economic resources. We do not control these other affiliates, as our ownership in these other affiliates is generally 50% or less. Intercompany balances and transactions are eliminated. As a result of exchange restrictions and other operating restrictions, during the periods presented, we did not have control over our Venezuelan subsidiaries. As such, our Venezuelan subsidiaries are not included within our consolidated financial results for any period presented.

Use of Estimates, Policy

The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. Estimates are used in determining, among other items, sales incentives accruals, tax reserves, share-based compensation, pension and retiree medical accruals, amounts and useful lives for intangible assets and future cash flows associated with impairment testing for indefinite-lived intangible assets, goodwill and other long-lived assets. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as current economic conditions, and adjust or revise our estimates as circumstances change. Additionally, the business and economic uncertainty resulting from volatile geopolitical conditions and changes in the interest rate and inflationary cost environment have made such estimates and assumptions more difficult to calculate. As future events and their effect cannot be determined with precision, actual results could differ significantly from those estimates.

Fiscal Period, Policy

Our fiscal year ends on the last Saturday of each December, resulting in a 53rd reporting week every five or six years. While our North America financial results are reported on a weekly calendar basis, our international operations are reported on a monthly calendar basis. The following chart details our quarterly reporting schedule:

Quarter

United States and Canada

International

First Quarter

12 weeks

January and February

Second Quarter

12 weeks

March, April and May

Third Quarter

12 weeks

June, July and August

Fourth Quarter

16 weeks

September, October, November and December

- Definition

Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-12

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-9

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482836/275-10-55-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-6

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 275
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-4

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-SubTopic 10
-Topic 275
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-SubTopic 10
-Topic 275
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-1

+ Details

Basis of Presentation and Our Segments (Tables)

12 Months Ended

Dec. 27, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Fiscal Period

Quarter

United States and Canada

International

First Quarter

12 weeks

January and February

Second Quarter

12 weeks

March, April and May

Third Quarter

12 weeks

June, July and August

Fourth Quarter

16 weeks

September, October, November and December

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Net revenue, significant expenses and operating profit of each segment are as follows:


	2025
	PFNA		PBNA		IB Franchise		EMEA		LatAm Foods		Asia Pacific Foods		Total
Net revenue	$	27,528	$	28,197	$	4,997	$	18,025	$	10,549	$	4,629	$	93,925
Segment cost of sales (a)	10,564		12,910		1,529		10,437		4,480		2,850
Segment selling, general and administrative expenses (a)	10,419		12,002		1,612		5,017		3,925		1,315
Restructuring and impairment charges (b)	344		281		14		195		52		12
Acquisition and divestiture-related charges (c)	28		422		—		—		—		3
Impairment and other charges (d)	—		1,523		73		270		—		80
Indirect tax impact (e)	—		—		—		—		82		—
Pension and retiree medical-related impact (f)	—		(30)		—		—		—		—
Segment operating profit	$	6,173	$	1,089	$	1,769	$	2,106	$	2,010	$	369	$	13,516
Corporate unallocated expenses													(2,018)
Operating profit													11,498
Other pension and retiree medical benefits expense													(133)
Net interest expense and other													(1,121)
Income before income taxes													$	10,244


	2024
	PFNA		PBNA		IB Franchise		EMEA		LatAm Foods		Asia Pacific Foods		Total
Net revenue	$	27,431	$	27,769	$	4,879	$	16,658	$	10,568	$	4,549	$	91,854
Segment cost of sales (a)	10,245		12,701		1,482		9,639		4,420		2,756
Segment selling, general and administrative expenses (a)(g)	10,204		11,964		1,689		4,787		4,047		1,402
Restructuring and impairment charges (b)	161		238		24		116		49		9
Acquisition and divestiture-related charges (c)	9		8		—		—		—		5
Impairment and other charges (d)	9		556		4		145		—		—
Indirect tax impact (e)	—		—		218		—		—		—
Product recall-related impact (h)	184		—		—		—		—		—
Segment operating profit	$	6,619	$	2,302	$	1,462	$	1,971	$	2,052	$	377	$	14,783
Corporate unallocated expenses													(1,896)
Operating profit													12,887
Other pension and retiree medical benefits expense													(22)
Net interest expense and other													(919)
Income before income taxes													$	11,946


	2023
	PFNA		PBNA		IB Franchise		EMEA		LatAm Foods		Asia Pacific Foods		Total
Net revenue	$	28,015	$	27,626	$	4,559	$	16,210	$	10,576	$	4,485	$	91,471
Segment cost of sales (a)	10,432		12,856		1,478		9,666		4,591		2,711
Segment selling, general and administrative expenses (a)	10,158		11,808		1,641		4,569		4,056		1,404
Restructuring and impairment charges (b)	42		41		11		227		29		8
Acquisition and divestiture-related charges (c)	—		16		—		(2)		—		2
Impairment and other charges/credits (d)	—		321		862		(14)		2		59
Product recall-related impact (h)	136		—		—		—		—		—
Segment operating profit	$	7,247	$	2,584	$	567	$	1,764	$	1,898	$	301	$	14,361
Corporate unallocated expenses													(2,375)
Operating profit													11,986
Other pension and retiree medical benefits income													250
Net interest expense and other													(819)
Income before income taxes													$	11,417

(a)Does not include items recorded in the cost of sales or selling, general and administrative expenses lines on our income statement that are presented in the restructuring and impairment charges, acquisition and divestiture-related charges, impairment and other charges/credits, indirect tax impact, product recall-related impact and pension and retiree medical-related impact lines of these tables.

(b)See Note 3 for further information related to restructuring and impairment charges.

(c)See Note 13 for further information related to acquisitions and divestiture-related charges.

(d)See below and Note 4 for impairment and other charges taken. In 2023, EMEA included adjustments for changes in estimates of previously recorded amounts.

(e)In 2025, we recorded a pre-tax charge of $82 million in selling, general and administrative expenses and income tax expense of $29 million in provision for income taxes (collectively, $0.08 per share) related to an indirect and income tax audit settlement in our LatAm Foods segment. In 2024, we recorded a pre-tax charge of $218 million ($218 million after-tax or $0.16 per share) in cost of sales related to an indirect tax reserve in our IB Franchise segment.

(f)We recognized pre-tax income of $30 million ($22 million after-tax or $0.02 per share) in our PBNA segment, recorded in selling, general and administrative expenses, associated with pension-related liabilities from previous acquisitions.

(g)We recognized a pre-tax gain of $122 million ($92 million after-tax or $0.07 per share) in our PFNA segment, recorded in selling, general and administrative expenses, related to the remeasurement of our previously held 50% equity ownership in Sabra at fair value. See Note 13 for further information.

(h)In 2024, we recorded a pre-tax charge of $187 million ($143 million after-tax or $0.10 per share) associated with the Quaker Recall with $176 million recorded in cost of sales related to property, plant and equipment write-offs, employee severance costs and other costs,

$8 million recorded in selling, general and administrative expenses and $3 million recorded in other pension and retiree medical benefits (expense)/income, which is not included in operating profit. In 2023, we recorded a pre-tax charge of $136 million ($104 million after-tax or $0.07 per share) in cost of sales for product returns, inventory write-offs and customer and consumer-related costs associated with the Quaker Recall.

Disaggregation of Revenue

Disaggregation of Net Revenue

Our primary performance obligation is the distribution and sales of beverage and convenient food products to our customers. The following table reflects the percentage of net revenue generated between our beverage business and our convenient food business:


	2025				2024				2023
	Beverages(a)		Convenient Foods		Beverages(a)		Convenient Foods		Beverages(a)		Convenient Foods
North America	51	%	49	%	50	%	50	%	50	%	50	%
International (b)	31	%	69	%	29	%	71	%	29	%	71	%
PepsiCo	42	%	58	%	42	%	58	%	41	%	59	%

(a)Beverage revenue from company-owned bottlers, which primarily includes our consolidated bottling operations in our PBNA and EMEA segments, is 36% of our consolidated net revenue in 2025 and 35% of our consolidated net revenue in both 2024 and 2023. Generally, our finished goods beverage operations produce higher net revenue, but lower operating margins as compared to concentrate sold to authorized bottling partners for the manufacture of finished goods beverages.

(b)Beverage and convenient food revenue generated from our EMEA segment is 37% and 63% of EMEA net revenue, respectively, in 2025, and 35% and 65% of EMEA net revenue, respectively, in both 2024 and 2023.

Impairment and Other Charges [Table Text Block]

Impairment and Other Charges

A summary of impairment and other charges taken, which are primarily as a result of our quantitative assessments, is as follows:


	2025		2024		2023		Affected Line Item in the Income Statement
PFNA
Other	$	—	$	9	$	—	Impairment of intangible assets
PBNA
Rockstar (a)	1,539		—		—		Impairment of intangible assets
TBG (b)	(16)		556		321		Selling, general and administrative expenses
IB Franchise
Rockstar (a)	73		—		—		Impairment of intangible assets
SodaStream (a)	—		—		862		Impairment of intangible assets
Other	—		4		—		Selling, general and administrative expenses
EMEA
Rockstar (a)	251		—		—		Impairment of intangible assets
TBG (b)	19		135		—		Selling, general and administrative expenses
Other (c)	—		10		(14)		Impairment of intangible assets, selling, general and administrative expenses and cost of sales
LatAm Foods
Other	—		—		2		Selling, general and administrative expenses
Asia Pacific Foods
Be & Cheery	80		—		59		Impairment of intangible assets
Total	$	1,946	$	714	$	1,230
After-tax amount (d)	$	1,491	$	584	$	1,014
Impact on net income attributable to PepsiCo per common share (d)	$	(1.09)	$	(0.42)	$	(0.73)

(a)See Note 4 for further information regarding impairment of intangible assets. For information on our policies for indefinite-lived intangible assets, see Note 2.

(b)See Note 9 for further information regarding our proportionate share of TBG’s indefinite-lived intangible assets impairment and other-than-temporary impairment of our investment in TBG. In 2024, we recorded an allowance for expected credit losses of $193 million, primarily related to outstanding receivables associated with the Juice Transaction. In 2025, we recorded adjustments for changes in estimates of previously recorded amounts.

(d)2025 includes a tax benefit of $39 million ($0.03 per share) related to the prior-year impairment of our investment in TBG.

Schedule Of Segment Reporting Information By Capital Spending, Depreciation And Amortization [Table Text Block]

Capital spending and depreciation and amortization of each segment are as follows:


	Capital Spending						Depreciation and Amortization
	2025		2024		2023		2025		2024		2023
PFNA	$	1,051	$	1,306	$	1,444	$	969	$	862	$	798
PBNA	1,344		1,541		1,723		1,093		1,069		1,025
IB Franchise	124		148		110		109		109		99
EMEA	744		880		831		549		477		448
LatAm Foods	672		809		814		417		382		362
Asia Pacific Foods	257		312		312		153		133		118
Total segment	4,192		4,996		5,234		3,290		3,032		2,850
Corporate	223		322		284		161		128		98
Total	$	4,415	$	5,318	$	5,518	$	3,451	$	3,160	$	2,948

Net Revenue And Property, Plant and Equipment, Net by Geographical Areas

Net revenue by country is as follows:


	2025		2024		2023
United States	$	52,228	$	51,668	$	52,165
Mexico	6,947		7,123		7,011
Russia	4,768		3,880		3,566
Canada	3,729		3,764		3,722
China	2,621		2,709		2,703
United Kingdom	2,142		2,063		1,946
Brazil	1,782		1,765		1,779
South Africa	1,767		1,859		1,707
All other countries	17,941		17,023		16,872
Total	$	93,925	$	91,854	$	91,471

Property, plant and equipment, net by geography is as follows:


	2025		2024
United States	$	16,671	$	16,550
International (a)	13,234		11,458
Total	$	29,905	$	28,008

(a)Mexico accounted for 9% and 8% of our consolidated property, plant and equipment, net as of December 27, 2025 and December 28, 2024, respectively. No other individual country exceeded 5% of our consolidated property, plant and equipment, net.

Our Significant Accounting Policies	12 Months Ended
Our Significant Accounting Policies	Dec. 27, 2025
Accounting Policies [Abstract]
Our Significant Accounting Policies	Our Significant Accounting Policies Revenue Recognition We recognize revenue when our performance obligation is satisfied. Our primary performance obligation (the distribution and sales of beverage and convenient food products) is satisfied upon the shipment or delivery of products to our customers, which is also when control is transferred. Merchandising activities are performed after a customer obtains control of the product, are accounted for as fulfillment of our performance obligation to ship or deliver product to our customers and are recorded in selling, general and administrative expenses. Merchandising activities are immaterial in the context of our contracts. In addition, we exclude from net revenue all sales, use, value-added and certain excise taxes assessed by government authorities on revenue producing transactions. The transfer of control of products to our customers is typically based on written sales terms that generally do not allow for a right of return, except in the instance of a product recall or other limited circumstances that may allow for product returns. Our policy for DSD is to remove and replace damaged and out-of-date products from store shelves to ensure that consumers receive the product quality and freshness they expect. Similarly, our policy for certain warehouse-distributed products is to replace damaged and out-of-date products. As a result, we record reserves, based on estimates, for product recall, anticipated damaged and out-of-date products. Our products are sold for cash or on credit terms. Our credit terms, which are established in accordance with local and industry practices, typically require payment within 30 days of delivery in the United States, and generally within 30 to 90 days internationally, and may allow discounts for early payment. We estimate and reserve for our expected credit loss exposure based on our experience with past due accounts and collectibility, write-off history, the aging of accounts receivable, our analysis of customer data, and forward-looking information (including the expected impact of a high interest rate and inflationary cost environment), leveraging estimates of creditworthiness and projections of default and recovery rates for certain of our customers. We are exposed to concentration of credit risk from our major customers, including Walmart. We have not experienced credit issues with these customers. In 2025, sales to Walmart and its affiliates (including Sam’s) represented approximately 14% of our consolidated net revenue, including concentrate sales to our independent bottlers, which were used in finished goods sold by them to Walmart. Total Marketplace Spending We offer sales incentives and discounts through various programs to customers and consumers. Total marketplace spending includes sales incentives, discounts, advertising and other marketing activities. Sales incentives and discounts are primarily accounted for as a reduction of revenue and include payments to customers for performing activities on our behalf, such as payments for in-store displays, payments to gain distribution of new products, payments for shelf space and discounts to promote lower retail prices. Sales incentives and discounts also include support provided to our independent bottlers through funding of advertising and other marketing activities. A number of our sales incentives, such as bottler funding to independent bottlers and customer volume rebates, are based on annual targets, and accruals are established during the year, as products are delivered, for the expected payout, which may occur after year-end once reconciled and settled. These accruals are based on contract terms and our historical experience with similar programs and require management judgment with respect to estimating customer and consumer participation and performance levels. Differences between estimated expense and actual incentive costs are normally insignificant and are recognized in earnings in the period such differences are determined. In addition, certain advertising and marketing costs are also based on annual targets and recognized during the year as incurred. The terms of most of our incentive arrangements do not exceed one year and, therefore, do not require highly uncertain long-term estimates. Certain arrangements, such as fountain pouring rights, may extend beyond one year. Upfront payments to customers under these arrangements are recognized over the shorter of the economic or contractual life, primarily as a reduction of revenue, and the remaining balances of $329 million as of December 27, 2025 and $237 million as of December 28, 2024 are included in prepaid expenses and other current assets and other assets on our balance sheet. For interim reporting, our policy is to allocate our forecasted full-year sales incentives for most of our programs to each of our interim reporting periods in the same year that benefits from the programs. The allocation methodology is based on our forecasted sales incentives for the full year and the proportion of each interim period’s actual gross revenue or volume, as applicable, to our forecasted annual gross revenue or volume, as applicable. Based on our review of the forecasts at each interim period, any changes in estimates and the related allocation of sales incentives are recognized beginning in the interim period that they are identified. In addition, we apply a similar allocation methodology for interim reporting purposes for certain advertising and other marketing activities. Our annual consolidated financial statements are not impacted by this interim allocation methodology. Advertising and other marketing activities, reported as selling, general and administrative expenses, totaled $5.4 billion in 2025, $5.9 billion in 2024 and $5.7 billion in 2023, including advertising expenses of $3.4 billion in 2025, $3.9 billion in 2024 and $3.8 billion in 2023. Deferred advertising costs are not expensed until the year first used and consist of: •media and personal service prepayments; •promotional materials in inventory; and •production costs of future media advertising. Deferred advertising costs of $48 million and $58 million as of December 27, 2025 and December 28, 2024, respectively, are classified as prepaid expenses and other current assets on our balance sheet. Distribution Costs Distribution costs, including the costs of shipping and handling activities, which include certain merchandising activities, are reported as selling, general and administrative expenses. Shipping and handling expenses were $16.7 billion in 2025, $16.0 billion in 2024 and $15.4 billion in 2023. Software Costs We capitalize certain computer software and software development costs incurred in connection with developing or obtaining computer software for internal use when both the preliminary project stage is completed and it is probable that the software will be used as intended. Capitalized software costs include (1) external direct costs of materials and services utilized in developing or obtaining computer software, (2) compensation and related benefits for employees who are directly associated with the software projects and (3) interest costs incurred while developing internal-use computer software. Capitalized software costs are included in property, plant and equipment on our balance sheet and amortized on a straight-line basis when placed into service over the estimated useful lives of the software, which approximate five to 10 years. Software amortization totaled $260 million in 2025, $199 million in 2024 and $159 million in 2023. Net capitalized software and development costs were $1.8 billion and $1.5 billion as of December 27, 2025 and December 28, 2024, respectively. Commitments and Contingencies We are subject to various claims and contingencies related to lawsuits, certain taxes and environmental matters, as well as commitments under contractual and other commercial obligations. We recognize liabilities for contingencies and commitments when a loss is probable and estimable. Research and Development We engage in a variety of research and development activities and continue to invest to accelerate growth and to drive innovation globally. Consumer research is excluded from research and development costs and included in other marketing costs. Research and development costs were $839 million, $813 million and $804 million in 2025, 2024 and 2023, respectively, and are reported within selling, general and administrative expenses. Goodwill and Other Intangible Assets Indefinite-lived intangible assets and goodwill are not amortized and, as a result, are assessed for impairment at least annually, using either a qualitative or quantitative approach. We perform this annual assessment during our third quarter, or more frequently if circumstances indicate that the carrying value may not be recoverable. Where we use the qualitative assessment, first we determine if, based on qualitative factors, it is more likely than not that an impairment exists. Factors considered include macroeconomic conditions (including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment), industry and competitive conditions, legal and regulatory environment, historical financial performance and significant changes in the brand or reporting unit. If the qualitative assessment indicates that it is more likely than not that an impairment exists, then a quantitative assessment is performed. In the quantitative assessment for indefinite-lived intangible assets and goodwill, an assessment is performed to determine the fair value of the indefinite-lived intangible asset and the reporting unit, respectively. Estimated fair value is determined using discounted cash flows and requires an analysis of several estimates including future cash flows or income consistent with management’s strategic business plans, annual sales growth rates, perpetuity growth assumptions and the selection of assumptions underlying a discount rate (weighted-average cost of capital) based on market data available at the time. Significant management judgment is necessary to estimate the impact of competitive operating, macroeconomic and other factors (including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment) to estimate future levels of sales, operating profit or cash flows. All assumptions used in our impairment evaluations for indefinite-lived intangible assets and goodwill, such as forecasted growth rates (including perpetuity growth assumptions) and weighted-average cost of capital, are based on the best available market information and are consistent with our internal forecasts and operating plans. A deterioration in these assumptions could adversely impact our results. Amortizable intangible assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. If an evaluation of the undiscounted future cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on its discounted future cash flows. See Note 4 for further information. Other Significant Accounting Policies Our other significant accounting policies are disclosed as follows: •Basis of Presentation – Note 1 includes a description of our policies regarding use of estimates, basis of presentation and consolidation. •Income Taxes – Note 5. •Share-Based Compensation – Note 6. •Pension, Retiree Medical and Savings Plans – Note 7. •Financial Instruments – Note 9. •Leases – Note 12. •Acquisitions and Divestitures – Note 13. •Supply Chain Financing Arrangements – Note 14. •Cash Equivalents – Cash equivalents are highly liquid investments with original maturities of three months or less. •Inventories – Inventories are valued at the lower of cost or net realizable value. Cost is determined using the average; first-in, first-out (FIFO); or, in limited instances, last-in, first-out (LIFO) methods. For inventories valued under the LIFO method, the differences between the LIFO and FIFO methods of valuing inventories are not material. •Property, Plant and Equipment – Note 15. Property, plant and equipment is recorded at historical cost. Depreciation is recognized on a straight-line basis over an asset’s estimated useful life. Construction in progress is not depreciated until ready for service. •Translation of Financial Statements of Foreign Subsidiaries – Generally, financial statements of foreign subsidiaries are translated into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for revenues and expenses. Adjustments resulting from translating net assets are reported as a separate component of accumulated other comprehensive loss within common shareholders’ equity as currency translation adjustment. For foreign subsidiaries operating in highly inflationary economies, the reporting currency of the immediate parent becomes the functional currency. Non-functional currency monetary assets and liabilities are remeasured at period-end exchange rates, with the impact of any changes in exchange rates included in net income. Non-monetary assets and liabilities are carried forward at historical exchange rates starting from when hyperinflationary accounting is implemented. Recently Issued Accounting Pronouncements Adopted In December 2023, the Financial Accounting Standards Board (FASB) issued guidance to enhance transparency of income tax disclosures. On an annual basis, the new guidance requires a public entity to disclose: (1) specific categories in the rate reconciliation, (2) additional information for reconciling items that are equal to or greater than 5% of the amount computed by multiplying income (or loss) from continuing operations before income tax expense (or benefit) by the applicable statutory income tax rate, (3) income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes, with foreign taxes disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5% of total income taxes paid, (4) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and (5) income tax expense (or benefit) from continuing operations disaggregated between federal (national), state and foreign. We adopted the guidance in our 2025 annual reporting, on a prospective basis. See Note 5 for further information. Not Yet Adopted In September 2025, the FASB issued guidance to improve the accounting for costs related to internal-use software. The new guidance eliminates project stages and requires capitalizing software costs to begin when (1) management has authorized and committed to funding the software project and (2) it is probable that the project will be completed and the software will be used to perform the function intended. When evaluating if a project is probable to be completed, significant development uncertainty must be assessed. Additionally, disclosures for property, plant and equipment will be required for all capitalized software costs. The guidance is effective in the first quarter of 2028 with early adoption permitted as of the beginning of an annual reporting period. Upon adoption, the guidance may be applied prospectively, retrospectively or using a modified transition approach. We are evaluating the impact of this guidance on our consolidated financial statements. In July 2025, the FASB issued guidance to provide for a practical expedient that an entity may assume that conditions as of the balance sheet date remain unchanged over the remaining life of the asset when estimating expected credit losses for current accounts receivable and current contract assets arising from revenue transactions from contracts with customers. The guidance is effective in the first quarter of 2026 with early adoption permitted, to be applied on a prospective basis. We will adopt the guidance when it becomes effective. The guidance is not expected to have a material impact on our consolidated financial statements. In November 2024, the FASB issued guidance to improve the disclosure of expenses in commonly presented expense captions. The new guidance requires a public entity to provide tabular disclosure, on an annual and interim basis, of amounts for the following expense categories: (1) purchases of inventory, (2) employee compensation, (3) depreciation and (4) intangible asset amortization, as included in each relevant expense caption. A relevant expense caption is an expense caption presented on the face of the income statement that contains any of the expense categories noted. Additionally, on an annual and interim basis, a qualitative description is required for amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. The guidance also requires certain amounts that are currently required to be disclosed to be included in the same tabular disclosure as these disaggregation requirements. Furthermore, on an annual and interim basis, a public entity is required to separately disclose selling expenses and annually, disclose a description of the selling expenses. The guidance is effective for 2027 annual reporting, and in the first quarter of 2028 for interim reporting, with early adoption permitted, to be applied on a prospective basis, with retrospective application permitted. We will adopt the guidance when it becomes effective, in our 2027 annual reporting and each quarter thereafter, on a prospective basis.

Basis of Presentation and Our Segments

12 Months Ended

Dec. 27, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis Of Presentation and Our Divisions

Basis of Presentation and Our Segments

Basis of Presentation

Raw materials, direct labor and plant overhead, as well as purchasing and receiving costs, costs directly related to production planning, inspection costs and raw materials handling facilities, are included in cost of sales. The costs of moving, storing and delivering finished product, including merchandising activities, are included in selling, general and administrative expenses.

Quarter

United States and Canada

International

First Quarter

12 weeks

January and February

Second Quarter

12 weeks

March, April and May

Third Quarter

12 weeks

June, July and August

Fourth Quarter

16 weeks

September, October, November and December

Unless otherwise noted, tabular dollars are in millions, except per share amounts. All per share amounts reflect common per share amounts, assume dilution unless otherwise noted, and are based on unrounded amounts. Certain reclassifications were made to the prior year’s consolidated financial statements to conform to the current year presentation.

Our Segments

We are organized into six reportable segments, as follows:

1)PepsiCo Foods North America (PFNA), which includes all of our convenient food businesses in the United States and Canada;

2)PepsiCo Beverages North America (PBNA), which includes all of our beverage businesses in the United States and Canada;

3)International Beverages Franchise (IB Franchise), which includes our international franchise beverage businesses, as well as our SodaStream business;

4)Europe, Middle East and Africa (EMEA), which includes our convenient food businesses and our beverage businesses with company-owned bottlers in Europe, the Middle East and Africa;

5)Latin America Foods (LatAm Foods), which includes all of our convenient food businesses in Latin America; and

6)Asia Pacific Foods, which consists of our convenient food businesses in Asia Pacific, including China, Australia and New Zealand, as well as India.

Through our operations, authorized bottlers, contract manufacturers and other third parties, we make, market, distribute and sell a wide variety of beverages and convenient foods, serving customers and consumers in more than 200 countries and territories with our largest operations in the United States, Mexico, Russia, Canada, China, the United Kingdom, Brazil and South Africa.

The accounting policies for the segments are the same as those described in Note 2, except for the following allocation methodologies:

•share-based compensation expense;

•pension and retiree medical expense; and

•derivatives.

Share-Based Compensation Expense

Our segments are held accountable for share-based compensation expense and, therefore, this expense is allocated to our segments as an incremental employee compensation cost. The expense allocated to our segments excludes any impact of changes in our assumptions during the year which reflect market conditions over which segment management has no control. Therefore, any variances between allocated expense and our actual expense are recognized in corporate unallocated expenses.

Pension and Retiree Medical Expense

Pension and retiree medical service costs measured at fixed discount rates are reflected in segment results. The variance between the fixed discount rate used to determine the service cost reflected in segment results and the discount rate as disclosed in Note 7 is reflected in corporate unallocated expenses.

Derivatives

We centrally manage commodity derivatives on behalf of our segments. These commodity derivatives include agricultural products, energy and metals. Commodity derivatives that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in segment results when the segments recognize the cost of the underlying commodity in operating profit. Therefore, the segments realize the economic effects of the derivative without experiencing any resulting mark-to-market volatility, which remains in corporate unallocated expenses. These derivatives hedge underlying commodity price risk and were not entered into for trading or speculative purposes.

Net Revenue, Significant Expenses and Operating Profit by Segment

Our chief operating decision maker (CODM) is our Chairman and Chief Executive Officer. Our CODM uses segment operating profit as the profit measure to evaluate segment performance and allocate resources across segments. Corporate unallocated expenses, other pension and retiree medical benefits (expense)/income and net interest expense and other are centrally managed costs and are therefore excluded from this profit measure to provide better transparency of our segment operating results. Our CODM considers variances of actual performance to our annual operating plan and periodic forecasts when making decisions.

Significant expenses are expenses which are regularly provided to the CODM and are included in segment operating profit. These consist of segment cost of sales, segment selling, general and administrative expenses, and various items affecting comparability. Segment cost of sales includes raw materials, direct labor and plant overhead, as well as purchasing and receiving costs, costs directly related to production planning, inspection costs and raw materials handling facilities, excluding the impact of items affecting comparability. Segment selling, general and administrative expenses include the costs to execute sales to customers, distribution costs, including the costs of shipping and handling activities, which include certain merchandising activities, costs related to brand and product marketing to consumers, other ongoing operating costs that are not directly related to manufacturing, distribution, selling, advertising or marketing activities as well as other income or expense items, excluding the impact of items affecting comparability. Items affecting comparability include restructuring and impairment charges, acquisition and divestiture-related charges, impairment and other charges/credits, indirect tax impact, product recall-related impact and pension and retiree medical-related impact.

Asset and other balance sheet information for segments is not provided to the CODM.

Net revenue, significant expenses and operating profit of each segment are as follows:


	2025
	PFNA		PBNA		IB Franchise		EMEA		LatAm Foods		Asia Pacific Foods		Total
Net revenue	$	27,528	$	28,197	$	4,997	$	18,025	$	10,549	$	4,629	$	93,925
Segment cost of sales (a)	10,564		12,910		1,529		10,437		4,480		2,850
Segment selling, general and administrative expenses (a)	10,419		12,002		1,612		5,017		3,925		1,315
Restructuring and impairment charges (b)	344		281		14		195		52		12
Acquisition and divestiture-related charges (c)	28		422		—		—		—		3
Impairment and other charges (d)	—		1,523		73		270		—		80
Indirect tax impact (e)	—		—		—		—		82		—
Pension and retiree medical-related impact (f)	—		(30)		—		—		—		—
Segment operating profit	$	6,173	$	1,089	$	1,769	$	2,106	$	2,010	$	369	$	13,516
Corporate unallocated expenses													(2,018)
Operating profit													11,498
Other pension and retiree medical benefits expense													(133)
Net interest expense and other													(1,121)
Income before income taxes													$	10,244


	2024
	PFNA		PBNA		IB Franchise		EMEA		LatAm Foods		Asia Pacific Foods		Total
Net revenue	$	27,431	$	27,769	$	4,879	$	16,658	$	10,568	$	4,549	$	91,854
Segment cost of sales (a)	10,245		12,701		1,482		9,639		4,420		2,756
Segment selling, general and administrative expenses (a)(g)	10,204		11,964		1,689		4,787		4,047		1,402
Restructuring and impairment charges (b)	161		238		24		116		49		9
Acquisition and divestiture-related charges (c)	9		8		—		—		—		5
Impairment and other charges (d)	9		556		4		145		—		—
Indirect tax impact (e)	—		—		218		—		—		—
Product recall-related impact (h)	184		—		—		—		—		—
Segment operating profit	$	6,619	$	2,302	$	1,462	$	1,971	$	2,052	$	377	$	14,783
Corporate unallocated expenses													(1,896)
Operating profit													12,887
Other pension and retiree medical benefits expense													(22)
Net interest expense and other													(919)
Income before income taxes													$	11,946


	2023
	PFNA		PBNA		IB Franchise		EMEA		LatAm Foods		Asia Pacific Foods		Total
Net revenue	$	28,015	$	27,626	$	4,559	$	16,210	$	10,576	$	4,485	$	91,471
Segment cost of sales (a)	10,432		12,856		1,478		9,666		4,591		2,711
Segment selling, general and administrative expenses (a)	10,158		11,808		1,641		4,569		4,056		1,404
Restructuring and impairment charges (b)	42		41		11		227		29		8
Acquisition and divestiture-related charges (c)	—		16		—		(2)		—		2
Impairment and other charges/credits (d)	—		321		862		(14)		2		59
Product recall-related impact (h)	136		—		—		—		—		—
Segment operating profit	$	7,247	$	2,584	$	567	$	1,764	$	1,898	$	301	$	14,361
Corporate unallocated expenses													(2,375)
Operating profit													11,986
Other pension and retiree medical benefits income													250
Net interest expense and other													(819)
Income before income taxes													$	11,417

(b)See Note 3 for further information related to restructuring and impairment charges.

(c)See Note 13 for further information related to acquisitions and divestiture-related charges.

(d)See below and Note 4 for impairment and other charges taken. In 2023, EMEA included adjustments for changes in estimates of previously recorded amounts.

Disaggregation of Net Revenue


	2025				2024				2023
	Beverages(a)		Convenient Foods		Beverages(a)		Convenient Foods		Beverages(a)		Convenient Foods
North America	51	%	49	%	50	%	50	%	50	%	50	%
International (b)	31	%	69	%	29	%	71	%	29	%	71	%
PepsiCo	42	%	58	%	42	%	58	%	41	%	59	%

Impairment and Other Charges

A summary of impairment and other charges taken, which are primarily as a result of our quantitative assessments, is as follows:


	2025		2024		2023		Affected Line Item in the Income Statement
PFNA
Other	$	—	$	9	$	—	Impairment of intangible assets
PBNA
Rockstar (a)	1,539		—		—		Impairment of intangible assets
TBG (b)	(16)		556		321		Selling, general and administrative expenses
IB Franchise
Rockstar (a)	73		—		—		Impairment of intangible assets
SodaStream (a)	—		—		862		Impairment of intangible assets
Other	—		4		—		Selling, general and administrative expenses
EMEA
Rockstar (a)	251		—		—		Impairment of intangible assets
TBG (b)	19		135		—		Selling, general and administrative expenses
Other (c)	—		10		(14)		Impairment of intangible assets, selling, general and administrative expenses and cost of sales
LatAm Foods
Other	—		—		2		Selling, general and administrative expenses
Asia Pacific Foods
Be & Cheery	80		—		59		Impairment of intangible assets
Total	$	1,946	$	714	$	1,230
After-tax amount (d)	$	1,491	$	584	$	1,014
Impact on net income attributable to PepsiCo per common share (d)	$	(1.09)	$	(0.42)	$	(0.73)

(a)See Note 4 for further information regarding impairment of intangible assets. For information on our policies for indefinite-lived intangible assets, see Note 2.

(d)2025 includes a tax benefit of $39 million ($0.03 per share) related to the prior-year impairment of our investment in TBG.

Other Segment Information

Capital spending and depreciation and amortization of each segment are as follows:


	Capital Spending						Depreciation and Amortization
	2025		2024		2023		2025		2024		2023
PFNA	$	1,051	$	1,306	$	1,444	$	969	$	862	$	798
PBNA	1,344		1,541		1,723		1,093		1,069		1,025
IB Franchise	124		148		110		109		109		99
EMEA	744		880		831		549		477		448
LatAm Foods	672		809		814		417		382		362
Asia Pacific Foods	257		312		312		153		133		118
Total segment	4,192		4,996		5,234		3,290		3,032		2,850
Corporate	223		322		284		161		128		98
Total	$	4,415	$	5,318	$	5,518	$	3,451	$	3,160	$	2,948

Net revenue by country is as follows:


	2025		2024		2023
United States	$	52,228	$	51,668	$	52,165
Mexico	6,947		7,123		7,011
Russia	4,768		3,880		3,566
Canada	3,729		3,764		3,722
China	2,621		2,709		2,703
United Kingdom	2,142		2,063		1,946
Brazil	1,782		1,765		1,779
South Africa	1,767		1,859		1,707
All other countries	17,941		17,023		16,872
Total	$	93,925	$	91,854	$	91,471

Property, plant and equipment, net by geography is as follows:


	2025		2024
United States	$	16,671	$	16,550
International (a)	13,234		11,458
Total	$	29,905	$	28,008

Corporate Unallocated Expenses

Corporate unallocated expenses include costs of our corporate headquarters, centrally managed initiatives such as our ongoing business transformation initiatives, unallocated research and development costs, foreign exchange transaction gains and losses, unallocated insurance and benefit programs, commodity derivative gains and losses, as well as certain other items.

Leases

12 Months Ended

Dec. 27, 2025

Leases [Abstract]

Lessee, Operating Leases

Leases

Lessee

We determine whether an arrangement is a lease at inception. We have operating leases for plants, warehouses, distribution centers, storage facilities, offices and other facilities, as well as machinery and equipment, including fleet. Our leases generally have remaining lease terms of up to 20 years, some of which include options to extend the lease term for up to five years and some of which include options to terminate the lease within one year. We consider these options in determining the lease term used to establish our right-of-use assets and lease liabilities. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.

As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.

We have lease agreements that contain both lease and non-lease components. For real estate leases, we account for lease components together with non-lease components (e.g., common-area maintenance).

Components of lease cost are as follows:


	2025		2024		2023
Operating lease cost (a)	$	880	$	788	$	666
Variable lease cost (b)	$	185	$	165	$	146
Short-term lease cost (c)	$	570	$	566	$	582

(a)Includes right-of-use asset amortization of $727 million, $655 million, and $570 million in 2025, 2024, and 2023, respectively.

(b)Primarily related to adjustments for inflation, common-area maintenance and property tax.

(c)Not recorded on our balance sheet.

In 2025, 2024 and 2023, we recognized gains of $291 million, $118 million and $52 million, respectively, on sale-leaseback transactions with lease terms of ten years or less.

Supplemental cash flow information and non-cash activity related to our operating leases are as follows:


	2025		2024		2023
Operating cash flow information:
Cash paid for amounts included in the measurement of lease liabilities	$	866	$	775	$	655
Non-cash activity:
Right-of-use assets obtained in exchange for lease obligations	$	1,046	$	1,218	$	1,088

Supplemental balance sheet information related to our operating leases is as follows:



	Balance Sheet Classification	2025		2024
Right-of-use assets	Other assets	$	3,745	$	3,383
Current lease liabilities	Accounts payable and other current liabilities	$	719	$	642
Noncurrent lease liabilities	Other liabilities	$	3,127	$	2,803

Weighted-average remaining lease term and discount rate for our operating leases are as follows:


	2025		2024		2023
Weighted-average remaining lease term	7 years		7 years		7 years
Weighted-average discount rate	5	%	4	%	4	%

Maturities of lease liabilities by year for our operating leases are as follows:


2026	$	858
2027	750
2028	631
2029	512
2030	434
2031 and beyond	1,342
Total lease payments	4,527
Less: Imputed interest	681
Present value of lease liabilities	$	3,846

Operating lease payments presented in the table above exclude approximately $900 million of minimum lease payments related to leases entered into but not yet commenced as of December 27, 2025, with weighted-average lease terms of thirteen years.

Finance leases were not material as of December 27, 2025, December 28, 2024 and December 30, 2023.

Lessor

We have various arrangements for certain foodservice and vending equipment under which we are the lessor. These leases meet the criteria for operating lease classification. Lease income associated with these leases is not material.

Leases (Tables)

12 Months Ended

Dec. 27, 2025

Leases [Abstract]

Lease, Cost [Table Text Block]

Components of lease cost are as follows:


	2025		2024		2023
Operating lease cost (a)	$	880	$	788	$	666
Variable lease cost (b)	$	185	$	165	$	146
Short-term lease cost (c)	$	570	$	566	$	582

(a)Includes right-of-use asset amortization of $727 million, $655 million, and $570 million in 2025, 2024, and 2023, respectively.

(b)Primarily related to adjustments for inflation, common-area maintenance and property tax.

(c)Not recorded on our balance sheet.

Lessee Operating Leases Supplemental Cash Flow Information and Noncash Activity Table [Table Text Block]

Supplemental cash flow information and non-cash activity related to our operating leases are as follows:


	2025		2024		2023
Operating cash flow information:
Cash paid for amounts included in the measurement of lease liabilities	$	866	$	775	$	655
Non-cash activity:
Right-of-use assets obtained in exchange for lease obligations	$	1,046	$	1,218	$	1,088

Lessee Operating Lease Balance Sheet Amounts and Lines [Table Text Block]

Supplemental balance sheet information related to our operating leases is as follows:



	Balance Sheet Classification	2025		2024
Right-of-use assets	Other assets	$	3,745	$	3,383
Current lease liabilities	Accounts payable and other current liabilities	$	719	$	642
Noncurrent lease liabilities	Other liabilities	$	3,127	$	2,803

Lessee Operating Lease Weighted Averages Table [Table Text Block]

Weighted-average remaining lease term and discount rate for our operating leases are as follows:


	2025		2024		2023
Weighted-average remaining lease term	7 years		7 years		7 years
Weighted-average discount rate	5	%	4	%	4	%

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

Maturities of lease liabilities by year for our operating leases are as follows:


2026	$	858
2027	750
2028	631
2029	512
2030	434
2031 and beyond	1,342
Total lease payments	4,527
Less: Imputed interest	681
Present value of lease liabilities	$	3,846

Supply Chain Financing (Tables)

12 Months Ended

Dec. 27, 2025

Text Block [Abstract]

Supplier Finance Program

A summary of our outstanding obligations confirmed as valid under the supplier finance program is as follows:


	2025		2024
Confirmed obligations outstanding at beginning of year	$	1,478	$	1,655
Invoices confirmed	6,668		6,552
Confirmed invoices paid	(6,547)		(6,636)
Translation and other	82		(93)
Confirmed obligations outstanding at end of year	$	1,681	$	1,478

Share-Based Compensation Share-Based Compensation (Stock Option Activity) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Beginning Balance	11,055
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,804	2,034	2,162
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period	(896)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period	(642)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance	11,321	11,055
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance	$ 143.88
Granted (in USD per share)	150.28
Exercised (in USD per share)	108.72
Forfeited/expired (in USD per share)	163.52
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance	146.60	$ 143.88
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	134.10
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$ 162.45
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$ 100,992
Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable	6,279
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	4 years 2 months 12 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	$ 98,385
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	4,793
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	8 years 2 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$ 2,468
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	6 years

Acquisitions & Divestitures

12 Months Ended

Dec. 27, 2025

Acquisitions & Divestitures [Abstract]

Mergers, Acquisitions and Dispositions Disclosures [Text Block]

Acquisitions and Divestitures

Acquisition of poppi

On May 19, 2025, we acquired all of the outstanding equity interest in poppi, a prebiotic soda business, for cash consideration of $1.95 billion and contingent consideration with an acquisition date fair value of $0.2 billion. See Note 9 for further information on the contingent consideration. In connection with this acquisition, other payments may be incurred, subject to the achievement of certain conditions.

We accounted for the transaction as a business combination in the second quarter of 2025. We recognized and measured the identifiable assets acquired and liabilities assumed at their estimated fair values on the date of acquisition, in our PBNA segment. The preliminary estimates of the fair value of the identifiable assets acquired and liabilities assumed in this transaction as of the acquisition date primarily include goodwill and other intangible assets of approximately $2.0 billion. These preliminary estimates include management’s assumptions and are subject to revision as additional information is obtained about the facts and circumstances that existed as of the acquisition date, primarily related to intangible assets, which may result in adjustments to the preliminary values discussed above as valuations are finalized. We expect to finalize these amounts as soon as possible, but no later than the second quarter of 2026.

Acquisition of Siete

On January 17, 2025, we acquired all of the outstanding equity interest in Siete, a Mexican-American foods business, for total consideration of $1.2 billion in cash.

We accounted for the transaction as a business combination in the first quarter of 2025. We recognized and measured the identifiable assets acquired and liabilities assumed at their estimated fair values on the date of acquisition, in our PFNA segment. The preliminary estimates of the fair value of the identifiable assets acquired and liabilities assumed in this transaction as of the acquisition date primarily include goodwill and other intangible assets of approximately $1.2 billion. These preliminary estimates include management’s assumptions and are subject to revision as additional information is obtained about the facts and circumstances that existed as of the acquisition date, primarily related to intangible assets, which may result in adjustments to the preliminary values discussed above as valuations are finalized. We will finalize these amounts in the first quarter of 2026.

Acquisition of remaining ownership in Sabra

On December 3, 2024, we acquired the Strauss Group’s 50% ownership in Sabra for total consideration of $241 million in cash, resulting in Sabra becoming a wholly-owned subsidiary. Upon consolidation, we recognized a pre-tax gain of $122 million ($92 million after-tax or $0.07 per share) in our PFNA segment, recorded in selling, general and administrative expenses, related to the remeasurement of our previously held 50% equity ownership in Sabra at fair value using a combination of the transaction price, net of a control premium, and discounted cash flows.

We accounted for the acquisition as a business combination. We recognized and measured the identifiable assets acquired and liabilities assumed at their estimated fair values on the date of acquisition in our PFNA segment, which primarily included goodwill and other intangible assets of $0.3 billion and property, plant and equipment of $0.1 billion. The purchase price allocation was finalized in the fourth quarter of 2025.

Acquisition and Divestiture-Related Charges

Acquisition and divestiture-related charges include merger and integration charges, transaction expenses, such as consulting, advisory and other professional fees, as well as fair value adjustments to contingent consideration and acquired inventory included in the acquisition-date balance sheets. Merger and integration charges include distribution agreement termination fees, impairment of certain acquisition-related intangible assets, employee-related costs, closing costs and other integration costs.

A summary of charges is as follows:


	2025		2024		2023
Cost of sales	$	57	$	—	$	—
Selling, general and administrative expenses	346		22		41
Impairment of intangible assets	50		—		—
Total	$	453	$	22	$	41
After-tax amount	$	347	$	18	$	23
Impact on net income attributable to PepsiCo per common share	$	(0.25)	$	(0.01)	$	(0.02)


	2025		2024		2023
PFNA	$	28	$	9	$	—
PBNA	422		8		16

EMEA (a)	—		—		(2)

Asia Pacific Foods	3		5		2
Corporate	—		—		25
Total	$	453	$	22	$	41

(a)Income amount represents adjustments for changes in estimates of previously recorded amounts.

Restructuring and Impairment Charges (Summary of 2019 Productivity Plan Charges) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Total Restructuring Cost and Reserve [Line Items]
Cash payments for restructuring charges	$ (796)	$ (436)	$ (434)
Restructuring Charges	983	727	445
2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Beginning Balance	364	197	196
Cash payments for restructuring charges	(796)	(436)	(434)
Non-cash charges and translation	(225)	(124)	(10)
Ending Balance	$ 326	$ 364	$ 197
Impact on net income attributable to PepsiCo per common share	$ (0.58)	$ (0.41)	$ (0.25)
Plan to Date through 12/27/2025	$ 3,610
Cash payments reported on the cash flow statement in pension and retiree medical contributions	12	$ 7	$ 1
Restructuring Charges	983	727	445
Other than 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	0
Severance and Other Employee Costs \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Beginning Balance	338	188	188
Cash payments for restructuring charges	(384)	(204)	(242)
Non-cash charges and translation	(1)	(30)	(1)
Ending Balance	308	338	188
Plan to Date through 12/27/2025	1,789
Restructuring Charges	355	384	243
Asset Impairments \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Beginning Balance	0	0	0
Cash payments for restructuring charges	0	0	0
Non-cash charges and translation	(240)	(114)	(2)
Ending Balance	0	0	0
Plan to Date through 12/27/2025	546
Restructuring Charges	240	114	2
Other Costs \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Beginning Balance	26	9	8
Cash payments for restructuring charges	(412)	(232)	(192)
Non-cash charges and translation	16	20	(7)
Ending Balance	18	26	9
Plan to Date through 12/27/2025	1,275
Restructuring Charges	388	229	200
Other pension and retiree medical benefits expense/(income) (a) \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Plan to Date through 12/27/2025	145
Restructuring, Settlement and Impairment Provisions, less Other pension and retiree medical benefits expense [Member] \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Plan to Date through 12/27/2025	3,465
Cost of sales \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	236	133	13
Selling, general and administrative expenses \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	728	551	433
Other pension and retiree medical benefits expense/(income) (a) \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	19	29	(1)
After-tax amount \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	792	563	349
Restructuring, Settlement and Impairment Provisions, less Other pension and retiree medical benefits expense [Member] \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	964	698	446
Impairment of intangible assets \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	0	14	0
Corporate \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Plan to Date through 12/27/2025	484
Restructuring Charges	66	101	88
Operating Segments [Member] \| PepsiCo Foods North America [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	344	161	42
Operating Segments [Member] \| PepsiCo Foods North America [Member] \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Plan to Date through 12/27/2025	776
Restructuring Charges	344	161	42
Operating Segments [Member] \| PepsiCo Beverages North America [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	281	238	41
Operating Segments [Member] \| PepsiCo Beverages North America [Member] \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Plan to Date through 12/27/2025	786
Restructuring Charges	281	238	41
Operating Segments [Member] \| International Beverage Franchise [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	14	24	11
Operating Segments [Member] \| International Beverage Franchise [Member] \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Plan to Date through 12/27/2025	65
Restructuring Charges	14	24	11
Operating Segments [Member] \| Europe, Middle East & Africa (Segment) [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	195	116	227
Operating Segments [Member] \| Europe, Middle East & Africa (Segment) [Member] \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Plan to Date through 12/27/2025	956
Restructuring Charges	195	116	227
Operating Segments [Member] \| Latin America Foods (Segment) [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	52	49	29
Operating Segments [Member] \| Latin America Foods (Segment) [Member] \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Plan to Date through 12/27/2025	299
Restructuring Charges	52	49	29
Operating Segments [Member] \| Asia Pacific Foods (Segment) [Member]
Total Restructuring Cost and Reserve [Line Items]
Restructuring Charges	12	9	8
Operating Segments [Member] \| Asia Pacific Foods (Segment) [Member] \| 2019 Productivity Plan [Member]
Total Restructuring Cost and Reserve [Line Items]
Plan to Date through 12/27/2025	99
Restructuring Charges	$ 12	$ 9	$ 8

Supplemental Financial Information (Schedule of Other Supplemental Information) (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Supplemental Financial Information [Abstract]
Interest paid	$ 1,748	$ 1,585	$ 1,401
Income taxes paid, net of refunds	3,083	3,064	2,532
Tax payments related to the TCJ Act	772	579	309
Cash and cash equivalents	9,159	8,505
Restricted Cash, Noncurrent	45	48
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	9,204	8,553	9,761	$ 5,100
Treasury Stock, Value	$ (41,832)	$ (41,021)
Treasury Stock, Common, Shares	500	495
Work-in-process	$ 143	$ 104
Finished goods	3,121	2,762
Debt discharged via legal defeasance	0	0	94
Purchase Commitment (Celsius)	554	0	$ 0
Raw materials	$ 2,581	$ 2,440

Accumulated Other Comprehensive Loss Attributable to Pepsico (Tables)

12 Months Ended

Dec. 27, 2025

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule Of Accumulated Other Comprehensive Income

The changes in the balances of each component of accumulated other comprehensive loss attributable to PepsiCo are as follows:


	Currency Translation Adjustment		Cash Flow Hedges		Pension and Retiree Medical		Available-for-Sale Debt Securities and Other(a)		Accumulated Other Comprehensive Loss Attributable to PepsiCo
Balance as of December 31, 2022 (b)	$	(12,948)	$	1	$	(2,361)	$	6	$	(15,302)
Other comprehensive (loss)/income before reclassifications (c)	(442)		(188)		(493)		608		(515)
Amounts reclassified from accumulated other comprehensive loss	108		146		37		—		291
Net other comprehensive (loss)/income	(334)		(42)		(456)		608		(224)
Tax amounts	27		10		98		(143)		(8)
Balance as of December 30, 2023 (b)	(13,255)		(31)		(2,719)		471		(15,534)
Other comprehensive loss before reclassifications (d)	(1,965)		(6)		(280)		(306)		(2,557)
Amounts reclassified from accumulated other comprehensive loss	—		158		285		—		443
Net other comprehensive (loss)/income	(1,965)		152		5		(306)		(2,114)
Tax amounts	3		(39)		—		72		36
Balance as of December 28, 2024 (b)	(15,217)		82		(2,714)		237		(17,612)
Other comprehensive income before reclassifications (e)	1,633		186		234		482		2,535
Amounts reclassified from accumulated other comprehensive loss	—		(132)		362		—		230
Net other comprehensive income	1,633		54		596		482		2,765
Tax amounts	90		(10)		(144)		(113)		(177)
Balance as of December 27, 2025 (b)	$	(13,494)	$	126	$	(2,262)	$	606	$	(15,024)

(a)The movements primarily represent fair value changes in available-for-sale debt securities, including our investment in Celsius convertible preferred stock. See Note 9 for further information.

(b)Pension and retiree medical amounts are net of taxes of $1,184 million as of December 31, 2022, $1,282 million as of both December 30, 2023 and December 28, 2024 and $1,138 million as of December 27, 2025.

(c)Currency translation adjustment primarily reflects depreciation of the Russian ruble and South African rand, partially offset by appreciation of the Mexican peso.

(d)Currency translation adjustment primarily reflects depreciation of the Mexican peso and Russian ruble.

(e)Currency translation adjustment primarily reflects appreciation of the Russian ruble and Mexican peso.

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

The reclassifications from accumulated other comprehensive loss to the income statement are summarized as follows:


	Amount Reclassified from Accumulated Other Comprehensive Loss						Affected Line Item in the Income Statement
	2025		2024		2023
Currency translation:
Divestitures	$	—	$	—	$	108	Selling, general and administrative expenses

Cash flow hedges:
Foreign exchange contracts	(1)		(1)		(3)		Net revenue
Foreign exchange contracts	13		(5)		64		Cost of sales
Cross-currency contracts	(67)		48		(31)		Selling, general and administrative expenses
Interest rate swap contracts	—		(7)		(9)		Selling, general and administrative expenses
Commodity contracts	(79)		122		126		Cost of sales
Commodity contracts	2		1		(1)		Selling, general and administrative expenses
Net (gains)/losses before tax	(132)		158		146
Tax amounts	32		(37)		(39)
Net (gains)/losses after tax	(100)		121		107

Pension and retiree medical items:
Amortization of net prior service credit	(3)		(31)		(33)		Other pension and retiree medical benefits (expense)/income
Amortization of net losses	86		73		56		Other pension and retiree medical benefits (expense)/income
Settlement/curtailment losses	279		243		14		Other pension and retiree medical benefits (expense)/income
Net losses before tax	362		285		37
Tax amounts	(79)		(62)		(7)
Net losses after tax	283		223		30






Total net losses reclassified for the year, net of tax	$	183	$	344	$	245

Financial Instruments (Fair Values of Financial Assets and Liabilities) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	May 19, 2025	Dec. 30, 2023
Derivatives, Fair Value [Line Items]
Short-term Investments	$ 371	$ 761
Total Financial Assets at Fair Value	2,619	1,491
Total Financial Liabilities at Fair Value	$ 987	$ 749
Collateral Received or Posted against our Asset or Liability positions	not material
Derivative Assets and Liabilities, Subject to Master Netting Arrangements, which are not offset on balance sheet.	not material	not material
Derivative Liability	$ 214	$ 246
Derivative Asset	151	114
Carrying Amount, Hedged Fixed-Rate Debt	2,000
Business Combination, Contingent Consideration, Liability	278	0
Business Combination, Contingent Consideration, Asset	0	0
Other, AFS debt securities
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-sale	275	256		$ 0
Celsius, AFS debt security
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-sale	1,852	785		$ 1,156
poppi acquisition
Derivatives, Fair Value [Line Items]
Business Combination, Contingent Consideration, Liability	278
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease)	98
Business Combination, Contingency Recognized at Acquisition Date, Liability Assumed, Fair Value			$ 180
Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount	300
Net Investment Hedging [Member]
Derivatives, Fair Value [Line Items]
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Liabilities, Fair Value	35	4
Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value, Net	0	1
Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Derivatives designated as hedging instruments, Assets, Total	122	82
Derivatives designated as hedging instruments, Liabilities, Total	135	174
Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivatives not designated as hedging instruments, Assets, Total	10	31
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	41	22
Fair Value, Inputs, Level 1 [Member] \| Liability [Member]
Derivatives, Fair Value [Line Items]
Short-term Investments	0	0
Fair Value, Inputs, Level 2 [Member] \| Fair Value Hedging
Derivatives, Fair Value [Line Items]
Interest Rate Fair Value Hedge Liability at Fair Value	3	46
Interest Rate Fair Value Hedge Asset at Fair Value	19	0
Fair Value, Inputs, Level 2 [Member] \| Assets [Member]
Derivatives, Fair Value [Line Items]
Deferred compensation	0	0
Fair Value, Inputs, Level 2 [Member] \| Liability [Member]
Derivatives, Fair Value [Line Items]
Deferred compensation	495	503
Level 3 \| Assets [Member]
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-sale	2,127	1,041
Level 3 \| Liability [Member]
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-sale	0	0
Assets [Member] \| Fair Value, Inputs, Level 1 [Member]
Derivatives, Fair Value [Line Items]
Short-term Investments	341	336
Cross Currency Interest Rate Contract [Member] \| Fair Value, Inputs, Level 2 [Member] \| Net Investment Hedging [Member]
Derivatives, Fair Value [Line Items]
Cross-currency contracts - Liability	34	4
Cross-Currency Contracts - Asset	0	1
Cross Currency Interest Rate Contract [Member] \| Fair Value, Inputs, Level 2 [Member] \| Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Cross-currency contracts - Liability	102	165
Cross-Currency Contracts - Asset	0	0
Foreign Exchange Contract \| Fair Value, Inputs, Level 2 [Member] \| Net Investment Hedging [Member]
Derivatives, Fair Value [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure	1	0
Foreign Currency Contract, Asset, Fair Value Disclosure	0	0
Foreign Exchange Contract \| Fair Value, Inputs, Level 2 [Member] \| Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Foreign Currency Cash Flow Hedge Liability at Fair Value	28	3
Foreign Currency Cash Flow Hedge Asset at Fair Value	6	55
Foreign Exchange Contract \| Fair Value, Inputs, Level 2 [Member] \| Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Foreign Currency Contracts, Liability, Fair Value Disclosure	32	12
Foreign Currency Contract, Asset, Fair Value Disclosure	6	28
Commodity Contracts \| Fair Value, Inputs, Level 2 [Member] \| Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Price Risk Cash Flow Hedge Asset, at Fair Value	116	27
Price Risk Cash Flow Hedge Liability, at Fair Value	5	6
Commodity Contracts \| Fair Value, Inputs, Level 2 [Member] \| Not Designated as Hedging Instrument
Derivatives, Fair Value [Line Items]
Price Risk Derivative Instruments Not Designated as Hedging Instruments Asset, at Fair Value	4	3
Price Risk Derivative Instruments Not Designated as Hedging Instruments Liability, at Fair Value	$ 9	$ 10

Consolidated Balance Sheet (Parenthetical) - $ / shares shares in Millions	Dec. 27, 2025	Dec. 28, 2024
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.0167	$ 0.0167
Common stock, authorized	3,600	3,600
Common stock, issued	1,367	1,372
Treasury Stock, Common, Shares	500	495

Financial Instruments

12 Months Ended

Dec. 27, 2025

Derivative Instruments and Hedges, Assets [Abstract]

Financial Instruments

Derivatives and Hedging

We are exposed to market risks arising from adverse changes in:

•commodity prices, affecting the cost of our raw materials and energy;

•foreign exchange rates and currency restrictions; and

•interest rates.

In the normal course of business, we manage commodity price, foreign exchange and interest rate risks through a variety of strategies, including productivity initiatives, global purchasing programs and hedging. Ongoing productivity initiatives involve the identification and effective implementation of meaningful cost-saving opportunities or efficiencies, including the use of derivatives. We do not use derivative instruments for trading or speculative purposes. Our global purchasing programs include fixed-price contracts and purchase orders and pricing agreements.

Our hedging strategies include the use of derivatives and non-derivative debt instruments. Certain derivatives are designated as either cash flow, fair value or net investment hedges and qualify for hedge accounting treatment, while others do not qualify and are marked to market through earnings. The accounting for qualifying hedges allows changes in a hedging instrument’s fair value to offset corresponding changes in the hedged item in the same reporting period that the hedged item impacts earnings. Gains or losses on derivatives designated as cash flow and net investment hedges are recorded in accumulated other comprehensive loss within common shareholders’ equity and reclassified to our income statement when the hedged transaction affects earnings for cash flow hedges and when the hedged foreign operation is either sold or substantially liquidated for net investment hedges. If it becomes probable that the hedged transaction will not occur, we immediately recognize the related hedging gains or losses in earnings; such gains or losses reclassified during the year ended December 27, 2025 were not material.

Cash flows from derivatives used to manage commodity price, foreign exchange or interest rate risks are classified as operating activities in the cash flow statement. We classify both the earnings and cash flow impact from these derivatives consistent with the underlying hedged item. Cash flows associated with the settlement of derivative instruments designated as net investment hedges of foreign operations are classified within investing activities.

Credit Risk

We perform assessments of our counterparty credit risk regularly, including reviewing netting agreements, if any, and a review of credit ratings, credit default swap rates and potential nonperformance of the counterparty. Based on our most recent assessment of our counterparty credit risk, we consider this risk to be low. In addition, we enter into derivative contracts with a variety of financial institutions that we believe are creditworthy in order to reduce our concentration of credit risk.

Certain of our agreements with our counterparties require us to post full collateral on derivative instruments in a net liability position if our credit rating is at A2 (Moody’s Investors Service, Inc.) or A (S&P Global Ratings) and we have been placed on credit watch for possible downgrade or if our credit rating falls below either of these levels. The fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position as of December 27, 2025 was $96 million. We have posted no collateral under these contracts and no credit-risk-related contingent features were triggered as of December 27, 2025.

Commodity Prices

We are subject to commodity price risk because our ability to recover increased costs through higher pricing may be limited in the competitive environment in which we operate. This risk is managed through

the use of fixed-price contracts and purchase orders, pricing agreements and derivative instruments, which primarily include swaps and futures. In addition, risk to our supply of certain raw materials is mitigated through purchases from multiple geographies and suppliers. We use derivatives, with terms of no more than two years, to hedge price fluctuations related to a portion of our anticipated commodity purchases, primarily for agricultural products, energy and metals. Derivatives used to hedge commodity price risk that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in segment results when the segments recognize the cost of the underlying commodity in operating profit.

Interest Rates

We centrally manage our debt and investment portfolios considering investment opportunities and risks, tax consequences and overall financing strategies. We use various interest rate derivative instruments including, but not limited to, interest rate swaps, cross-currency interest rate swaps, Treasury locks and swap locks to manage our overall interest expense. These instruments effectively change the interest rate of specific debt issuances. Certain of our fixed rate indebtedness have been swapped to floating rates. The notional amount, interest payment and maturity date of our interest rate swap contracts match the principal, interest payment and maturity date of the related debt, and they have terms of no more than six years. Our Treasury locks and swap locks are entered into to protect against unfavorable interest rate changes relating to forecasted debt transactions.

As of December 27, 2025, approximately 11% of total debt was subject to variable rates, after the impact of the related interest rate swap contracts, compared to approximately 13% as of December 28, 2024.

Foreign Exchange

We are exposed to foreign exchange risks in the international markets in which our products are made, manufactured, distributed or sold. Additionally, we are exposed to foreign exchange risk from foreign currency purchases and foreign currency assets and liabilities created in the normal course of business. We manage this risk through sourcing purchases from local suppliers, negotiating contracts in local currencies with foreign suppliers and through the use of derivatives including, but not limited to, forward contracts and cross-currency interest rate swap contracts. Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses on our income statement as incurred. The forward contracts and cross-currency interest rate swap contracts have terms of no more than two years and twelve years, respectively. The notional amount, interest payment and maturity date of our cross-currency interest rate swap contracts match the principal, interest payment and maturity date of the related foreign currency debt. For foreign currency derivatives that do not qualify for hedge accounting treatment, gains and losses were offset by changes in the underlying hedged items, resulting in no material net impact on earnings.

Net Investment Hedges

We are exposed to foreign exchange risk from net investments in our foreign operations. We manage this risk for certain of our foreign operations by utilizing derivative and non-derivative instruments, including cross-currency interest rate swaps, forward contracts and foreign currency denominated debt designated as net investment hedges. The cross-currency interest rate swaps and forward contracts have terms of no more than ten years and one year, respectively.

We use the spot method to assess hedge effectiveness for our net investment hedges. Excluded components in the form of interest accruals on cross-currency interest rate swaps are recorded in net

interest expense and other. Excluded components in the form of forward points on forward contracts are recorded in selling, general and administrative expenses.

The notional amounts of our financial instruments used to hedge the above risks as of December 27, 2025 and December 28, 2024 are as follows:


	Notional Amounts(a)
	2025		2024
Commodity contracts	$	1.5	$	1.4
Interest rate swap contracts	$	2.0	$	2.0
Foreign exchange contracts (b)	$	3.1	$	3.1
Cross-currency contracts	$	1.7	$	1.2
Non-derivative debt instruments (b)	$	4.4	$	2.9

(a)In billions.

Debt Securities

Available-for-Sale

Investments in available-for-sale debt securities are reported at fair value. Changes in the fair value of available-for-sale debt securities are generally recognized in accumulated other comprehensive loss within common shareholders’ equity. Changes in the fair value of available-for-sale debt securities impact earnings only when such securities are sold, or an allowance for expected credit losses or impairment is recognized. We regularly evaluate our investment portfolio for expected credit losses and impairment. In making this judgment, we evaluate, among other things, the extent to which the fair value of a debt security is less than its amortized cost; the financial condition of the issuer, including the credit quality, and any changes thereto; and our intent to sell, or whether we will more likely than not be required to sell, the debt security before recovery of its amortized cost basis. Our assessment of whether a debt security has a credit loss or is impaired could change in the future due to new developments or changes in assumptions related to any particular debt security.

In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States and invested $550 million in Series A convertible preferred shares (Series A shares) issued by Celsius, which included certain conversion and redemption features. Shares underlying the transaction were priced at $75 per share ($25 per share after a three-for-one stock split in 2023), and are entitled to a 5% annual dividend, payable either in cash or in-kind. On August 28, 2025, as part of the Celsius Transaction described in Note 4, we acquired Series B convertible preferred shares (Series B shares) issued by Celsius, valued at $585 million upon acquisition, excluding acquisition-related charges. Shares underlying the transaction were priced at $51.75 per share and are entitled to a 5% annual dividend, payable either in cash or in-kind. In addition, as part of this transaction, the conversion and redemption periods of the Series A shares were extended to match the terms of the newly issued Series B shares, which was accounted for as a modification. Both series of shares include certain conversion and redemption features and convert into Celsius common shares after six years from issuance of the Series B shares if certain market-based conditions are met, or can be redeemed for cash after seven years from issuance of the Series B shares. Given our redemption rights associated with both series of shares, we classified our investments as Level 3 investments in available-for-sale debt securities.

The activity related to our Level 3 investments in certain available-for-sale debt securities is as follows:


	2025		2024
Celsius:
Balance, beginning of year	$	785	$	1,156
Acquired	590		—
Net unrealized gain/(loss)	507		(350)
Cash dividends received	(30)		(21)
Balance, end of year	1,852		785
Other:
Balance, beginning of year	256		—
Transfer from Level 2 (a)	—		184
Net unrealized gain	19		72
Balance, end of year	275		256
Total Level 3 available-for-sale balance, end of year	$	2,127	$	1,041

(a)Unobservable inputs to the fair value became more significant.

There were no impairment charges related to our investments in available-for-sale debt securities in the years ended December 27, 2025, December 28, 2024 and December 30, 2023. There were net unrealized pre-tax gains of $860 million and $334 million as of December 27, 2025 and December 28, 2024, respectively, associated with our available-for-sale debt securities.

TBG Investment

We hold a 39% noncontrolling interest in TBG, operating across North America and Europe, and we account for our investment under the equity method.

In 2023, we recorded our proportionate share of TBG’s earnings, which included an impairment of TBG’s indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our investment, both of which resulted in pre-tax impairment charges of $321 million ($243 million after-tax or $0.18 per share), recorded in selling, general and administrative expenses in our PBNA segment. We estimated the fair value of our ownership in TBG using discounted cash flows and an option pricing model related to our liquidation preference in TBG, which we categorized as Level 3 in the fair value hierarchy.

In 2024, after identifying several indicators of impairment such as worsening operating losses and liquidity position, we quantitatively assessed our investment in TBG for impairment and, consequently, recorded an other-than-temporary impairment of our remaining investment, resulting in pre-tax impairment charges of $498 million ($416 million after-tax or $0.30 per share), with $409 million in our PBNA segment and $89 million in our EMEA segment, recorded in selling, general and administrative expenses. We estimated the fair value of our ownership in TBG using discounted cash flows. We also recorded an allowance for expected credit losses in selling, general and administrative expenses in 2024, primarily related to outstanding receivables associated with the Juice Transaction; see Note 1 for further information.

Recurring Fair Value Measurements

The fair values of our financial assets and liabilities as of December 27, 2025 and December 28, 2024 are categorized as follows:


		2025				2024
	Fair Value Hierarchy Levels(a)	Assets(a)		Liabilities(a)		Assets(a)		Liabilities(a)
Available-for-sale debt securities (b)	3	$	2,127	$	—	$	1,041	$	—
Index funds (c)	1	341		—		336		—
Deferred compensation (d)	2	—		495		—		503
Contingent consideration (e)	3	—		278		—		—


Derivatives designated as fair value hedging instruments:
Interest rate swap contracts (f)	2	19		3		—		46


Derivatives designated as cash flow hedging instruments:
Foreign exchange contracts (g)	2	6		28		55		3
Cross-currency contracts (g)	2	—		102		—		165

Commodity contracts (h)	2	116		5		27		6
		122		135		82		174
Derivatives designated as net investment hedging instruments:
Foreign exchange contracts (g)	2	—		1		—		—
Cross-currency contracts (g)	2	—		34		1		4
		—		35		1		4

Derivatives not designated as hedging instruments:
Foreign exchange contracts (g)	2	6		32		28		12

Commodity contracts (h)	2	4		9		3		10
		10		41		31		22
Total derivatives at fair value (i)		151		214		114		246
Total		$	2,619	$	987	$	1,491	$	749

(c)Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.

(d)Based on the fair value of investments corresponding to employees’ investment elections.

(g)Based on recently reported market transactions of spot and/or forward rates.

(h)Primarily based on recently reported market transactions of swap arrangements.

The carrying amounts of our cash and cash equivalents and short-term investments recorded at amortized cost approximate fair value (classified as Level 2 in the fair value hierarchy) due to their short-term maturity. The fair value of our debt obligations as of December 27, 2025 and December 28, 2024 was $46 billion and $40 billion, respectively, based upon prices of identical or similar instruments in the marketplace, which are considered Level 2 inputs.

Losses/(gains) on our fair value hedges recognized in the income statement are as follows:



	2025		2024
Interest rate swap contracts (a)	$	(62)	$	46

Losses/(gains) on our cash flow hedges are categorized as follows:



	Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss			Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(a)
		2025		2024		2025		2024
Foreign exchange contracts		$	95	$	(101)	$	12	$	(6)
Cross-currency contracts		(63)		46		(67)		48
Commodity contracts		(218)		57		(77)		123

Total		$	(186)	$	2	$	(132)	$	165

Losses/(gains) on our net investment hedges are categorized as follows:


	Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss			Losses/(Gains) Recognized in Income Statement(a)
		2025		2024		2025		2024
Non-derivative debt instruments		$	337	$	(133)	$	—	$	—
Cross-currency contracts		33		3		(13)		(5)
Foreign exchange contracts		(13)		—		—		—
Total		$	357	$	(130)	$	(13)	$	(5)

(a)Amount excluded from the assessment of effectiveness recognized in earnings associated with cross-currency interest rate swaps and

forward contracts.

Based on current market conditions, we expect to reclassify net gains of $100 million related to our cash flow hedges from accumulated other comprehensive loss within common shareholders’ equity into net income during the next 12 months.

Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows:




	2025						2024
	Cost of sales		Selling, general and administrative expenses		Total		Cost of sales		Selling, general and administrative expenses		Total
Foreign exchange contracts	$	1	$	66	$	67	$	1	$	2	$	3
Commodity contracts	16		6		22		2		8		10
Total	$	17	$	72	$	89	$	3	$	10	$	13

Financial Instruments - Notional Amounts of Financial Instruments (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 21, 2026	Dec. 27, 2025	Dec. 28, 2024
Non-derivative Debt Instruments
Derivatives [Line Items]
Non-derivative Debt Instruments		$ 4,400	$ 2,900
Commodity Contracts
Derivatives [Line Items]
Derivative, Notional Amount		1,500	1,400
Foreign Exchange Contract
Derivatives [Line Items]
Derivative, Notional Amount		3,100	3,100
Foreign Exchange Contract \| Net Investment Hedging [Member] \| Subsequent Event
Derivatives [Line Items]
Derivative, Notional Amount, Change in Designation	$ 1,600
Cross Currency Interest Rate Contract [Member]
Derivatives [Line Items]
Derivative, Notional Amount		1,700	1,200
Interest Rate Swap [Member]
Derivatives [Line Items]
Derivative, Notional Amount		$ 2,000	$ 2,000
Non-derivative Debt Instruments \| Net Investment Hedging [Member] \| Subsequent Event
Derivatives [Line Items]
Derivative, Notional Amount, Change in Designation	$ 4,500

Pension, Retiree Medical and Savings Plans Pension, Retiree Medical and Savings Plans (Policies)	12 Months Ended
	Dec. 27, 2025
Retirement Benefits [Abstract]
Pension and Other Postretirement Plans, Policy [Policy Text Block]	Gains and losses resulting from actual experience differing from our assumptions, including the difference between the actual and expected return on plan assets, as well as changes in our assumptions, are determined at each measurement date. These differences are recognized as a component of net gain or loss in accumulated other comprehensive loss within common shareholders’ equity. If this net accumulated gain or loss exceeds 10% of the greater of the market-related value of plan assets or plan obligations, a portion of the net gain or loss is included in other pension and retiree medical benefits (expense)/income for the following year based upon the average remaining service life for participants in PepsiCo Employees Retirement Hourly Plan (Plan H) (approximately 10 years) and retiree medical (approximately 12 years), and the remaining life expectancy for participants in PepsiCo Employees Retirement Plan I (Plan I) (approximately 26 years). The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost/(credit)) is included in other pension and retiree medical benefits (expense)/income on a straight-line basis over the average remaining service life for participants in Plan H, and the remaining life expectancy for participants in Plan I, except that prior service cost/(credit) for salaried participants subject to the benefit accruals freeze effective December 31, 2025 was amortized on a straight-line basis over the period up to the effective date of the freeze.

Debt Obligations and Commitments

12 Months Ended

Dec. 27, 2025

Debt Disclosure [Abstract]

Debt Disclosure

Debt Obligations

The following table summarizes our debt obligations:


	2025(a)		2024(a)
Short-term debt obligations (b)
Current maturities of long-term debt	$	4,030	$	4,004
Commercial paper (3.8% and 4.5%)	2,641		2,818
Other borrowings	190		260
	$	6,861	$	7,082
Long-term debt obligations (b)



Notes due 2025 (3.2%)	$	—	$	3,999
Notes due 2026 (3.6% and 3.7%)	4,003		3,941
Notes due 2027 (3.2% and 3.1%)	3,933		3,370
Notes due 2028 (2.4% and 2.1%)	4,203		3,240
Notes due 2029 (4.3% and 4.6%)	4,043		3,239
Notes due 2030 (3.2% and 2.6%)	4,171		2,472
Notes due 2031-2060 (3.4% and 3.2%)	25,956		20,928
Other, due 2025-2042	42		39
	46,351		41,228
Less: current maturities of long-term debt obligations	4,030		4,004
Total	$	42,321	$	37,224

(a)Amounts are shown net of unamortized net discounts of $224 million and $267 million for 2025 and 2024, respectively.

As of December 27, 2025 and December 28, 2024, our international debt of $272 million and $325 million, respectively, was related to borrowings from external parties, including various lines of credit. These lines of credit are subject to normal banking terms and conditions and are fully committed at least to the extent of our borrowings.

In 2025, we issued the following senior notes:


Interest Rate		Maturity Date	Principal Amount(a)
4.400	%	February 2027	$	500
4.450	%	February 2028	$	750
4.600	%	February 2030	$	1,000
5.000	%	February 2035	$	1,250
4.100	%	January 2029	$	750
4.300	%	July 2030	$	650
4.650	%	July 2032	$	850
5.000	%	July 2035	$	1,250
3.450	%	July 2037	€	500	(b)
4.050	%	July 2055	€	500	(b)

(a)Excludes debt issuance costs, discounts and premiums.

(b)These notes, issued in euros, were designated as net investment hedges to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.

The net proceeds from the issuances of the above notes were used for general corporate purposes, including the repayment of commercial paper.

In 2025, we entered into a new five-year unsecured revolving credit agreement (2025 Five-Year Credit Agreement), which expires on May 23, 2030. The 2025 Five-Year Credit Agreement enables us and our borrowing subsidiaries to borrow up to $5.0 billion in U.S. dollars and/or euros, including a $0.75 billion swing line subfacility for euro-denominated borrowings permitted to be borrowed on a same-day basis, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $5.75 billion (or the equivalent amount in euros). Additionally, we may, up to two times during the term of the 2025 Five-Year Credit Agreement, request renewal of the agreement for an additional one-year period. The 2025 Five-Year Credit Agreement replaced our $5.0 billion five-year credit agreement, dated as of May 24, 2024.

Also in 2025, we entered into a new 364-day unsecured revolving credit agreement (2025 364-Day Credit Agreement), which expires on May 22, 2026. The 2025 364-Day Credit Agreement enables us and our borrowing subsidiaries to borrow up to $5.0 billion in U.S. dollars and/or euros, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $5.75 billion (or the equivalent amount in euros). We may request renewal of this facility for an additional 364-day period or convert any amounts outstanding into a term loan for a period of up to one year, which term loan would mature no later than the anniversary of the then effective termination date. The 2025 364-Day Credit Agreement replaced our $5.0 billion 364-day credit agreement, dated as of May 24, 2024.

Funds borrowed under the 2025 Five-Year Credit Agreement and the 2025 364-Day Credit Agreement may be used for general corporate purposes. Subject to certain conditions, we may borrow, prepay and reborrow amounts under these agreements. As of December 27, 2025, there were no outstanding borrowings under the 2025 Five-Year Credit Agreement or the 2025 364-Day Credit Agreement.

In 2023, we discharged via legal defeasance $94 million outstanding principal amount of certain notes originally issued by our subsidiary, The Quaker Oats Company, following the deposit of $102 million of U.S. government securities with the Bank of New York Mellon, as trustee, in the fourth quarter of 2022.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

Basis of Presentation and Our Segments (Schedule of Segment reporting Information, by Segment) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Segment Reporting Information [Line Items]
Net Revenue	$ 93,925	$ 91,854	$ 91,471
Restructuring Charges	983	727	445
Operating Profit	11,498	12,887	11,986
Product recall-related impact	0	187	136
Product recall-related impact - after tax		$ 143	$ 104
Product recall-related impact - per share amount		$ 0.10	$ 0.07
Acquisition and divestiture-related charges	453	$ 22	$ 41
Impairment and other charges	1,946	714	1,230
Other pension and retiree medical benefits (expense)/income	(133)	(22)	250
Net interest expense and other	(1,121)	(919)	(819)
Income before income taxes	10,244	11,946	11,417
Sabra acquisition
Segment Reporting Information [Line Items]
Gain (Loss) on Investments		122
Gain (Loss) on Investments, after tax		$ 92
Gain (Loss) on Investments, per share impact		$ 0.07
Cost of sales
Segment Reporting Information [Line Items]
Acquisition and divestiture-related charges	57	$ 0	0
Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Acquisition and divestiture-related charges	346	22	41
2019 Productivity Plan [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	983	727	445
2019 Productivity Plan [Member] \| Cost of sales
Segment Reporting Information [Line Items]
Restructuring Charges	236	133	13
2019 Productivity Plan [Member] \| Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Restructuring Charges	728	551	433
PepsiCo Foods North America [Member] \| Cost of sales
Segment Reporting Information [Line Items]
Product recall-related impact - pre-tax		176
PepsiCo Foods North America [Member] \| Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Product recall-related impact - pre-tax		8
PepsiCo Foods North America [Member] \| Pension charges associated with Quaker Recall
Segment Reporting Information [Line Items]
Product recall-related impact - pre-tax		3
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating Profit	13,516	14,783	14,361
Operating Segments [Member] \| PepsiCo Foods North America [Member]
Segment Reporting Information [Line Items]
Net Revenue	27,528	27,431	28,015
Segment cost of sales	10,564	10,245	10,432
Segment selling, general and administrative expenses	10,419	10,204	10,158
Restructuring Charges	344	161	42
Operating Profit	6,173	6,619	7,247
Acquisition and divestiture-related charges	28	9	0
Impairment and other charges	0	9	0
Indirect and Income Tax Impact	0	0
Product recall-related impact - pre-tax		184	136
Pension and retiree medical-related impact	0
Operating Segments [Member] \| PepsiCo Foods North America [Member] \| 2019 Productivity Plan [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	344	161	42
Operating Segments [Member] \| International Beverage Franchise [Member]
Segment Reporting Information [Line Items]
Net Revenue	4,997	4,879	4,559
Segment cost of sales	1,529	1,482	1,478
Segment selling, general and administrative expenses	1,612	1,689	1,641
Restructuring Charges	14	24	11
Operating Profit	1,769	1,462	567
Acquisition and divestiture-related charges	0	0	0
Impairment and other charges	73	4	862
Indirect and Income Tax Impact	0	218
Product recall-related impact - pre-tax		0	0
Pension and retiree medical-related impact	0
Operating Segments [Member] \| International Beverage Franchise [Member] \| Cost of sales
Segment Reporting Information [Line Items]
Indirect and Income Tax Impact		218
Indirect and Income Tax Impact - after tax		$ 218
Indirect and Income Tax Impact - per share amount		$ 0.16
Operating Segments [Member] \| International Beverage Franchise [Member] \| 2019 Productivity Plan [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	14	$ 24	11
Operating Segments [Member] \| PepsiCo Beverages North America [Member]
Segment Reporting Information [Line Items]
Net Revenue	28,197	27,769	27,626
Segment cost of sales	12,910	12,701	12,856
Segment selling, general and administrative expenses	12,002	11,964	11,808
Restructuring Charges	281	238	41
Operating Profit	1,089	2,302	2,584
Acquisition and divestiture-related charges	422	8	16
Impairment and other charges	1,523	556	321
Indirect and Income Tax Impact	0	0
Product recall-related impact - pre-tax		0	0
Pension and retiree medical-related impact	(30)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment, after tax	$ (22)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment, per share amount	$ (0.02)
Operating Segments [Member] \| PepsiCo Beverages North America [Member] \| 2019 Productivity Plan [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	$ 281	238	41
Operating Segments [Member] \| Asia Pacific Foods (Segment) [Member]
Segment Reporting Information [Line Items]
Net Revenue	4,629	4,549	4,485
Segment cost of sales	2,850	2,756	2,711
Segment selling, general and administrative expenses	1,315	1,402	1,404
Restructuring Charges	12	9	8
Operating Profit	369	377	301
Acquisition and divestiture-related charges	3	5	2
Impairment and other charges	80	0	59
Indirect and Income Tax Impact	0	0
Product recall-related impact - pre-tax		0	0
Pension and retiree medical-related impact	0
Operating Segments [Member] \| Asia Pacific Foods (Segment) [Member] \| 2019 Productivity Plan [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	12	9	8
Operating Segments [Member] \| Europe, Middle East & Africa (Segment) [Member]
Segment Reporting Information [Line Items]
Net Revenue	18,025	16,658	16,210
Segment cost of sales	10,437	9,639	9,666
Segment selling, general and administrative expenses	5,017	4,787	4,569
Restructuring Charges	195	116	227
Operating Profit	2,106	1,971	1,764
Acquisition and divestiture-related charges	0	0	(2)
Impairment and other charges	270	145	(14)
Indirect and Income Tax Impact	0	0
Product recall-related impact - pre-tax		0	0
Pension and retiree medical-related impact	0
Operating Segments [Member] \| Europe, Middle East & Africa (Segment) [Member] \| 2019 Productivity Plan [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	195	116	227
Operating Segments [Member] \| Latin America Foods (Segment) [Member]
Segment Reporting Information [Line Items]
Net Revenue	10,549	10,568	10,576
Segment cost of sales	4,480	4,420	4,591
Segment selling, general and administrative expenses	3,925	4,047	4,056
Restructuring Charges	52	49	29
Operating Profit	2,010	2,052	1,898
Acquisition and divestiture-related charges	0	0	0
Impairment and other charges	0	0	2
Indirect and Income Tax Impact	82	0
Product recall-related impact - pre-tax		0	0
Pension and retiree medical-related impact	$ 0
Indirect and income tax impact - per share	$ 0.08
Operating Segments [Member] \| Latin America Foods (Segment) [Member] \| Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Indirect and Income Tax Impact	$ 82
Operating Segments [Member] \| Latin America Foods (Segment) [Member] \| Provision for Income Tax Associated With Indirect and Income Tax Impact
Segment Reporting Information [Line Items]
Indirect and Income Tax Impact	29
Operating Segments [Member] \| Latin America Foods (Segment) [Member] \| 2019 Productivity Plan [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	52	49	29
Corporate
Segment Reporting Information [Line Items]
Operating Profit	(2,018)	(1,896)	(2,375)
Corporate \| 2019 Productivity Plan [Member]
Segment Reporting Information [Line Items]
Restructuring Charges	$ 66	$ 101	$ 88

Pension, Retiree Medical and Savings Plans (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 26, 2026	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Defined Benefit Plan Disclosure [Line Items]
Pension strategy investment term, years		5 years
Defined Contribution Plan, Cost		$ 434,000,000	$ 411,000,000	$ 356,000,000
amortization corridor		10.00%
Defined Benefit Plan, Average Remaining Service Period of Active Plan Participants, Retiree Medical Expense		12 years
Reporting Unit, Zero or Negative Carrying Amount, Number		0
Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax		$ 237,000,000
Expected return on plan assets		7.50%	7.40%	7.40%
Pre-tax non-cash settlement charge, net of tax, per share		$ 0.13
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax		$ 183,000,000
Defined Benefit Plan, Plan Assets, Amount		10,949,000,000	$ 10,609,000,000	$ 11,541,000,000
Domestic-Plan I [Member]
Defined Benefit Plan Disclosure [Line Items]
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax		$ 237,000,000	$ 213,000,000
Defined Benefit Plan, Average remaining life expectancy of Inactive Plan Participants, Pension Expense		26 years
Pre-tax non-cash settlement charge, net of tax, per share		$ 0.13	$ 0.12
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax		$ 183,000,000	$ 165,000,000
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets		7.10%	7.10%	7.10%
Defined Benefit Plan, Plan Assets, Amount		$ 155,000,000	$ 163,000,000	$ 183,000,000
Domestic plan -Plan H [Member]
Defined Benefit Plan Disclosure [Line Items]
Average remaining service period of active plan participants, pension expense		10 years
Forecast [Member] \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets	7.80%

Basis of Presentation and Our Segments - Schedule of Pre-Tax Other Impairment Charges (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	$ 1,946	$ 714	$ 1,230
Impairment and other charges - after-tax	$ 1,491	$ 584	$ 1,014
Impairment and other charges - per share amount	$ (1.09)	$ (0.42)	$ (0.73)
Prior-year tax benefit related to impairment of TBG investment	$ 39
Prior-year tax benefit related to impairment of TBG investment - Per share	$ 0.03
Allowance for expected credit losses - impact of TBG		$ 193
PepsiCo Foods North America [Member] \| Operating Segments [Member]
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	$ 0	9	$ 0
PepsiCo Beverages North America [Member] \| Operating Segments [Member]
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	1,523	556	321
International Beverage Franchise [Member] \| Operating Segments [Member]
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	73	4	862
Europe, Middle East & Africa (Segment) [Member] \| Other major class or type
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	0	10	(14)
Europe, Middle East & Africa (Segment) [Member] \| Operating Segments [Member]
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	270	145	(14)
Latin America Foods (Segment) [Member] \| Operating Segments [Member]
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	0	0	2
Asia Pacific Foods (Segment) [Member] \| Operating Segments [Member]
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	80	0	59
Selling, general and administrative expenses \| PepsiCo Beverages North America [Member] \| Tropicana Brands Group
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	(16)	556	321
Selling, general and administrative expenses \| International Beverage Franchise [Member] \| Other major class or type
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	0	4	0
Selling, general and administrative expenses \| Europe, Middle East & Africa (Segment) [Member] \| Tropicana Brands Group
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	19	135	0
Selling, general and administrative expenses \| Latin America Foods (Segment) [Member] \| Other major class or type
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	0	0	2
Impairment of intangible assets \| PepsiCo Foods North America [Member] \| Other major class or type
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	0	9	0
Impairment of intangible assets \| PepsiCo Beverages North America [Member] \| Rockstar
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	1,539	0	0
Impairment of intangible assets \| International Beverage Franchise [Member] \| Rockstar
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	73	0	0
Impairment of intangible assets \| International Beverage Franchise [Member] \| Soda Stream
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	0	0	862
Impairment of intangible assets \| Europe, Middle East & Africa (Segment) [Member] \| Rockstar
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	251	0	0
Impairment of intangible assets \| Asia Pacific Foods (Segment) [Member] \| Be & Cheery
Schedule of Pre-Tax Other Impairment Charges [Line Items]
Impairment and other charges	$ 80	$ 0	$ 59

Pension, Retiree Medical and Savings Plans Pension, Retiree Medical and Savings Plans (Target Asset Allocations) (Details)	Dec. 26, 2026	Dec. 27, 2025
Fixed Income
Target Asset Allocation [Line Items]
Target investment allocation percentage		56.00%
U.S. Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage		22.00%
International Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage		18.00%
Real Estate Funds [Member]
Target Asset Allocation [Line Items]
Target investment allocation percentage		4.00%
Forecast [Member] \| Fixed Income
Target Asset Allocation [Line Items]
Target investment allocation percentage	58.00%
Forecast [Member] \| U.S. Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage	22.00%
Forecast [Member] \| International Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage	16.00%
Forecast [Member] \| Real Estate Funds [Member]
Target Asset Allocation [Line Items]
Target investment allocation percentage	4.00%

Intangible Assets (Indefinite-Lived Intangible Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Indefinite-lived Intangible Assets [Line Items]
Impairment of Intangible Assets (Excluding Goodwill)	$ 1,993	$ 33	$ 927
Goodwill, Impairment Loss	0	$ 0
Intangible Assets, Net (Excluding Goodwill)	$ 500

- Definition

Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.

+ References + Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482686/350-30-45-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-3

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

+ Details

Consolidated Balance Sheet - USD ($) shares in Millions, $ in Millions	Dec. 27, 2025	Dec. 28, 2024
ASSETS
Cash and cash equivalents	$ 9,159	$ 8,505
Short-term Investments	371	761
Accounts and notes receivable, net	11,506	10,333
Inventories	5,845	5,306
Prepaid expenses and other current assets	1,068	921
Assets, Current	27,949	25,826
Property, Plant and Equipment, net	29,905	28,008
Amortizable Intangible Assets, net	1,219	1,102
Goodwill	18,916	17,534
Indefinite-lived Intangible Assets (Excluding Goodwill)	13,847	13,699
Equity Method Investments	2,038	1,985
Deferred Income Tax Assets, Net	4,541	4,362
Other Assets	8,984	6,951
Total Assets	107,399	99,467
LIABILITIES AND EQUITY
Short-term debt obligations	6,861	7,082
Accounts payable and other current liabilities	25,903	24,454
Liabilities, Current	32,764	31,536
Long-Term Debt Obligations	42,321	37,224
Deferred Income Tax Liabilities, Net	3,802	3,484
Other Liabilities, Noncurrent	7,965	9,052
Liabilities	86,852	81,296
Commitments and contingencies
Common stock, authorized	3,600	3,600
Common stock, issued	1,367	1,372
PepsiCo Common Shareholders’ Equity
Common stock, par value 12/3¢ per share (authorized 3,600 shares, issued, net of repurchased common stock at par value: 1,380 and 1,391 shares, respectively)	$ 23	$ 23
Additional Paid in Capital, Common Stock	4,451	4,385
Retained Earnings (Accumulated Deficit)	72,788	72,266
Accumulated Other Comprehensive Income (Loss), Net of Tax	$ (15,024)	$ (17,612)
Treasury Stock, Common, Shares	500	495
Treasury Stock, Value	$ (41,832)	$ (41,021)
Stockholders' Equity Attributable to Parent	20,406	18,041
Stockholders' Equity Attributable to Noncontrolling Interest	141	130
Total Equity	20,547	18,171
Liabilities and Equity	107,399	99,467
Other Investments	$ 2,526	$ 1,346
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets	Other Assets
Accounts Receivable, Allowance for Credit Loss, Current	$ 230	$ 356

Accumulated Other Comprehensive Loss Attributable to Pepsico (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Beginning balance (CTA)	$ (15,217)	$ (13,255)	$ (12,948)
Other comprehensive (loss)/income before reclassifications (CTA)	1,633	(1,965)	(442)
Amounts reclassified from accumulated other comprehensive loss (CTA)	0	0	108
Net other comprehensive (loss)/income (CTA)	1,633	(1,965)	(334)
Tax amounts (CTA)	90	3	27
Ending balance (CTA)	(13,494)	(15,217)	(13,255)
Beginning balance (PRM)	(2,714)	(2,719)	(2,361)
Other comprehensive loss before reclassifications (PRM)	234	(280)	(493)
Amounts reclassified from accumulated other comprehensive loss (PRM)	362	285	37
Net other comprehensive (loss)/income (PRM)	596	5	(456)
Tax amounts (PRM)	(144)	0	98
Ending balance (PRM)	(2,262)	(2,714)	(2,719)
Beginning balance (AFS - Debt Securities and Other)	237	471	6
Other comprehensive (loss)/income before reclassifications (AFS - Debt Securities and Other)	482	(306)	608
Amounts reclassified from accumulated other comprehensive loss (AFS - Debt Securities and Other)	0	0	0
Net other comprehensive (loss)/income (AFS - Debt Securities and Other)	482	(306)	608
Tax amounts (AFS - Debt Securities and Other)	(113)	72	(143)
Ending balance (AFS - Debt Securities and Other)	606	237	471
Accumulated other comprehensive loss attributable to PepsiCo	(15,024)	(17,612)	(15,534)	$ (15,302)
Other comprehensive (loss)/income before reclassifications (AOCL attributable to PepsiCo)	2,535	(2,557)	(515)
Amounts reclassified from accumulated other comprehensive loss (AOCL attributable to PepsiCo)	230	443	291
Net other comprehensive (loss)/income (AOCL attributable to PepsiCo)	2,765	(2,114)	(224)
Tax amounts (AOCL attributable to PepsiCo)	(177)	36	(8)
Net of taxes decrease to opening balance of accumulated other comprehensive loss attributable to Pepsico	1,138		1,282	$ 1,184
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance (Cash Flow Hedge)	82	(31)	1
Other comprehensive (loss)/income before reclassifications (Cash Flow Hedge)	186	(6)	(188)
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, Reclassification, before Tax	(132)	158	146
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax	54	152	(42)
Tax amounts (Cash Flow Hedge)	(10)	(39)	10
Ending balance (Cash Flow Hedge)	$ 126	$ 82	$ (31)

Consolidated Statement of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Income Statement [Abstract]
Net Revenue	$ 93,925	$ 91,854	$ 91,471
Cost of sales	43,066	41,744	41,881
Gross profit	50,859	50,110	49,590
Selling, general and administrative expenses	37,368	37,190	36,677
Impairment of Intangible Assets (Excluding Goodwill)	1,993	33	927
Operating Profit	11,498	12,887	11,986
Other pension and retiree medical benefits (expense)/income	(133)	(22)	250
Net interest expense and other	(1,121)	(919)	(819)
Income before income taxes	10,244	11,946	11,417
Provision for income taxes	1,949	2,320	2,262
Net income	8,295	9,626	9,155
Less: Net income attributable to noncontrolling interests	55	48	81
Net Income Attributable to PepsiCo	$ 8,240	$ 9,578	$ 9,074
Net Income Attributable to PepsiCo per Common Share
Basic	$ 6.02	$ 6.97	$ 6.59
Diluted	$ 6.00	$ 6.95	$ 6.56
Weighted-average common shares outstanding
Basic	1,369	1,373	1,376
Diluted	1,373	1,378	1,383

Income Taxes - Schedule of Income Taxes Paid (Refunded) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Income Tax Paid, by Individual Jurisdiction [Line Items]
Income taxes paid, net of refunds	$ 3,083	$ 3,064	$ 2,532
Maximum Percentage of Income Taxes Paid to Any Single State or Local Jurisdiction	5.00%
Foreign Tax Jurisdiction, Other
Income Tax Paid, by Individual Jurisdiction [Line Items]
Income taxes paid, net of refunds	$ 759
State and Local Jurisdiction
Income Tax Paid, by Individual Jurisdiction [Line Items]
Income taxes paid, net of refunds	243
Foreign Tax Jurisdiction
Income Tax Paid, by Individual Jurisdiction [Line Items]
Income taxes paid, net of refunds	1,733
Foreign Tax Jurisdiction \| IRELAND
Income Tax Paid, by Individual Jurisdiction [Line Items]
Income taxes paid, net of refunds	424
Foreign Tax Jurisdiction \| MEXICO
Income Tax Paid, by Individual Jurisdiction [Line Items]
Income taxes paid, net of refunds	313
Foreign Tax Jurisdiction \| RUSSIAN FEDERATION
Income Tax Paid, by Individual Jurisdiction [Line Items]
Income taxes paid, net of refunds	237
Domestic Tax Jurisdiction
Income Tax Paid, by Individual Jurisdiction [Line Items]
Income taxes paid, net of refunds	$ 1,107

Intangible Assets (Tables)

12 Months Ended

Dec. 27, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Amortizable Intangible Assets, Net

A summary of our amortizable intangible assets is as follows:


		2025						2024						2023
	Average Useful Life (Years)	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
Acquired franchise rights	56 – 60	$	835	$	(244)	$	591	$	821	$	(223)	$	598
Customer relationships (a)	15 – 24	773		(347)		426		565		(279)		286
Brands	20 – 40	1,084		(1,021)		63		1,051		(977)		74
Other identifiable intangibles	10 – 24	433		(294)		139		420		(276)		144
Total		$	3,125	$	(1,906)	$	1,219	$	2,857	$	(1,755)	$	1,102
Amortization expense						$	83					$	74	$	75

(a)Increase is primarily related to acquisitions of poppi and Siete. See Note 13 for further information on acquisitions.

Future Amortization of Intangible Assets


	2026		2027		2028		2029		2030
Five-year projected amortization	$	78	$	74	$	73	$	72	$	63

Schedule of Goodwill

The change in the book value of goodwill is as follows:


	PFNA		PBNA		IB Franchise		EMEA(a)		LatAm Foods		Asia Pacific Foods		Total
Balance as of December 30, 2023	$	642	$	11,961	$	1,986	$	2,382	$	393	$	364	$	17,728
Acquisitions (b)	159		—		—		—		—		3		162

Translation and other	(10)		(36)		(68)		(188)		(39)		(15)		(356)
Balance as of December 28, 2024	791		11,925		1,918		2,194		354		352		17,534
Acquisitions (b)	625		179		—		—		—		—		804
Translation and other	6		21		3		494		31		23		578
Balance as of December 27, 2025	$	1,422	$	12,125	$	1,921	$	2,688	$	385	$	375	$	18,916

(b)Primarily related to the acquisitions of Sabra in 2024 and Siete in 2025 in our PFNA segment and poppi in our PBNA segment. See Note 13 for further information on acquisitions.

Schedule of Indefinite-Lived Intangible Assets

The components of indefinite-lived intangible assets are as follows:


	2025		2024
Goodwill	$	18,916	$	17,534
Other indefinite-lived intangible assets
Reacquired franchise rights	7,542		7,437
Acquired franchise rights (a)	2,099		1,858
Brands (b)	4,206		4,404
Total indefinite-lived intangible assets	$	32,763	$	31,233

(a)Increase is primarily related to acquired distribution rights for the Alani Nu brand.

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

+ Details

Accumulated Other Comprehensive Loss Attributable to Pepsico Reclassification of Accumulated Other Comprehensive Loss to the Condensed Consolidated Statement of Income (PRM) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax	$ (3)	$ (31)	$ (33)
Amortization and settlement of (losses)/gains	86	73	56
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax	279	243	14
Amounts reclassified from accumulated other comprehensive loss (PRM)	362	285	37
Tax amounts	(79)	(62)	(7)
Net losses after tax	283	223	30
Total net losses reclassified for the year, net of tax	$ 183	$ 344	$ 245

- Definition

Amount after tax of reclassification adjustments of other comprehensive income (loss).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480870/815-30-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-17

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 20
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481694/830-30-45-20

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482765/220-10-50-4

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 15
-SubTopic 10
-Topic 220
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482739/220-10-55-15

+ Details

Legal Contingencies	12 Months Ended
Legal Contingencies	Dec. 27, 2025
Commitments and Contingencies Disclosure [Abstract]
Legal Matters and Contingencies	Legal Contingencies The Company is party to a variety of litigation, claims, legal or regulatory proceedings, inquiries and investigations. While the results of such litigation, claims, legal or regulatory proceedings, inquiries and investigations cannot be predicted with certainty, management believes that the final outcome of the foregoing is not expected to have a material adverse effect on our financial condition, results of operations or cash flows.

Pension, Retiree Medical and Savings Plans (Categorized Plan Assets Measured at Fair Value) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Defined Benefit Plan Disclosure [Line Items]
Maximum Real estate notice period	90 days
Minimum Real estate notice period	30 days
Cash Collateral for Borrowed Securities	$ 430	$ 447
US Plan Assets [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	11,104	10,772
Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	3,652	3,397	$ 3,528
Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	10,949	10,609	11,541
Securities Loaned	649	630
Postretirement Health Coverage [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	$ 155	$ 163	$ 183
Defined Benefit Plan, Equity Securities, Large Cap [Member]
Defined Benefit Plan Disclosure [Line Items]
Representation of one fund in total U.S. plan assets	12.00%	12.00%
Fixed Income Commingled funds [Member] \| Level 1 \| Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	$ 616	$ 557
Mortgage-backed Securities, Issued by Private Enterprises [Member] \| Level 2 \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	134	125
US Government Agencies Debt Securities [Member] \| Level 2 \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	1,573	1,538
Corporate Bonds [Member] \| Level 2 \| Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	610	469
Corporate Bonds [Member] \| Level 2 \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	3,963	3,903
Government Securities \| Level 2 \| Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	$ 987	$ 932
Corporate Bonds
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Percentage	31.00%	31.00%
Contracts With Insurance Companies \| Level 3 \| Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	$ 0	$ 29
Contracts With Insurance Companies \| Level 3 \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	1	1
Cash And Cash Equivalents \| Level 1 \| Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	85	128
Cash And Cash Equivalents \| Level 1 \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	446	456
Cash And Cash Equivalents \| Level 2 \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	254	276
Cash And Cash Equivalents \| Fair Value, Inputs, Level 1, 2 and 3 \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	700	732
Real Estate Funds [Member] \| Fair Value Measured at Net Asset Value Per Share \| Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	122	79
Real Estate Funds [Member] \| Fair Value Measured at Net Asset Value Per Share \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	817	561
Dividends And Interest Receivable \| Fair Value Measured at Net Asset Value Per Share \| Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	17	31
Dividends And Interest Receivable \| Fair Value Measured at Net Asset Value Per Share \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	(332)	(358)
Equity Securities [Member] \| Level 1 \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	4,248	4,270
Equity Securities [Member] \| Fair Value, Inputs, Level 1, 2 and 3 \| Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	1,215	1,172
Sub-Total U.S. Plan Assets \| Fair Value, Inputs, Level 1, 2 and 3 \| Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	10,619	10,569
Sub-Total International Plan Assets \| Fair Value, Inputs, Level 1, 2 and 3 \| Foreign Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Amount	$ 3,513	$ 3,287

Financial Instruments Financial Instruments (Policies)	12 Months Ended
Financial Instruments Financial Instruments (Policies)	Dec. 27, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives, Policy	We do not use derivative instruments for trading or speculative purposes. Our global purchasing programs include fixed-price contracts and purchase orders and pricing agreements. Our hedging strategies include the use of derivatives and non-derivative debt instruments. Certain derivatives are designated as either cash flow, fair value or net investment hedges and qualify for hedge accounting treatment, while others do not qualify and are marked to market through earnings. The accounting for qualifying hedges allows changes in a hedging instrument’s fair value to offset corresponding changes in the hedged item in the same reporting period that the hedged item impacts earnings. Gains or losses on derivatives designated as cash flow and net investment hedges are recorded in accumulated other comprehensive loss within common shareholders’ equity and reclassified to our income statement when the hedged transaction affects earnings for cash flow hedges and when the hedged foreign operation is either sold or substantially liquidated for net investment hedges. If it becomes probable that the hedged transaction will not occur, we immediately recognize the related hedging gains or losses in earnings; such gains or losses reclassified during the year ended December 27, 2025 were not material. Cash flows from derivatives used to manage commodity price, foreign exchange or interest rate risks are classified as operating activities in the cash flow statement. We classify both the earnings and cash flow impact from these derivatives consistent with the underlying hedged item. Cash flows associated with the settlement of derivative instruments designated as net investment hedges of foreign operations are classified within investing activities. Credit Risk We perform assessments of our counterparty credit risk regularly, including reviewing netting agreements, if any, and a review of credit ratings, credit default swap rates and potential nonperformance of the counterparty. Based on our most recent assessment of our counterparty credit risk, we consider this risk to be low. In addition, we enter into derivative contracts with a variety of financial institutions that we believe are creditworthy in order to reduce our concentration of credit risk.

- Definition

Disclosure of accounting policy for its derivative instruments and hedging activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479693/815-10-S50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8C

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-7

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4F
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4F

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/815/tableOfContent

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(n))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

+ Details

Income Taxes

12 Months Ended

Dec. 27, 2025

Income Tax Disclosure [Abstract]

Income Taxes

The components of income before income taxes are as follows:


	2025		2024		2023
United States	$	806	$	2,590	$	4,120
Foreign	9,438		9,356		7,297
	$	10,244	$	11,946	$	11,417

The provision for income taxes consisted of the following:


	2025		2024		2023
Current:
U.S. Federal	$	299	$	1,033	$	1,133
Foreign	1,583		1,406		1,201
State	42		255		309
	1,924		2,694		2,643
Deferred:
U.S. Federal	116		(306)		(109)
Foreign	(116)		(10)		(212)
State	25		(58)		(60)
	25		(374)		(381)
	$	1,949	$	2,320	$	2,262

A reconciliation of the U.S. Federal statutory tax rate to our 2025 annual tax rate is as follows:


	Amount		Tax Rate
U.S. Federal statutory tax	$	2,151	21.0	%
State income tax, net of U.S. Federal tax benefit (a)	25		0.2
Changes in valuation allowances	12		0.1
Foreign tax effects
Ireland
Statutory income tax rate differential	(119)		(1.2)
Other	24		0.2
Singapore
Tax incentive	(113)		(1.1)
Other	(26)		(0.3)
Switzerland
Changes in valuation allowances	(149)		(1.5)
Other	32		0.3
Bermuda
Statutory income tax rate differential	(310)		(3.0)
Other foreign jurisdictions	21		0.2

Effect of cross-border tax laws (b)
Transfer pricing adjustments	128		1.3
Global intangible low-tax income (GILTI)	115		1.1
Other	(110)		(1.0)
Tax credits	(29)		(0.3)
Changes in unrecognized tax benefits	181		1.8
Nondeductible and nontaxable items, net	(31)		(0.3)
Other	147		1.5
Reported tax	$	1,949	19.0	%

(a)State taxes in California, Illinois, New Jersey, Texas, Minnesota, Oregon, Wisconsin, Louisiana, Michigan, and Arizona make up the majority (greater than 50%) of the tax effect in this category.

(b)Includes the impact of any tax credits.

A reconciliation of the U.S. Federal statutory tax rate to our 2024 and 2023 annual tax rate is as follows:


	2024		2023
U.S. Federal statutory tax rate	21.0	%	21.0	%
State income tax, net of U.S. Federal tax benefit	1.3		1.8
Lower taxes on foreign results	(2.5)		(2.5)


Juice Transaction	—		(0.1)

Other, net	(0.4)		(0.4)
Annual tax rate	19.4	%	19.8	%

A summary of income taxes paid in 2025 is as follows:


	Amount
U.S. Federal	$	1,107
U.S. State and Local (a)	243






Foreign
Ireland	424
Mexico	313
Russia	237

Other	759
	1,733
Total	$	3,083

(a)No single state or local jurisdiction accounts for more than 5% of the total income taxes paid.

Tax Cuts and Jobs Act

As of December 27, 2025, our mandatory transition tax liability was $965 million, which must be paid in 2026 and will represent our final payment under the provisions of the TCJ Act. We reduced our liability through cash payments by $772 million in 2025, $579 million in 2024 and $309 million in 2023.

The TCJ Act also created a requirement that certain income earned by foreign subsidiaries, known as GILTI, must be included in the gross income of their U.S. shareholder. The FASB allows an accounting policy election of either recognizing deferred taxes for temporary differences expected to reverse as GILTI in future years or recognizing such taxes as a current-period expense when incurred. We elected to treat the tax effect of GILTI as a current-period expense when incurred.

Other Tax Matters

On July 4, 2025, the One Big Beautiful Bill (OBBB) Act, which includes a broad range of tax reform provisions, was signed into law in the United States. The OBBB Act did not have a material impact on our annual effective tax rate in 2025 and we do not expect it to have a material impact in 2026.

Numerous countries, including European Union member states, have enacted or are expected to enact legislation incorporating the OECD model rules for a global minimum tax rate of 15% with widespread implementation expected by the end of 2026. Legislation enacted as of December 27, 2025 did not have a material impact on our financial statements for 2025. As the legislation becomes effective in countries in which we do business, our taxes will increase and negatively impact our provision for income taxes.

In 2024 and 2023, tax benefits of $54 million ($0.04 per share) and $68 million ($0.05 per share), respectively, were recorded related to the impairment of certain consolidated investments.

Deferred tax liabilities and assets are comprised of the following:


	2025		2024
Deferred tax liabilities
Property, plant and equipment	$	2,047	$	1,868
Right-of-use assets	819		772
Debt guarantee of wholly-owned subsidiary	578		578
Recapture of net operating losses	488		488
Pension liabilities	238		112

Other	486		301
Gross deferred tax liabilities	4,656		4,119

Deferred tax assets
Net carryforwards	6,849		6,737
Intangible assets other than nondeductible goodwill	1,996		1,599
Lease liabilities	819		773
Share-based compensation	141		148
Retiree medical benefits	96		104
Other employee-related benefits	372		415

Deductible state tax and interest benefits	181		202
Capitalized research and development	134		256
Other	927		948
Gross deferred tax assets	11,515		11,182
Valuation allowances	(6,120)		(6,185)
Deferred tax assets, net	5,395		4,997
Net deferred tax (assets)/liabilities	$	(739)	$	(878)

A summary of our valuation allowance activity is as follows:


	2025		2024		2023
Balance, beginning of year	$	6,185	$	6,478	$	5,013
(Benefit)/provision	(284)		(198)		1,419
Other additions/(deductions)	219		(95)		46
Balance, end of year	$	6,120	$	6,185	$	6,478

Reserves

A number of years may elapse before a particular matter, for which we have established a reserve, is audited and finally resolved. The number of years with open tax audits varies depending on the tax jurisdiction. Our major taxing jurisdictions and the related open tax audits are as follows:


Jurisdiction	Years Open to Audit	Years Currently Under Audit
United States	2014-2024	2014-2019
Mexico	2014-2024	2014-2020
Canada (Domestic)	2021-2024	2021
Canada (International)	2012-2024	2012-2021
Russia	2022-2024	None

Our annual tax rate is based on our income, statutory tax rates and tax planning strategies and transactions, including transfer pricing arrangements, available to us in the various jurisdictions in which we operate. Significant judgment is required in determining our annual tax rate and in evaluating our tax positions. We establish reserves when, despite our belief that our tax return positions are fully supportable, we believe that certain positions are subject to challenge and that we likely will not succeed. We adjust these reserves, as well as the related interest, in light of changing facts and circumstances, such as the progress of a tax audit, new tax laws, relevant court cases or tax authority settlements. Settlement of any particular issue would usually require the use of cash. Favorable resolution would be recognized as a reduction to our annual tax rate in the year of resolution.

As of December 27, 2025, the total gross amount of reserves for income taxes, reported in other liabilities, was $2.4 billion. We accrue interest related to reserves for income taxes in our provision for income taxes and any associated penalties are recorded in selling, general and administrative expenses. The gross amount of interest accrued, reported in other liabilities, was $450 million as of December 27, 2025, of which $2 million of tax benefit was recognized in 2025, reflecting the release of federal interest accruals. The gross amount of interest accrued, reported in other liabilities, was $469 million as of December 28, 2024, of which $103 million of tax expense was recognized in 2024.

A reconciliation of unrecognized tax benefits is as follows:


	2025		2024
Balance, beginning of year	$	2,284	$	2,093
Additions for tax positions related to the current year	153		210
Additions for tax positions from prior years	124		108
Reductions for tax positions from prior years	(76)		(46)
Settlement payments	(114)		(24)
Statutes of limitations expiration	(18)		(31)
Translation and other	23		(26)
Balance, end of year	$	2,376	$	2,284

Carryforwards and Allowances

Operating loss carryforwards and income tax credits totaling $35.5 billion as of December 27, 2025 are being carried forward in a number of foreign and state jurisdictions where we are permitted to use tax operating losses and income tax credits from prior periods to reduce future taxable income or income tax liabilities. These operating losses and income tax credits will expire as follows: $0.8 billion in 2026, $29.9 billion between 2027 and 2044 and $4.8 billion may be carried forward indefinitely. We establish valuation allowances for our deferred tax assets if, based on the available evidence, it is not more likely than not that some portion or all of the deferred tax assets will be realized.

Undistributed International Earnings

As of December 27, 2025, we had approximately $12 billion of undistributed international earnings. We intend to continue to reinvest $12 billion of earnings outside the United States for the foreseeable future and while future distribution of these earnings would not be subject to U.S. federal tax expense, no deferred tax liabilities with respect to items such as certain foreign exchange gains or losses, foreign withholding taxes or state taxes have been recognized. It is not practicable for us to determine the amount of unrecognized tax expense on these reinvested international earnings.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477617/942-740-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478822/944-740-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

Debt Obligations and Commitments (Schedule of Long and Short-Term Debt Contractual Commitments) - USD (Details) - USD ($) $ in Millions	Dec. 27, 2025	Dec. 28, 2024
Debt Instrument [Line Items]
Debt, Current	$ 6,861	$ 7,082
Long-term Debt	46,351	41,228
Long-Term Debt, Excluding Current Maturities	42,321	37,224
Debt Instrument, Unamortized Discount	224	267
Other Borrowings Short-term [Member]
Debt Instrument [Line Items]
Other borrowings	190	260
Commercial Paper	$ 2,641	$ 2,818
Commercial Paper
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	3.80%	4.50%
Current Maturities Of Long Term Debt [Member]
Debt Instrument [Line Items]
Long-term Debt, Current Maturities	$ 4,030	$ 4,004
Notes Due 2025 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage		3.20%
Notes due	$ 0	$ 3,999
Notes Due 2026 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	3.60%	3.70%
Notes due	$ 4,003	$ 3,941
Notes Due 2027 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	3.20%	3.10%
Notes due	$ 3,933	$ 3,370
Notes Due 2027 [Member] \| Four Point Four Percent Notes Due February 2027
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 500
Debt Instrument, Interest Rate, Stated Percentage	4.40%
Notes Due 2028
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.40%	2.10%
Notes due	$ 4,203	$ 3,240
Notes Due 2028 \| Four Point Four Five Percent Notes Due February 2028
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 750
Debt Instrument, Interest Rate, Stated Percentage	4.45%
Less: Current Maturities Of Long Term Debt Obligations [Member]
Debt Instrument [Line Items]
Long-term Debt, Current Maturities	$ 4,030	$ 4,004
Notes Due 2029
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	4.30%	4.60%
Notes due	$ 4,043	$ 3,239
Notes Due 2029 \| Four Point One Percent Notes due January 2029
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 750
Debt Instrument, Interest Rate, Stated Percentage	4.10%
Notes due 2031-2060
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	3.40%	3.20%
Notes due	$ 25,956	$ 20,928
Other Debt Instruments due 2025-2042
Debt Instrument [Line Items]
Other notes due	$ 42	$ 39
Notes Due 2030
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	3.20%	2.60%
Notes due	$ 4,171	$ 2,472
Notes Due 2030 \| Four Point Six Percent Notes due February 2030
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	4.60%
Notes Due 2030 \| Four Point Three Percent Notes due July 2030
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 650
Debt Instrument, Interest Rate, Stated Percentage	4.30%
Notes Due 2032 \| Four Point Six Five Percent Notes due July 2032
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 850
Debt Instrument, Interest Rate, Stated Percentage	4.65%
Notes Due 2035 [Member] \| Five Percent Notes Due February 2035
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 1,250
Debt Instrument, Interest Rate, Stated Percentage	5.00%
Notes Due 2035 [Member] \| Five Percent Notes due July 2035
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 1,250
Debt Instrument, Interest Rate, Stated Percentage	5.00%

Leases (Details) - USD ($) $ in Millions	12 Months Ended
Leases (Details) - USD ($) $ in Millions	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Option to Extend	five years
Lessee, Operating Lease, Option to Terminate	one year
Operating Lease, Cost	$ 880	$ 788	$ 666
Variable Lease, Cost	185	165	146
Short-term Lease, Cost	570	566	582
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	1,046	1,218	1,088
Operating Lease, Payments	866	775	$ 655
Operating Lease, Right-of-Use Asset	$ 3,745	$ 3,383
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accounts payable and other current liabilities	Accounts payable and other current liabilities
Operating Lease, Liability, Current	$ 719	$ 642
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Operating Lease, Liability, Noncurrent	$ 3,127	$ 2,803
Operating Lease, Liability	$ 3,846
Operating Lease, Weighted Average Discount Rate, Percent	5.00%	4.00%	4.00%
Operating Lease, Weighted Average Remaining Lease Term	7 years	7 years	7 years
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months	$ 858
Lessee, Operating Lease, Liability, Payments, Due Year Two	750
Lessee, Operating Lease, Liability, Payments, Due Year Three	631
Lessee, Operating Lease, Liability, Payments, Due Year Four	512
Lessee, Operating Lease, Liability, Payments, Due Year Five	434
Lessee, Operating Lease, Liability, Payments, Due after Year Five	1,342
Lessee, Operating Lease, Liability, Payments, Due	4,527
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	$ 681
Operating Lease, Liability, Statement of Financial Position [Extensible List]	Other Liabilities
Sale and Leaseback Transaction, Gain (Loss), Net	$ 291	$ 118	$ 52
Operating lease right-of-use asset amortization	$ 727	$ 655	$ 570
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets	Other Assets
Unrecorded Unconditional Purchase Obligation, Purchases	$ 900
Maximum
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	20 years

Our Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Statement [Line Items]
Credit Terms, Receivable U.S.	30 days
Credit Terms, Receivables International (Outside U.S.) Maximum	90 days
Credit Terms, Receivables International (Outside U.S.) Minimum	30 days
Amount of prepaid incentive arrangements	$ 329	$ 237
Advertising and other marketing activities	5,400	5,900	$ 5,700
Advertising expenses	3,400	3,900	3,800
Deferred advertising costs	48	58
Shipping and handling expenses	16,700	16,000	15,400
Capitalized Computer Software, Net	1,800	1,500
Capitalized Computer Software, Amortization	260	199	159
Research and development costs	$ 839	$ 813	$ 804

Restructuring and Impairment Charges

12 Months Ended

Dec. 27, 2025

Restructuring and Related Activities [Abstract]

Restructuring, Impairment, and Other Activities Disclosure [Text Block]

Restructuring and Impairment Charges

2019 Multi-Year Productivity Plan

The 2019 Productivity Plan leverages new technology and business models to further simplify, harmonize and automate processes; re-engineers our go-to-market and information systems, including deploying the right automation for each market; and simplifies our organization and optimizes our manufacturing and supply chain footprint. To build on the successful implementation of the 2019 Productivity Plan, in 2024, we further expanded and extended the plan through the end of 2030 to take advantage of additional opportunities within the initiatives described above. As a result, we expect to incur pre-tax charges of approximately $6.15 billion, including cash expenditures of approximately $5.1 billion. These pre-tax charges are expected to consist of approximately 50% of severance and other employee-related costs, 15% for asset impairments (all non-cash) resulting from plant closures and related actions and 35% for other costs associated with the implementation of our initiatives.

The total plan pre-tax charges are expected to be incurred by segment approximately as follows:


	PFNA		PBNA		IB Franchise		EMEA		LatAm Foods		Asia Pacific Foods		Corporate
Expected pre-tax charges	20	%	25	%	2	%	25	%	10	%	3	%	15	%

A summary of our 2019 Productivity Plan charges is as follows:


	2025		2024		2023
Cost of sales	$	236	$	133	$	13
Selling, general and administrative expenses	728		551		433
Impairment of intangible assets	—		14		—
Other pension and retiree medical benefits expense/(income) (a)	19		29		(1)
Total restructuring and impairment charges	$	983	$	727	$	445
After-tax amount	$	792	$	563	$	349
Impact on net income attributable to PepsiCo per common share	$	(0.58)	$	(0.41)	$	(0.25)


	2025		2024		2023		Plan to Date through 12/27/2025
PFNA	$	344	$	161	$	42	$	776
PBNA	281		238		41		786
IB Franchise	14		24		11		65
EMEA	195		116		227		956
LatAm Foods	52		49		29		299
Asia Pacific Foods	12		9		8		99
Corporate	66		101		88		484
	964		698		446		3,465
Other pension and retiree medical benefits expense/(income) (a)	19		29		(1)		145
Total	$	983	$	727	$	445	$	3,610

(a)Income amount represents adjustments for changes in estimates of previously recorded amounts.


	Plan to Date through 12/27/2025
Severance and other employee costs	$	1,789
Asset impairments	546
Other costs	1,275
Total	$	3,610

Severance and other employee costs primarily include severance and other termination benefits, as well as voluntary separation arrangements. Other costs primarily include costs associated with the implementation of our initiatives, including consulting and other professional fees, as well as contract termination costs.

A summary of our 2019 Productivity Plan is as follows:


	Severance and Other Employee Costs		Asset Impairments		Other Costs		Total


Liability as of December 31, 2022	$	188	$	—	$	8	$	196
2023 restructuring charges	243		2		200		445
Cash payments (a)	(242)		—		(192)		(434)
Non-cash charges and translation	(1)		(2)		(7)		(10)
Liability as of December 30, 2023	188		—		9		197
2024 restructuring charges	384		114		229		727
Cash payments (a)	(204)		—		(232)		(436)
Non-cash charges and translation	(30)		(114)		20		(124)
Liability as of December 28, 2024	338		—		26		364
2025 restructuring charges	355		240		388		983
Cash payments (a)	(384)		—		(412)		(796)
Non-cash charges and translation	(1)		(240)		16		(225)
Liability as of December 27, 2025	$	308	$	—	$	18	$	326

(a)Excludes cash expenditures of $12 million in 2025, $7 million in 2024 and $1 million in 2023, reported in the cash flow statement in pension and retiree medical plan contributions.

Substantially all of the restructuring accrual at December 27, 2025 is expected to be paid by the end of 2026.

Other Productivity Initiatives

There were no material charges related to other productivity and efficiency initiatives outside the scope of the 2019 Productivity Plan.

We regularly evaluate different productivity initiatives beyond the productivity plan and other initiatives described above.

For information on additional impairment charges, see Notes 1, 4 and 9.

Accumulated Other Comprehensive Loss Attributable to Pepsico

12 Months Ended

Dec. 27, 2025

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Comprehensive Income (Loss) Note [Text Block]

Accumulated Other Comprehensive Loss Attributable to PepsiCo

The changes in the balances of each component of accumulated other comprehensive loss attributable to PepsiCo are as follows:


	Currency Translation Adjustment		Cash Flow Hedges		Pension and Retiree Medical		Available-for-Sale Debt Securities and Other(a)		Accumulated Other Comprehensive Loss Attributable to PepsiCo
Balance as of December 31, 2022 (b)	$	(12,948)	$	1	$	(2,361)	$	6	$	(15,302)
Other comprehensive (loss)/income before reclassifications (c)	(442)		(188)		(493)		608		(515)
Amounts reclassified from accumulated other comprehensive loss	108		146		37		—		291
Net other comprehensive (loss)/income	(334)		(42)		(456)		608		(224)
Tax amounts	27		10		98		(143)		(8)
Balance as of December 30, 2023 (b)	(13,255)		(31)		(2,719)		471		(15,534)
Other comprehensive loss before reclassifications (d)	(1,965)		(6)		(280)		(306)		(2,557)
Amounts reclassified from accumulated other comprehensive loss	—		158		285		—		443
Net other comprehensive (loss)/income	(1,965)		152		5		(306)		(2,114)
Tax amounts	3		(39)		—		72		36
Balance as of December 28, 2024 (b)	(15,217)		82		(2,714)		237		(17,612)
Other comprehensive income before reclassifications (e)	1,633		186		234		482		2,535
Amounts reclassified from accumulated other comprehensive loss	—		(132)		362		—		230
Net other comprehensive income	1,633		54		596		482		2,765
Tax amounts	90		(10)		(144)		(113)		(177)
Balance as of December 27, 2025 (b)	$	(13,494)	$	126	$	(2,262)	$	606	$	(15,024)

(a)The movements primarily represent fair value changes in available-for-sale debt securities, including our investment in Celsius convertible preferred stock. See Note 9 for further information.

(c)Currency translation adjustment primarily reflects depreciation of the Russian ruble and South African rand, partially offset by appreciation of the Mexican peso.

(d)Currency translation adjustment primarily reflects depreciation of the Mexican peso and Russian ruble.

(e)Currency translation adjustment primarily reflects appreciation of the Russian ruble and Mexican peso.

The reclassifications from accumulated other comprehensive loss to the income statement are summarized as follows:


	Amount Reclassified from Accumulated Other Comprehensive Loss						Affected Line Item in the Income Statement
	2025		2024		2023
Currency translation:
Divestitures	$	—	$	—	$	108	Selling, general and administrative expenses

Cash flow hedges:
Foreign exchange contracts	(1)		(1)		(3)		Net revenue
Foreign exchange contracts	13		(5)		64		Cost of sales
Cross-currency contracts	(67)		48		(31)		Selling, general and administrative expenses
Interest rate swap contracts	—		(7)		(9)		Selling, general and administrative expenses
Commodity contracts	(79)		122		126		Cost of sales
Commodity contracts	2		1		(1)		Selling, general and administrative expenses
Net (gains)/losses before tax	(132)		158		146
Tax amounts	32		(37)		(39)
Net (gains)/losses after tax	(100)		121		107

Pension and retiree medical items:
Amortization of net prior service credit	(3)		(31)		(33)		Other pension and retiree medical benefits (expense)/income
Amortization of net losses	86		73		56		Other pension and retiree medical benefits (expense)/income
Settlement/curtailment losses	279		243		14		Other pension and retiree medical benefits (expense)/income
Net losses before tax	362		285		37
Tax amounts	(79)		(62)		(7)
Net losses after tax	283		223		30






Total net losses reclassified for the year, net of tax	$	183	$	344	$	245

Acquisitions & Divestitures - Siete acquisition (Details) - Siete acquisition - USD ($) $ in Millions	Jan. 17, 2025	Dec. 27, 2025
Acquisitions & Divestitures [Line Items]
Business Combination, Consideration Transferred	$ 1,200
Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Indefinite-Lived		$ 1,200

Intangible Assets, Schedule of Indefinite-Lived Intangible Assets (including Goodwill) (Details) - USD ($) $ in Millions	Dec. 27, 2025	Dec. 28, 2024
Indefinite-lived Intangible Assets [Line Items]
Intangible Assets, Net (Including Goodwill)	$ 32,763	$ 31,233
Indefinite-lived Intangible Assets (Excluding Goodwill)	13,847	13,699
Reacquired Franchise Rights
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets (Excluding Goodwill)	7,542	7,437
Acquired Franchise Rights
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets (Excluding Goodwill)	2,099	1,858
Trade Names
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets (Excluding Goodwill)	4,206	4,404
Goodwill [Member]
Indefinite-lived Intangible Assets [Line Items]
Intangible Assets, Net (Including Goodwill)	$ 18,916	$ 17,534

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Pension, Retiree Medical and Savings Plans (Tables)

12 Months Ended

Dec. 27, 2025

Defined Benefit Plan Disclosure [Line Items]

Selected Financial Information For Pension And Retiree Medical Plans

Selected financial information for our pension and retiree medical plans is as follows:


	Pension								Retiree Medical
	U.S.				International
	2025		2024		2025		2024		2025		2024
Change in projected benefit obligation
Obligation at beginning of year	$	11,324	$	12,035	$	2,786	$	2,986	$	616	$	677
Service cost	312		347		47		46		31		31
Interest cost	586		585		152		144		30		32
Plan amendments	10		12		1		1		—		—
Participant contributions	—		—		2		2		—		—
Experience loss/(gain)	247		(563)		(74)		(55)		18		(44)
Benefit payments	(640)		(617)		(112)		(108)		(74)		(78)
Settlement/curtailment	(678)		(506)		(109)		(62)		—		—
Special termination benefits	21		31		—		—		—		1
Other, including foreign currency adjustment	—		—		234		(168)		2		(3)
Obligation at end of year	11,182		11,324		2,927		2,786		623		616

Change in fair value of plan assets
Fair value at beginning of year	10,609		11,541		3,397		3,528		163		183
Actual return on plan assets	1,296		(10)		149		142		15		5
Employer contributions/funding	354		236		67		59		51		53
Participant contributions	—		—		2		2		—		—
Benefit payments	(640)		(617)		(112)		(108)		(74)		(78)
Settlement	(670)		(539)		(109)		(62)		—		—
Other, including foreign currency adjustment	—		(2)		258		(164)		—		—
Fair value at end of year	10,949		10,609		3,652		3,397		155		163
Funded status	$	(233)	$	(715)	$	725	$	611	$	(468)	$	(453)





Amounts recognized
Other assets	$	413	$	388	$	983	$	792	$	—	$	—
Other current liabilities	(61)		(85)		(14)		(10)		(55)		(52)
Other liabilities	(585)		(1,018)		(244)		(171)		(413)		(401)
Net amount recognized	$	(233)	$	(715)	$	725	$	611	$	(468)	$	(453)

Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	$	3,035	$	3,618	$	612	$	633	$	(295)	$	(333)
Prior service cost/(credit)	61		54		(3)		(5)		(9)		(14)
Total	$	3,096	$	3,672	$	609	$	628	$	(304)	$	(347)

Changes recognized in net loss/(gain) included in other comprehensive loss
Net (gain)/loss arising in current year	$	(252)	$	320	$	(21)	$	8	$	14	$	(36)
Amortization and settlement recognition	(331)		(298)		(59)		(43)		25		25
Foreign currency translation loss/(gain)	—		—		59		(39)		(1)		1
Total	$	(583)	$	22	$	(21)	$	(74)	$	38	$	(10)

Accumulated benefit obligation at end of year	$	11,093	$	11,069	$	2,740	$	2,638

Schedule of Net Benefit Costs [Table Text Block]

The components of total pension and retiree medical benefit costs are as follows:


	Pension												Retiree Medical
	U.S.						International
	2025		2024		2023		2025		2024		2023		2025		2024		2023
Service cost	$	312	$	347	$	327	$	47	$	46	$	43	$	31	$	31	$	29
Other pension and retiree medical benefits expense/(income):
Interest cost	586		585		593		152		144		141		30		32		36
Expected return on plan assets	(805)		(871)		(851)		(202)		(205)		(192)		(11)		(13)		(13)
Amortization of prior service costs/(credits)	3		(24)		(26)		(1)		(2)		(1)		(5)		(5)		(6)
Amortization of net losses/(gains)	84		77		70		27		21		13		(25)		(25)		(27)
Net settlement/curtailment losses (a)	247		254		4		32		22		10		—		—		—
Special termination benefits	21		31		(1)		—		—		—		—		1		—
Total other pension and retiree medical benefits expense/(income)	136		52		(211)		8		(20)		(29)		(11)		(10)		(10)
Total	$	448	$	399	$	116	$	55	$	26	$	14	$	20	$	21	$	19

Weighted-Average Assumptions Used To Determine Projected Benefit Liability And Benefit Expense For Pension And Retiree Medical Plans

The following table provides the weighted-average assumptions used to determine net periodic benefit cost and projected benefit obligation for our pension and retiree medical plans:


	Pension												Retiree Medical
	U.S.						International
	2025		2024		2023		2025		2024		2023		2025		2024		2023
Net Periodic Benefit Cost
Service cost discount rate	5.8	%	5.1	%	5.4	%	7.8	%	6.9	%	7.0	%	5.6	%	5.1	%	5.4	%
Interest cost discount rate	5.4	%	5.1	%	5.4	%	5.3	%	5.0	%	5.4	%	5.2	%	5.0	%	5.3	%
Expected return on plan assets	7.5	%	7.4	%	7.4	%	5.8	%	5.8	%	5.7	%	7.1	%	7.1	%	7.1	%
Rate of salary increases	3.9	%	3.9	%	3.2	%	4.0	%	4.3	%	4.2	%

Projected Benefit Obligation
Discount rate	5.5	%	5.7	%	5.1	%	5.8	%	5.5	%	5.1	%	5.2	%	5.5	%	5.1	%
Rate of salary increases	3.1	%	3.9	%	3.9	%	4.5	%	4.0	%	4.3	%

Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets

The following table provides selected information about plans with accumulated benefit obligation and total projected benefit obligation in excess of plan assets:


	Pension								Retiree Medical
	U.S.				International
	2025		2024		2025		2024		2025		2024
Selected information for plans with accumulated benefit obligation in excess of plan assets
Obligation for service to date	$	(7,123)	$	(7,315)	$	(279)	$	(194)
Fair value of plan assets	$	6,480	$	6,399	$	177	$	135
Selected information for plans with projected benefit obligation in excess of plan assets
Benefit obligation	$	(7,126)	$	(7,502)	$	(435)	$	(346)	$	(623)	$	(616)
Fair value of plan assets	$	6,480	$	6,399	$	177	$	165	$	155	$	163

Future Benefit Payments

Our estimated future benefit payments are as follows:


	2026		2027		2028		2029		2030		2031 - 2035
Pension	$	1,259	$	963	$	951	$	977	$	999	$	5,242
Retiree medical (a)	$	76	$	74	$	72	$	70	$	68	$	305

Employer Contributions

Contributions to our pension and retiree medical plans were as follows:


	Pension						Retiree Medical
	2025		2024		2023		2025		2024		2023
Discretionary (a)	$	261	$	161	$	267	$	—	$	—	$	—
Non-discretionary	160		134		97		51		53		46
Total	$	421	$	295	$	364	$	51	$	53	$	46

(a)Includes $250 million contribution in 2025, $150 million contribution in 2024 and $250 million contribution in 2023 to fund our U.S. qualified defined benefit plans.

Target Investment Allocation

For 2026 and 2025, our expected long-term rate of return on U.S. plan assets is 7.8% and 7.5%, respectively. Our target investment allocations for U.S. plan assets are as follows:


	2026		2025
Fixed income	58	%	56	%
U.S. equity	22	%	22	%
International equity	16	%	18	%
Real estate	4	%	4	%

Schedule Of Plan Assets Measured At Fair Value Table Text Block


	Fair Value Hierarchy Level	2025		2024
U.S. plan assets (a)(b)
Equity securities, including preferred stock (c)	1	$	4,248	$	4,270
Government securities (d)	2	1,573		1,538
Corporate bonds (d)	2	3,963		3,903
Mortgage-backed securities (d)	2	134		125
Contracts with insurance companies (e)	3	1		1
Cash and cash equivalents (f) (g)	1, 2	700		732
Sub-total U.S. plan assets		10,619		10,569
Investments measured at net asset value (h)		817		561
Securities lending payables, net of dividends and interest receivable (g)		(332)		(358)
Total U.S. plan assets		$	11,104	$	10,772
International plan assets
Equity securities (c)	1	$	1,215	$	1,172
Government securities (d)	2	987		932
Corporate bonds (d)	2	610		469
Fixed income commingled funds (i)	1	616		557
Contracts with insurance companies (e)	3	—		29
Cash and cash equivalents	1	85		128
Sub-total international plan assets		3,513		3,287
Investments measured at net asset value (h)		122		79
Dividends and interest receivable		17		31
Total international plan assets		$	3,652	$	3,397

(b)Includes securities loaned to borrowers under the securities lending program with fair value of $649 million and $630 million in 2025 and 2024, respectively.

(f)Includes Level 1 assets of $446 million and $456 million, and Level 2 assets of $254 million and $276 million for 2025 and 2024, respectively.

(i)Based on the published price of the fund.

Schedule of Health Care Cost Trend Rates

Retiree Medical Cost Trend Rates

The assumed health care cost trend rates are as follows:


	2026		2025
Average increase assumed	8	%	5	%
Ultimate projected increase	4	%	4	%
Year of ultimate projected increase	2046		2046

Basis of Presentation and Our Segments (Narrative) (Details)	12 Months Ended
	Dec. 27, 2025 segment country
Basis Of Presentation And Our Divisions [Line Items]
Number of Reportable Segments \| segment	6
Manufacture and sell in (number of countries) \| country	200
Maximum [Member]
Basis Of Presentation And Our Divisions [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent	50.00%

Intangible Assets (Schedule of Finite-Lived Intangible Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross	$ 3,125	$ 2,857
Finite-Lived Intangible Assets, Accumulated Amortization	1,906	1,755
Amortizable intangible assets, net	1,219	1,102
Amortization of intangible assets	83	74	$ 75
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross	773	565
Finite-Lived Intangible Assets, Accumulated Amortization	347	279
Amortizable intangible assets, net	$ 426	286
Customer Relationships [Member] \| Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	15 years
Customer Relationships [Member] \| Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	24 years
Acquired Franchise Rights
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross	$ 835	821
Finite-Lived Intangible Assets, Accumulated Amortization	244	223
Amortizable intangible assets, net	$ 591	598
Acquired Franchise Rights \| Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	56 years
Acquired Franchise Rights \| Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	60 years
Brands [Member]
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross	$ 1,084	1,051
Finite-Lived Intangible Assets, Accumulated Amortization	1,021	977
Amortizable intangible assets, net	$ 63	74
Brands [Member] \| Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years
Brands [Member] \| Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	40 years
Other Identifiable Intangibles
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross	$ 433	420
Finite-Lived Intangible Assets, Accumulated Amortization	294	276
Amortizable intangible assets, net	$ 139	$ 144
Other Identifiable Intangibles \| Minimum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years
Other Identifiable Intangibles \| Maximum
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Asset, Useful Life	24 years

Our Significant Accounting Policies - Software Costs (Useful Life) (Details) - Software and Software Development Costs	Dec. 27, 2025
Maximum
Property, Plant and Equipment [Line Items]
Average Useful Life (Years)	10 years
Minimum
Property, Plant and Equipment [Line Items]
Average Useful Life (Years)	5 years

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
Cybersecurity Risk Management and Strategy Disclosure	Dec. 27, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	We are regularly subject to cyberattacks and other cyber incidents. In response, we have implemented cybersecurity processes, technologies, and controls to aid in our efforts to assess, identify, and manage cybersecurity risks. Our enterprise risk management framework considers cybersecurity risk alongside other company risks as part of our overall risk assessment process. Our enterprise risk management team collaborates with our Cybersecurity function, led by the Company’s Chief Strategy and Transformation Officer and the Company’s Chief Information Security Officer, to gather insights for identifying, assessing and managing cybersecurity threat risks, their severity, and potential mitigations. We assess PepsiCo’s Cybersecurity program using an industry-leading cybersecurity framework from the National Institute of Standards and Technology. To help assess and identify our cybersecurity risks, we maintain internal resources to perform penetration testing designed to simulate evolving tactics and techniques of real-world threat actors, engage with industry partners and law enforcement and intelligence communities and conduct tabletop exercises and periodic risk interviews across our business. We also engage an independent third party to perform internal and external penetration testing of PepsiCo’s environment periodically and engage other third parties to periodically conduct assessments of our cybersecurity capabilities. In addition, we continue to expand training and awareness practices to mitigate human risk, including mandatory computer-based training, internal communications, and regular phishing awareness campaigns that are designed to emulate real-world contemporary threats and provide immediate feedback (and, if necessary, additional training or remedial action) to employees. Our processes also address cybersecurity risks associated with our use of third-party service providers including suppliers, software and cloud-based service providers. We proactively evaluate the cybersecurity risk of a third party by utilizing a repository of risk assessments, external monitoring sources, threat intelligence and predictive analytics to better inform PepsiCo during contracting and vendor selection processes. Additionally, we require those third parties to agree by contract to implement appropriate security controls. Security issues are documented and tracked and periodic monitoring is conducted for third parties in order to mitigate risk. In addition to the processes, technologies, and controls that we have in place to reduce the likelihood of a successful material cyberattack, the Company has established well-defined response procedures to address cyber events that do occur. The program provides for the coordination of various corporate functions and governance groups and serves as a framework for the execution of responsibilities across businesses and operational roles. Our incident response plan coordinates the activities we take to prepare for, detect, respond to and recover from cybersecurity incidents, which include processes to triage, assess severity for, escalate, contain, investigate, and remediate the incident, as well as to assess for potential disclosure, comply with potentially applicable legal obligations and mitigate brand and reputational damage. We also maintain insurance coverage that, subject to its terms and conditions, is intended to address costs associated with certain aspects of cyber incidents and information systems failures.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	We are regularly subject to cyberattacks and other cyber incidents. In response, we have implemented cybersecurity processes, technologies, and controls to aid in our efforts to assess, identify, and manage cybersecurity risks. Our enterprise risk management framework considers cybersecurity risk alongside other company risks as part of our overall risk assessment process.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	Given that cybersecurity risks can impact various areas of responsibility of the Committees of the Board, the Board believes it is useful and effective for the full Board to maintain direct oversight over cybersecurity matters. In 2021, the Board amended our Corporate Governance Guidelines to specifically mention cybersecurity as an area of Board oversight to reflect this existing practice.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	The Board receives and provides feedback on regular updates from management, including from the Company’s Chief Strategy and Transformation Officer and the Company’s Chief Information Security Officer, regarding cybersecurity governance processes, the status of projects to strengthen internal cybersecurity, results from third-party assessments, and also discusses any significant cyber incidents, including recent incidents at other companies and the emerging threat landscape.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	The Board receives and provides feedback on regular updates from management, including from the Company’s Chief Strategy and Transformation Officer and the Company’s Chief Information Security Officer, regarding cybersecurity governance processes, the status of projects to strengthen internal cybersecurity, results from third-party assessments, and also discusses any significant cyber incidents, including recent incidents at other companies and the emerging threat landscape.
Cybersecurity Risk Role of Management [Text Block]	Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by the Company’s Chief Strategy and Transformation Officer and the Company’s Chief Information Security Officer. Such individuals have significant prior work experience in various roles across multiple industries involving managing information security, developing cybersecurity strategy, implementing effective information and cybersecurity programs and managing compliance environments. These members of management are informed about and monitor the prevention, mitigation, detection, and remediation of cybersecurity incidents through their management of, and participation in, the cybersecurity risk management and strategy processes described above, including the operation of our incident response plan.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	Our cybersecurity risk management and strategy processes, which are discussed in greater detail above, are led by the Company’s Chief Strategy and Transformation Officer and the Company’s Chief Information Security Officer.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Such individuals have significant prior work experience in various roles across multiple industries involving managing information security, developing cybersecurity strategy, implementing effective information and cybersecurity programs and managing compliance environments.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	These members of management are informed about and monitor the prevention, mitigation, detection, and remediation of cybersecurity incidents through their management of, and participation in, the cybersecurity risk management and strategy processes described above, including the operation of our incident response plan.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Financial Instruments - Losses (Gains) Recognized in the Income Statement - Non-designated Hedges (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024
Nondesignated Hedges
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	$ 89	$ 13
Nondesignated Hedges - Selling, General and Administrative Expenses
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	72	10
Nondesignated Hedges - Cost of Sales
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	17	3
Foreign Exchange Contract Losses/(Gains) Included in Cost of Sales \| Nondesignated Hedges - Cost of Sales
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	1	1
Foreign Exchange Contract Losses/(Gains) Included in Selling, General and Administrative Expenses \| Nondesignated Hedges - Selling, General and Administrative Expenses
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	66	2
Foreign Exchange Forward Contracts \| Nondesignated Hedges
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	67	3
Commodity Contract Losses/(Gains) Included in Cost of Sales \| Nondesignated Hedges - Cost of Sales
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	16	2
Commodity Contract Losses/(Gains) Included in Selling, General and Administrative Expenses \| Nondesignated Hedges - Selling, General and Administrative Expenses
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	6	8
Commodity Contracts \| Nondesignated Hedges
Derivative Instruments, Loss (Gain) [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	$ 22	$ 10

Financial Instruments - TBG Impairment (Detail) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 27, 2025
Tropicana Brands Group
TBG Impairment [Line Items]
Asset Impairment Charges	$ 498	$ 321
Asset Impairment Charges, after-tax	$ 416	$ 243
Impairment Effect on Earnings Per Share, after Tax	$ 0.30	$ 0.18
PepsiCo Beverages North America [Member] \| Tropicana Brands Group
TBG Impairment [Line Items]
Asset Impairment Charges	$ 409
Europe, Middle East & Africa (Segment) [Member] \| Tropicana Brands Group
TBG Impairment [Line Items]
Asset Impairment Charges	$ 89
Tropicana JV
TBG Impairment [Line Items]
Equity Method Investment, Ownership Percentage			39.00%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Accumulated Other Comprehensive Loss Attributable to Pepsico Reclassification of Accumulated Other Comprehensive Loss to the Condensed Consolidated Statement of Income (Cash Flow Hedges) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, Reclassification, before Tax	$ (132)	$ 158	$ 146
Tax amounts	32	(37)	(39)
Net (gains)/losses after tax	(100)	121	107
Foreign Exchange Forward Contracts \| Cash Flow Hedges \| Revenue, Net
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, Reclassification, before Tax	(1)	(1)	(3)
Foreign Exchange Forward Contracts \| Cash Flow Hedges \| Cost of sales
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, Reclassification, before Tax	13	(5)	64
Cross Currency Interest Rate Contract [Member] \| Cash Flow Hedges \| Selling, general and administrative expenses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, Reclassification, before Tax	(67)	48	(31)
Interest Rate Contracts \| Cash Flow Hedges \| Selling, general and administrative expenses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, Reclassification, before Tax	0	(7)	(9)
Commodity Contracts \| Cash Flow Hedges \| Cost of sales
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, Reclassification, before Tax	(79)	122	126
Commodity Contracts \| Cash Flow Hedges \| Selling, general and administrative expenses
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive (Income) Loss, Cash Flow Hedge, (Gain) Loss, Reclassification, before Tax	$ 2	$ 1	$ (1)

Supplemental Financial Information (Tables)

12 Months Ended

Dec. 27, 2025

Supplemental Financial Information [Abstract]

Additional Financial Information Disclosure [Text Block]

Supplemental Financial Information

Balance Sheet


		2025		2024		2023
Accounts and notes receivable
Trade receivables		$	9,265	$	8,487
Other receivables		2,471		2,202
Total		11,736		10,689
Allowance, beginning of year		356		175		$	150
Net amounts charged to expense (a)		61		228		55
Deductions		(55)		(36)		(26)
Translation and other (a)		(132)		(11)		(4)
Allowance, end of year		230		356		$	175
Accounts and notes receivable, net		$	11,506	$	10,333

Property, plant and equipment, net	Average Useful Life (Years)
Land		$	1,110	$	1,136
Buildings and improvements	15 - 44	13,875		11,938
Machinery and equipment, including fleet and software	5 - 15	41,113		36,990
Construction in progress		4,811		5,941
		60,909		56,005
Accumulated depreciation		(31,004)		(27,997)
Property, plant and equipment, net		$	29,905	$	28,008
Depreciation expense		$	3,213	$	2,945	$	2,714

Other assets
Noncurrent notes and accounts receivable		$	136	$	111
Deferred marketplace spending		205		100
Pension plans		1,449		1,190
Right-of-use assets		3,745		3,383
Other investments (b)		2,526		1,346
Other		923		821
Total		$	8,984	$	6,951



Accounts payable and other current liabilities
Accounts payable (c)		$	11,704	$	10,997
Accrued marketplace spending		3,512		3,458
Accrued compensation and benefits		2,230		2,256
Dividends payable		1,967		1,885
Current lease liabilities		719		642
Other current liabilities (d)		5,771		5,216
Total		$	25,903	$	24,454

(a)In 2024, we recognized an allowance for expected credit losses related to outstanding receivables from TBG associated with the Juice Transaction. In 2025, the outstanding receivables and related allowance were reclassified to noncurrent notes and accounts receivable. See Note 1 for further information.

(b)Includes our investment in Celsius convertible preferred stock. See Note 9 for further information.

(c)Increase primarily reflects timing of payments and currency translation adjustments, partially offset by a decrease in capital expenditure payables.

(d)Increase primarily reflects acquisition of poppi. See Note 13 for further information on acquisitions.

Statement of Cash Flows


	2025		2024		2023
Interest paid	$	1,748	$	1,585	$	1,401
Income taxes paid, net of refunds (a)	$	3,083	$	3,064	$	2,532

(a)Includes tax payments of $772 million in 2025, $579 million in 2024 and $309 million in 2023 related to the TCJ Act.

Supplemental Non-Cash Activity


	2025		2024		2023
Debt discharged via legal defeasance	$	—	$	—	$	94
Investment obtained for certain assets (see Notes 4 and 9)	$	554	$	—	$	—

The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement:


	2025		2024
Cash and cash equivalents	$	9,159	$	8,505

Restricted cash included in other assets (a)	45		48
Total cash and cash equivalents and restricted cash	$	9,204	$	8,553

(a)Primarily relates to collateral posted against certain of our derivative positions.

Our Significant Accounting Policies (Policies)	12 Months Ended
Our Significant Accounting Policies (Policies)	Dec. 27, 2025
Accounting Policies [Abstract]
Revenue [Policy Text Block]	Revenue Recognition We recognize revenue when our performance obligation is satisfied. Our primary performance obligation (the distribution and sales of beverage and convenient food products) is satisfied upon the shipment or delivery of products to our customers, which is also when control is transferred. Merchandising activities are performed after a customer obtains control of the product, are accounted for as fulfillment of our performance obligation to ship or deliver product to our customers and are recorded in selling, general and administrative expenses. Merchandising activities are immaterial in the context of our contracts. In addition, we exclude from net revenue all sales, use, value-added and certain excise taxes assessed by government authorities on revenue producing transactions. The transfer of control of products to our customers is typically based on written sales terms that generally do not allow for a right of return, except in the instance of a product recall or other limited circumstances that may allow for product returns. Our policy for DSD is to remove and replace damaged and out-of-date products from store shelves to ensure that consumers receive the product quality and freshness they expect. Similarly, our policy for certain warehouse-distributed products is to replace damaged and out-of-date products. As a result, we record reserves, based on estimates, for product recall, anticipated damaged and out-of-date products. Our products are sold for cash or on credit terms. Our credit terms, which are established in accordance with local and industry practices, typically require payment within 30 days of delivery in the United States, and generally within 30 to 90 days internationally, and may allow discounts for early payment. We estimate and reserve for our expected credit loss exposure based on our experience with past due accounts and collectibility, write-off history, the aging of accounts receivable, our analysis of customer data, and forward-looking information (including the expected impact of a high interest rate and inflationary cost environment), leveraging estimates of creditworthiness and projections of default and recovery rates for certain of our customers. We are exposed to concentration of credit risk from our major customers, including Walmart. We have not experienced credit issues with these customers. In 2025, sales to Walmart and its affiliates (including Sam’s) represented approximately 14% of our consolidated net revenue, including concentrate sales to our independent bottlers, which were used in finished goods sold by them to Walmart.
Sales Incentives And Other Marketplace Spending, Policy [Policy Text Block]	Total Marketplace Spending We offer sales incentives and discounts through various programs to customers and consumers. Total marketplace spending includes sales incentives, discounts, advertising and other marketing activities. Sales incentives and discounts are primarily accounted for as a reduction of revenue and include payments to customers for performing activities on our behalf, such as payments for in-store displays, payments to gain distribution of new products, payments for shelf space and discounts to promote lower retail prices. Sales incentives and discounts also include support provided to our independent bottlers through funding of advertising and other marketing activities. A number of our sales incentives, such as bottler funding to independent bottlers and customer volume rebates, are based on annual targets, and accruals are established during the year, as products are delivered, for the expected payout, which may occur after year-end once reconciled and settled. These accruals are based on contract terms and our historical experience with similar programs and require management judgment with respect to estimating customer and consumer participation and performance levels. Differences between estimated expense and actual incentive costs are normally insignificant and are recognized in earnings in the period such differences are determined. In addition, certain advertising and marketing costs are also based on annual targets and recognized during the year as incurred. The terms of most of our incentive arrangements do not exceed one year and, therefore, do not require highly uncertain long-term estimates. Certain arrangements, such as fountain pouring rights, may extend beyond one year. Upfront payments to customers under these arrangements are recognized over the shorter of the economic or contractual life, primarily as a reduction of revenue, and the remaining balances of $329 million as of December 27, 2025 and $237 million as of December 28, 2024 are included in prepaid expenses and other current assets and other assets on our balance sheet. For interim reporting, our policy is to allocate our forecasted full-year sales incentives for most of our programs to each of our interim reporting periods in the same year that benefits from the programs. The allocation methodology is based on our forecasted sales incentives for the full year and the proportion of each interim period’s actual gross revenue or volume, as applicable, to our forecasted annual gross revenue or volume, as applicable. Based on our review of the forecasts at each interim period, any changes in estimates and the related allocation of sales incentives are recognized beginning in the interim period that they are identified. In addition, we apply a similar allocation methodology for interim reporting purposes for certain advertising and other marketing activities. Our annual consolidated financial statements are not impacted by this interim allocation methodology. Advertising and other marketing activities, reported as selling, general and administrative expenses, totaled $5.4 billion in 2025, $5.9 billion in 2024 and $5.7 billion in 2023, including advertising expenses of $3.4 billion in 2025, $3.9 billion in 2024 and $3.8 billion in 2023. Deferred advertising costs are not expensed until the year first used and consist of: •media and personal service prepayments; •promotional materials in inventory; and •production costs of future media advertising. Deferred advertising costs of $48 million and $58 million as of December 27, 2025 and December 28, 2024, respectively, are classified as prepaid expenses and other current assets on our balance sheet.
Selling, General and Administrative Expenses, Policy	Distribution Costs Distribution costs, including the costs of shipping and handling activities, which include certain merchandising activities, are reported as selling, general and administrative expenses. Shipping and handling expenses were $16.7 billion in 2025, $16.0 billion in 2024 and $15.4 billion in 2023.
Internal Use Software, Policy [Policy Text Block]	Software Costs We capitalize certain computer software and software development costs incurred in connection with developing or obtaining computer software for internal use when both the preliminary project stage is completed and it is probable that the software will be used as intended. Capitalized software costs include (1) external direct costs of materials and services utilized in developing or obtaining computer software, (2) compensation and related benefits for employees who are directly associated with the software projects and (3) interest costs incurred while developing internal-use computer software. Capitalized software costs are included in property, plant and equipment on our balance sheet and amortized on a straight-line basis when placed into service over the estimated useful lives of the software, which approximate five to 10 years. Software amortization totaled $260 million in 2025, $199 million in 2024 and $159 million in 2023. Net capitalized software and development costs were $1.8 billion and $1.5 billion as of December 27, 2025 and December 28, 2024, respectively.
Commitments and Contingencies, Policy [Policy Text Block]	Commitments and Contingencies We are subject to various claims and contingencies related to lawsuits, certain taxes and environmental matters, as well as commitments under contractual and other commercial obligations. We recognize liabilities for contingencies and commitments when a loss is probable and estimable.
Research and Development Expense, Policy [Policy Text Block]	Research and Development We engage in a variety of research and development activities and continue to invest to accelerate growth and to drive innovation globally. Consumer research is excluded from research and development costs and included in other marketing costs. Research and development costs were $839 million, $813 million and $804 million in 2025, 2024 and 2023, respectively, and are reported within selling, general and administrative expenses.
Goodwill and Intangible Assets, Policy [Policy Text Block]	Goodwill and Other Intangible Assets Indefinite-lived intangible assets and goodwill are not amortized and, as a result, are assessed for impairment at least annually, using either a qualitative or quantitative approach. We perform this annual assessment during our third quarter, or more frequently if circumstances indicate that the carrying value may not be recoverable. Where we use the qualitative assessment, first we determine if, based on qualitative factors, it is more likely than not that an impairment exists. Factors considered include macroeconomic conditions (including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment), industry and competitive conditions, legal and regulatory environment, historical financial performance and significant changes in the brand or reporting unit. If the qualitative assessment indicates that it is more likely than not that an impairment exists, then a quantitative assessment is performed. In the quantitative assessment for indefinite-lived intangible assets and goodwill, an assessment is performed to determine the fair value of the indefinite-lived intangible asset and the reporting unit, respectively. Estimated fair value is determined using discounted cash flows and requires an analysis of several estimates including future cash flows or income consistent with management’s strategic business plans, annual sales growth rates, perpetuity growth assumptions and the selection of assumptions underlying a discount rate (weighted-average cost of capital) based on market data available at the time. Significant management judgment is necessary to estimate the impact of competitive operating, macroeconomic and other factors (including those related to volatile geopolitical conditions and a high interest rate and inflationary cost environment) to estimate future levels of sales, operating profit or cash flows. All assumptions used in our impairment evaluations for indefinite-lived intangible assets and goodwill, such as forecasted growth rates (including perpetuity growth assumptions) and weighted-average cost of capital, are based on the best available market information and are consistent with our internal forecasts and operating plans. A deterioration in these assumptions could adversely impact our results. Amortizable intangible assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. If an evaluation of the undiscounted future cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on its discounted future cash flows. See Note 4 for further information.
Other Significant Accounting Policies [Policy Text Block]	Other Significant Accounting Policies Our other significant accounting policies are disclosed as follows: •Basis of Presentation – Note 1 includes a description of our policies regarding use of estimates, basis of presentation and consolidation. •Income Taxes – Note 5. •Share-Based Compensation – Note 6. •Pension, Retiree Medical and Savings Plans – Note 7. •Financial Instruments – Note 9. •Leases – Note 12. •Acquisitions and Divestitures – Note 13. •Supply Chain Financing Arrangements – Note 14. •Cash Equivalents – Cash equivalents are highly liquid investments with original maturities of three months or less. •Inventories – Inventories are valued at the lower of cost or net realizable value. Cost is determined using the average; first-in, first-out (FIFO); or, in limited instances, last-in, first-out (LIFO) methods. For inventories valued under the LIFO method, the differences between the LIFO and FIFO methods of valuing inventories are not material. •Property, Plant and Equipment – Note 15. Property, plant and equipment is recorded at historical cost. Depreciation is recognized on a straight-line basis over an asset’s estimated useful life. Construction in progress is not depreciated until ready for service. •Translation of Financial Statements of Foreign Subsidiaries – Generally, financial statements of foreign subsidiaries are translated into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for revenues and expenses. Adjustments resulting from translating net assets are reported as a separate component of accumulated other comprehensive loss within common shareholders’ equity as currency translation adjustment. For foreign subsidiaries operating in highly inflationary economies, the reporting currency of the immediate parent becomes the functional currency. Non-functional currency monetary assets and liabilities are remeasured at period-end exchange rates, with the impact of any changes in exchange rates included in net income. Non-monetary assets and liabilities are carried forward at historical exchange rates starting from when hyperinflationary accounting is implemented.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements Adopted In December 2023, the Financial Accounting Standards Board (FASB) issued guidance to enhance transparency of income tax disclosures. On an annual basis, the new guidance requires a public entity to disclose: (1) specific categories in the rate reconciliation, (2) additional information for reconciling items that are equal to or greater than 5% of the amount computed by multiplying income (or loss) from continuing operations before income tax expense (or benefit) by the applicable statutory income tax rate, (3) income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes, with foreign taxes disaggregated by individual jurisdictions in which income taxes paid is equal to or greater than 5% of total income taxes paid, (4) income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and (5) income tax expense (or benefit) from continuing operations disaggregated between federal (national), state and foreign. We adopted the guidance in our 2025 annual reporting, on a prospective basis. See Note 5 for further information. Not Yet Adopted In September 2025, the FASB issued guidance to improve the accounting for costs related to internal-use software. The new guidance eliminates project stages and requires capitalizing software costs to begin when (1) management has authorized and committed to funding the software project and (2) it is probable that the project will be completed and the software will be used to perform the function intended. When evaluating if a project is probable to be completed, significant development uncertainty must be assessed. Additionally, disclosures for property, plant and equipment will be required for all capitalized software costs. The guidance is effective in the first quarter of 2028 with early adoption permitted as of the beginning of an annual reporting period. Upon adoption, the guidance may be applied prospectively, retrospectively or using a modified transition approach. We are evaluating the impact of this guidance on our consolidated financial statements. In July 2025, the FASB issued guidance to provide for a practical expedient that an entity may assume that conditions as of the balance sheet date remain unchanged over the remaining life of the asset when estimating expected credit losses for current accounts receivable and current contract assets arising from revenue transactions from contracts with customers. The guidance is effective in the first quarter of 2026 with early adoption permitted, to be applied on a prospective basis. We will adopt the guidance when it becomes effective. The guidance is not expected to have a material impact on our consolidated financial statements. In November 2024, the FASB issued guidance to improve the disclosure of expenses in commonly presented expense captions. The new guidance requires a public entity to provide tabular disclosure, on an annual and interim basis, of amounts for the following expense categories: (1) purchases of inventory, (2) employee compensation, (3) depreciation and (4) intangible asset amortization, as included in each relevant expense caption. A relevant expense caption is an expense caption presented on the face of the income statement that contains any of the expense categories noted. Additionally, on an annual and interim basis, a qualitative description is required for amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. The guidance also requires certain amounts that are currently required to be disclosed to be included in the same tabular disclosure as these disaggregation requirements. Furthermore, on an annual and interim basis, a public entity is required to separately disclose selling expenses and annually, disclose a description of the selling expenses. The guidance is effective for 2027 annual reporting, and in the first quarter of 2028 for interim reporting, with early adoption permitted, to be applied on a prospective basis, with retrospective application permitted. We will adopt the guidance when it becomes effective, in our 2027 annual reporting and each quarter thereafter, on a prospective basis.

Supplemental Financial Information

12 Months Ended

Dec. 27, 2025

Supplemental Financial Information [Abstract]

Additional Financial Information Disclosure [Text Block]

Supplemental Financial Information

Balance Sheet


		2025		2024		2023
Accounts and notes receivable
Trade receivables		$	9,265	$	8,487
Other receivables		2,471		2,202
Total		11,736		10,689
Allowance, beginning of year		356		175		$	150
Net amounts charged to expense (a)		61		228		55
Deductions		(55)		(36)		(26)
Translation and other (a)		(132)		(11)		(4)
Allowance, end of year		230		356		$	175
Accounts and notes receivable, net		$	11,506	$	10,333

Property, plant and equipment, net	Average Useful Life (Years)
Land		$	1,110	$	1,136
Buildings and improvements	15 - 44	13,875		11,938
Machinery and equipment, including fleet and software	5 - 15	41,113		36,990
Construction in progress		4,811		5,941
		60,909		56,005
Accumulated depreciation		(31,004)		(27,997)
Property, plant and equipment, net		$	29,905	$	28,008
Depreciation expense		$	3,213	$	2,945	$	2,714

Other assets
Noncurrent notes and accounts receivable		$	136	$	111
Deferred marketplace spending		205		100
Pension plans		1,449		1,190
Right-of-use assets		3,745		3,383
Other investments (b)		2,526		1,346
Other		923		821
Total		$	8,984	$	6,951



Accounts payable and other current liabilities
Accounts payable (c)		$	11,704	$	10,997
Accrued marketplace spending		3,512		3,458
Accrued compensation and benefits		2,230		2,256
Dividends payable		1,967		1,885
Current lease liabilities		719		642
Other current liabilities (d)		5,771		5,216
Total		$	25,903	$	24,454

(b)Includes our investment in Celsius convertible preferred stock. See Note 9 for further information.

(c)Increase primarily reflects timing of payments and currency translation adjustments, partially offset by a decrease in capital expenditure payables.

(d)Increase primarily reflects acquisition of poppi. See Note 13 for further information on acquisitions.

Statement of Cash Flows


	2025		2024		2023
Interest paid	$	1,748	$	1,585	$	1,401
Income taxes paid, net of refunds (a)	$	3,083	$	3,064	$	2,532

(a)Includes tax payments of $772 million in 2025, $579 million in 2024 and $309 million in 2023 related to the TCJ Act.

Supplemental Non-Cash Activity


	2025		2024		2023
Debt discharged via legal defeasance	$	—	$	—	$	94
Investment obtained for certain assets (see Notes 4 and 9)	$	554	$	—	$	—

The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement:


	2025		2024
Cash and cash equivalents	$	9,159	$	8,505

Restricted cash included in other assets (a)	45		48
Total cash and cash equivalents and restricted cash	$	9,204	$	8,553

(a)Primarily relates to collateral posted against certain of our derivative positions.

Pension, Retiree Medical and Savings Plans (Components of Benefit Expense) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Domestic Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 312	$ 347	$ 327
Interest cost	586	585	593
Expected return on plan assets	(805)	(871)	(851)
Amortization of prior service costs/(credits)	3	(24)	(26)
Amortization of net losses/(gains)	84	77	70
Net settlement/curtailment losses (a)	247	254	4
Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits	21	31	(1)
Defined Benefit Plan, Other Cost (Credit)	(136)	(52)	211
Total	$ 448	399	116
Pre-tax non-cash settlement charge, net of tax, per share	$ 0.13
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax	$ 183
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax	237
International
Defined Benefit Plan Disclosure [Line Items]
Service cost	47	46	43
Interest cost	152	144	141
Expected return on plan assets	(202)	(205)	(192)
Amortization of prior service costs/(credits)	(1)	(2)	(1)
Amortization of net losses/(gains)	27	21	13
Net settlement/curtailment losses (a)	32	22	10
Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits	0	0
Special termination benefits	0	0	0
Defined Benefit Plan, Other Cost (Credit)	(8)	20	29
Total	55	26	14
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	31	31	29
Interest cost	30	32	36
Expected return on plan assets	(11)	(13)	(13)
Amortization of prior service costs/(credits)	(5)	(5)	(6)
Amortization of net losses/(gains)	(25)	(25)	(27)
Net settlement/curtailment losses (a)	0	0	0
Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits	0	(1)
Special termination benefits	0	1	0
Defined Benefit Plan, Other Cost (Credit)	11	10	10
Total	$ 20	$ 21	$ 19
Domestic-Plan I [Member]
Defined Benefit Plan Disclosure [Line Items]
Pre-tax non-cash settlement charge, net of tax, per share	$ 0.13	$ 0.12
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax	$ 183	$ 165
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax	$ 237	$ 213

Supply Chain Financing (Details) - USD ($) $ in Millions	12 Months Ended
Supply Chain Financing (Details) - USD ($) $ in Millions	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Supplier Finance Program [Line Items]
Supplier Finance Program, Obligation, Current	$ 1,681	$ 1,478	$ 1,655
Supplier Finance Program, Obligation, Addition	6,668	6,552
Supplier Finance Program, Obligation, Settlement	6,547	6,636
Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)	$ 82	$ (93)
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]	Accounts payable and other current liabilities	Accounts payable and other current liabilities	Accounts payable and other current liabilities

Basis of Presentation and Our Segments (Segment Reporting Information by Capital Spending and Amortization of Intangible Assets, Depreciation and Other Amortization) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Segment Reporting Information [Line Items]
Capital Spending	$ 4,415	$ 5,318	$ 5,518
Depreciation and Other Amortization	3,451	3,160	2,948
Operating Segments [Member]
Segment Reporting Information [Line Items]
Capital Spending	4,192	4,996	5,234
Depreciation and Other Amortization	3,290	3,032	2,850
Operating Segments [Member] \| PepsiCo Foods North America [Member]
Segment Reporting Information [Line Items]
Capital Spending	1,051	1,306	1,444
Depreciation and Other Amortization	969	862	798
Operating Segments [Member] \| International Beverage Franchise [Member]
Segment Reporting Information [Line Items]
Capital Spending	124	148	110
Depreciation and Other Amortization	109	109	99
Operating Segments [Member] \| PepsiCo Beverages North America [Member]
Segment Reporting Information [Line Items]
Capital Spending	1,344	1,541	1,723
Depreciation and Other Amortization	1,093	1,069	1,025
Operating Segments [Member] \| Asia Pacific Foods (Segment) [Member]
Segment Reporting Information [Line Items]
Capital Spending	257	312	312
Depreciation and Other Amortization	153	133	118
Operating Segments [Member] \| Latin America Foods (Segment) [Member]
Segment Reporting Information [Line Items]
Capital Spending	672	809	814
Depreciation and Other Amortization	417	382	362
Operating Segments [Member] \| Europe, Middle East & Africa (Segment) [Member]
Segment Reporting Information [Line Items]
Capital Spending	744	880	831
Depreciation and Other Amortization	549	477	448
Corporate
Segment Reporting Information [Line Items]
Capital Spending	223	322	284
Depreciation and Other Amortization	$ 161	$ 128	$ 98

Pension, Retiree Medical and Savings Plans (Selected Financial Information for Pension and Retiree Medical Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Pension Plans, Defined Benefit
Change in fair value of plan assets
Employer contributions/funding	$ 421	$ 295	$ 364
Retiree Medical Plan
Change in projected benefit obligation
Obligation at beginning of year	616	677
Service cost	31	31	29
Interest cost	30	32	36
Plan amendments	0	0
Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant	0	0
Experience loss/(gain)	18	(44)
Settlement/curtailment	0	0
Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits	0	(1)
Other, including foreign currency adjustment	2	(3)
Obligation at end of year	623	616	677
Defined Benefit Plan, Benefit Obligation, Benefits Paid	(74)	(78)
Change in fair value of plan assets
Fair value at beginning of year	163	183
Actual return on plan assets	15	5
Employer contributions/funding	51	53	46
Participant contributions	0	0
Defined Benefit Plan, Plan Assets, Benefits Paid	(74)	(78)
Defined Benefit Plan, Plan Assets, Payment for Settlement	0	0
Other, including foreign currency adjustment	0	0
Fair value at end of year	155	163	183
Funded status	(468)	(453)
Amounts recognized
Other assets	0	0
Other current liabilities	(55)	(52)
Other liabilities	(413)	(401)
Net amount recognized	(468)	(453)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	(295)	(333)
Prior service cost/(credit)	(9)	(14)
Total	(304)	(347)
Changes recognized in net loss/(gain) included in other comprehensive loss
Net (gain)/loss arising in current year	14	(36)
Amortization and settlement recognition	25	25
Foreign currency translation loss/(gain)	(1)	1
Total	38	(10)
Domestic Plan
Change in projected benefit obligation
Obligation at beginning of year	11,324	12,035
Service cost	312	347	327
Interest cost	586	585	593
Plan amendments	10	12
Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant	0	0
Experience loss/(gain)	247	(563)
Settlement/curtailment	(678)	(506)
Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits	21	31	(1)
Other, including foreign currency adjustment	0	0
Obligation at end of year	11,182	11,324	12,035
Defined Benefit Plan, Benefit Obligation, Benefits Paid	(640)	(617)
Change in fair value of plan assets
Fair value at beginning of year	10,609	11,541
Actual return on plan assets	1,296	(10)
Employer contributions/funding	354	236
Participant contributions	0	0
Defined Benefit Plan, Plan Assets, Benefits Paid	(640)	(617)
Defined Benefit Plan, Plan Assets, Payment for Settlement	(670)	(539)
Other, including foreign currency adjustment	0	(2)
Fair value at end of year	10,949	10,609	11,541
Funded status	(233)	(715)
Amounts recognized
Other assets	413	388
Other current liabilities	(61)	(85)
Other liabilities	(585)	(1,018)
Net amount recognized	(233)	(715)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	3,035	3,618
Prior service cost/(credit)	61	54
Total	3,096	3,672
Changes recognized in net loss/(gain) included in other comprehensive loss
Net (gain)/loss arising in current year	(252)	320
Amortization and settlement recognition	(331)	(298)
Foreign currency translation loss/(gain)	0	0
Total	(583)	22
Accumulated benefit obligation at end of year	11,093	11,069
Foreign Plan [Member]
Change in projected benefit obligation
Obligation at beginning of year	2,786	2,986
Service cost	47	46	43
Interest cost	152	144	141
Plan amendments	1	1
Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant	2	2
Experience loss/(gain)	(74)	(55)
Settlement/curtailment	(109)	(62)
Defined Benefit Plan, Benefit Obligation, Special and Contractual Termination Benefits	0	0
Other, including foreign currency adjustment	234	(168)
Obligation at end of year	2,927	2,786	2,986
Defined Benefit Plan, Benefit Obligation, Benefits Paid	(112)	(108)
Change in fair value of plan assets
Fair value at beginning of year	3,397	3,528
Actual return on plan assets	149	142
Employer contributions/funding	67	59
Participant contributions	2	2
Defined Benefit Plan, Plan Assets, Benefits Paid	(112)	(108)
Defined Benefit Plan, Plan Assets, Payment for Settlement	(109)	(62)
Other, including foreign currency adjustment	258	(164)
Fair value at end of year	3,652	3,397	$ 3,528
Funded status	725	611
Amounts recognized
Other assets	983	792
Other current liabilities	(14)	(10)
Other liabilities	(244)	(171)
Net amount recognized	725	611
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	612	633
Prior service cost/(credit)	(3)	(5)
Total	609	628
Changes recognized in net loss/(gain) included in other comprehensive loss
Net (gain)/loss arising in current year	(21)	8
Amortization and settlement recognition	(59)	(43)
Foreign currency translation loss/(gain)	59	(39)
Total	(21)	(74)
Accumulated benefit obligation at end of year	$ 2,740	$ 2,638

Financial Instruments - Losses (Gains) on Derivative Instruments - Net Investment Hedges (Details) - Net Investment Hedging [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024
Derivative Instruments, Loss (Gain) [Line Items]
Other Comprehensive (Income) Loss, Net Investment Hedge, (Gain) Loss, before Tax	$ 357	$ (130)
Loss (Gain) on Net Investment Hedge Recognized in Net Income, Net, Pretax	(13)	(5)
Cross Currency Interest Rate Contract [Member]
Derivative Instruments, Loss (Gain) [Line Items]
Other Comprehensive (Income) Loss, Net Investment Hedge, (Gain) Loss, before Tax	33	3
Loss (Gain) on Net Investment Hedge Recognized in Net Income, Net, Pretax	(13)	(5)
Foreign Exchange Contract
Derivative Instruments, Loss (Gain) [Line Items]
Other Comprehensive (Income) Loss, Net Investment Hedge, (Gain) Loss, before Tax	(13)	0
Loss (Gain) on Net Investment Hedge Recognized in Net Income, Net, Pretax	0	0
Debt Securities
Derivative Instruments, Loss (Gain) [Line Items]
Other Comprehensive (Income) Loss, Net Investment Hedge, (Gain) Loss, before Tax	337	(133)
Loss (Gain) on Net Investment Hedge Recognized in Net Income, Net, Pretax	$ 0	$ 0

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Financial Instruments - Celsius and Other AFS (Detail) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Celsius and Other AFS [Line Items]
Impairment Losses, Investments, Available-for-Sale Securities1	$ 0	$ 0	$ 0
Significant unobservable input used in level 3 fair value measurement - Other AFS, discount rate assumption		8.30%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax	860	$ 334
Total, AFS debt securities
Celsius and Other AFS [Line Items]
Debt Securities, Available-for-sale	2,127	1,041
Celsius, AFS debt security
Celsius and Other AFS [Line Items]
Payments to Acquire Debt Securities, Available-for-Sale	$ 585			$ 550
Preferred Stock, Redemption Terms	seven
Preferred Stock, Convertible, Conversion Price	$ 51.75		$ 25	$ 75
Preferred Stock, Dividend Rate, Percentage	5.00%			5.00%
Preferred Stock, Convertible, Terms	six
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)	$ (30)	$ (21)
Significant unobservable input used in level 3 fair value measurement - Celsius	8.50%	7.30%
Significant unobservable input used in level 3 fair value measurement - Celsius, probability assumption	80.00%	80.00%
Fair Value, Recurring Basis, Unobservable Input Reconciliation, Asset (Liability), Gain (Loss), OCI	$ 507	$ (350)
Debt Securities, Available-for-sale	1,852	785	$ 1,156
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases	590	0
Other, AFS debt securities
Celsius and Other AFS [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3	0	184
Fair Value, Recurring Basis, Unobservable Input Reconciliation, Asset (Liability), Gain (Loss), OCI	$ 19	72
Significant unobservable input used in level 3 fair value measurement - Other AFS, discount rate assumption	8.30%
Debt Securities, Available-for-sale	$ 275	$ 256	$ 0

Basis of Presentation and Our Segments (Segment Reporting Information by % of Disaggregated Net Revenue) (Details)	12 Months Ended
	Dec. 27, 2025	Dec. 28, 2024	Dec. 30, 2023
Disaggregation of Revenue [Line Items]
Disaggregation of Net Revenue - Beverages	42.00%	42.00%	41.00%
Disaggregation of Net Revenue - Convenient Foods	58.00%	58.00%	59.00%
Disaggregation of beverage revenue from company-owned bottlers	36.00%	35.00%	35.00%
EMEA
Disaggregation of Revenue [Line Items]
Disaggregation of Net Revenue - Beverages	37.00%	35.00%	35.00%
Disaggregation of Net Revenue - Convenient Foods	63.00%	65.00%	65.00%
International (Outside of North America)
Disaggregation of Revenue [Line Items]
Disaggregation of Net Revenue - Beverages	31.00%	29.00%	29.00%
Disaggregation of Net Revenue - Convenient Foods	69.00%	71.00%	71.00%
North America
Disaggregation of Revenue [Line Items]
Disaggregation of Net Revenue - Beverages	51.00%	50.00%	50.00%
Disaggregation of Net Revenue - Convenient Foods	49.00%	50.00%	50.00%

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-7

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 91
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479777/606-10-55-91

+ Details

Income Taxes (Policies)	12 Months Ended
Income Taxes (Policies)	Dec. 27, 2025
Income Tax Disclosure [Abstract]
Income Tax, Policy	Our annual tax rate is based on our income, statutory tax rates and tax planning strategies and transactions, including transfer pricing arrangements, available to us in the various jurisdictions in which we operate. Significant judgment is required in determining our annual tax rate and in evaluating our tax positions. We establish reserves when, despite our belief that our tax return positions are fully supportable, we believe that certain positions are subject to challenge and that we likely will not succeed. We adjust these reserves, as well as the related interest, in light of changing facts and circumstances, such as the progress of a tax audit, new tax laws, relevant court cases or tax authority settlements. Settlement of any particular issue would usually require the use of cash. Favorable resolution would be recognized as a reduction to our annual tax rate in the year of resolution.

- Definition

Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.

+ References + Details

Share-Based Compensation Share Based Compensation (PEP unit + BOD activity paragraphs) (Details) - shares	Dec. 27, 2025	Dec. 28, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Phantom Units Granted Under Director Deferral Program, Shares Outstanding	341,000	311,000

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(v)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 1D
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 35
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480483/718-10-35-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(01)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details